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Abstract
The development and approval of new drugs is an expensive process. The total
cost for the approval of a new compound is on average 1.0 - 1.2 billion dollars and
the entire process lasts about 12 - 15 years (1). The main difficulties are related to
poor pharmacokinetics, lack of efficacy and unwanted side effects. These problems
have naturally led to the question if new and alternative methodologies can be
developed to find reliable and low cost alternatives to existing practices.
Nowadays, computer-assisted tools are used to support the decision process
along the early stages of the drug discovery path leading from the identifica-
tion of a suitable biomolecular target to the design/optimization of drug-like
molecules. This process includes assessments about target druggability, screening
of molecular libraries and the optimization of lead compounds where new drug-like
molecules able to bind with sufficiently affinity and specificity to a disease-involved
protein are designed. Existing computational methods used by the pharmaceu-
tical industry are usually focused on the screening of library compounds such as
docking, chemoinformatics and other ligand-based methods to predict and im-
prove binding affinities, but their reliable application requires improvements in
accuracy.
New quantitative methods based on molecular simulations of drug binding
to a protein could greatly improve prospects for the reliable in-silico design of
new potent drug candidates. A common parameter used by medicinal chemists to
quantify the affinity between candidate ligands and a target protein is represented
by the free energy of binding. However, despite the increased amount of structural
information, predicting binding free energy is still a challenge and this technique
has found limited use beyond academia. A major reason for limited adoption in
the industry is that reliable computer models of drug binding to a protein must
reproduce the change in molecular conformations of the drug and protein upon
complex formation and this includes the correct modelling of weak non-covalent
interactions such as hydrogen bonds, burials of hydrophobic surface areas, Van der
Waals interactions, fixations of molecular degrees of freedom solvation/desolvation
of polar groups and different entropy contributions related to the solvent and
protein interactions. For several classes of proteins these phenomena are not easy
to model and often require extremely computationally intensive simulations.
The main goal of the thesis was to explore efficient ways of computing binding
affinities by using molecular simulations. With this aim, novel software to compute
relative binding free energies has been developed. The implementation is based on
alchemical transformations and it extended a preexisted piece of software Sire, a
molecular modeling framework, by using the OpenMM APIs to run fast molecular
dynamics simulations on the latest GPGPU technology. This new piece of software
has equipped the scientific community with a flexible and fast tool, not only
to predict relative binding affinities, but also a starting point to develop new
sampling methods for instance hybrid molecular dynamics and Monte Carlo. The
implementation has been validated on the prediction of relative hydration free
energy of small molecules, showing good agreement with experimental data. In
addition, non-additive effects to binding affinities in series of congeneric Thrombin
inhibitors were investigated. Although excellent agreement between predicted
and experimental relative binding affinities was achieved, it was not possible to
accurately predict the non-additivity levels in most of the examined inhibitors,
thus suggesting that improved force fields are required to further advance the
state-of-the art of the field.
“When I was a child I wanted to heal the cherry trees everytime I
thought that red fruits were wounded. I was sure that health had
abondoned them along with the snow white flowers they had lost. A
dream, it was a dream which didn’t last for long, so I swore I would
have been a doctor and not for a god nor even as a game but for the
cherry trees to bloom again, for the cherry trees to bloom again”
— Fabrizio De André. Un Medico
1
Introduction
1.1 An Introduction to the modern Galilean scientific method
S
ince human being have been able to reason they have tried to answer
questions about nature and the world they live in. In the beginning
ideas and questions were formulated in mythological, religious or philo-
sophical contexts. One common feature was their generality typically trying to
explain “whatever is” by presenting absolute truths to ancient and definitive ques-
tions such as “What life is”, “Why are we living”. However, a few centuries later
the human curiosity took a different path, human being became interested in more
“defined” natural phenomena; general questions were avoided and replaced by well
defined investigations. This revolution happened in the Hellenic world (507 BC
- 323 BC) where Science started its first steps as a set of logical propositions on
natural phenomena (Plato’s and Aristotle’s Academy 428/427 BC - 348/347 BC).
This new philosophy aimed to unveil the essential form of the natural world by
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conducting a mere and qualitative observation in many cases. The Hellenic ideas
were rediscovered during the medieval age when many scientists set the foundation
of the scientific method. Galileo Galilei (1564-1642) played a major role in this
endeavour. Actually, Galileo never wrote an essay on the scientific method and
he never clarified the relationship between what he called “le sensate esperienze”
(the experiment) and “le matematiche dimostrazioni” (the mathematical proofs)
but his procedures and methods were introduced in several of Galileo’s papers
and today they form the core of the scientific method. The different stages of
the method can be divided into three main processes: the observation, the theory
formalization, and the experimental validation.
• The observation is related to the data collection on a specific natural phe-
nomenon. Data is collected on “measurable quantities” i.e. quantities that
can be linked to numbers using a measurement process. This was the great
innovation compared to the Hellenic Science; the qualitative observations
were replaced by quantitative measurements.
• The theory formalization links the measurable quantities by using a mathe-
matical description. The theory should not just be based on the data related
to a specific experiment but it should be “deductive” i.e. the theory should
be able to predict and explain future observations. However, the theory
does not present final answers or absolute truths, and in case of failures,
it is replaced by a broader theory which encompasses the previous like a
special case without marking an end to this refinement process.
• The experimental validation is the last step of the method. In this stage an
experiment is performed under laboratory conditions many times to check
if there is agreement between the data predicted by the theory and the
experimental observations.
These stages can be represented by using the diagram in Figure 1.1.
In the scientific method the mathematical description which models the ob-
served natural phenomenon is extremely important. Since its introduction, this





Figure 1.1: The main stages of the scientific method.
approach to the rationalisation of the natural world has achieved remarkable suc-
cesses in many scientific disciplines, but nowadays, the real applicability of the
mathematical model to relevant systems is placing significant limits to the theory
predictions. In the real world, exact solutions are indeed a notable exception.
The major issue is the difficulty to find solutions in a closed form of many prob-
lems, which often involve the resolution of partial differential equations e.g. the
Maxwell equations, the Schrödinger equation and the N body-problem to cite only
few. One of the most famous quotes from Dirac is (2):
“The underlying physical laws necessary for the mathematical theory
of a large part of physics and the whole of chemistry are thus com-
pletely known, and the difficulty is only that the exact application of
these laws leads to equations much too complicated to be soluble”
In order to partially overcome the problem, exact solutions have been replaced
by approximations often derived by using numerical methods. In this framework
the Turing and von Neumann’s ideas on computability (3;4) have found natural
growth to the present day, i.e. the application of algorithms to numerically re-
solve the mathematical model of a theory applied to systems by using computa-
tional machines. In other words, in this sense, it is possible to modify the idea
itself of scientific method to introdce the concept of simulation, which numeri-
cally approximates the theory predictions (Figure 1.2). Currently the main role
for simulation is to compare the experimental data with the predicted one; if the
level of agreement is not satisfactory the model is judged poor and it needs to be
revised. This is a new form of modern experiment where different theories can be






Figure 1.2: The main stages of the modern scientific method.
tested before being subjected to a real experiment.
Nowadays, computer simulations are an important tool to complement the
traditional approaches to theory and experiment (5). Nonetheless, simulations can
be more that a simple tool: simulations can produce revelations, lead to the un-
expected (5), which is extremely important in many contexts to open new research
paths. At the beginning of 1970s (5) a heated debate was whether computer sim-
ulations have to be considered theories or experiments. The theory side argued
that they cannot be considered experiments because no measurement process is
involved. On the other side, the experimental position countered that simulation
results are used like experiments to check theory validities. In addition, simula-
tion results are prone to problem of reproducibility and statistical errors (5). How
we think about simulations is important. If we accept that simulations are exper-
iments we may be temped to abandon laboratory experiments. The danger lies
in severing simulations from reality; it is easy to simulate abstract models whose
results have an intrinsic meaning only.
Since their introduction, simulations have permeated many scientific contexts
such as Physics, Chemistry and Engineering and more recently Biology. Histori-
cally, Metropolis et al. performed the first liquid simulations using the Metropolis
Monte Carlo (MMC) method on the Maniac I machine at Los Alamos Labora-
tory (6). Nearly at the same time Fermi et al. (7) were able to perform simulations
on the anharmonic dynamics of a one-dimensional crystal. Alder performed the
first MD simulation on hard sphere dynamics in 1956 (8).
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The main theme of this thesis is the application of the newest molecular sim-
ulation methodologies to biological systems and in particular the study of free-
energy in the protein-ligand binding context. Justifications of the importance of
this topic in Drug Discovery are detailed in the following paragraphs.
1.2 Drug Discovery
The drug discovery and development process aims to produce new pharmaceutical
drugs to cure illnesses in an effective way. This process is interdisciplinary and,
often, involves knowledge from different scientific fields such as Chemistry, Biol-
ogy, Physics and Computer Science. Due to its importance to human life, many
efforts have been made to improve its efficacy and reliability. The idea of drug
discovery has its roots in chemotherapy or therapia sterilisans magna originating
from the beginning of 1900s. The possibility of building “magic bullets”, i.e. ar-
tificial compounds that were able to kill microorganisms without damaging the
host organism, was advanced by P. Ehrlich when he was able to synthesize a com-
pound to cure syphilis (9). Drug discovery has changed over the last century and,
nowadays, the development of new drugs is often performed following a protocol
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Figure 1.3: The Critical path of Drug Discovery. A potential drug compound
is selected/designed after preliminary biological research on a biomolecule that
causes a disease. The drug candidate must complete a series of tests regarding
its potential and safety. On average 5000 - 10000 compounds are submitted and
evaluated for each candidate that finishes the pathway(1). The main failures are
in the clinical tests and, on average the approval time is between 12-15 years. A
key point along the path is the design of new ligands highlighted in orange.
In the critical path two main different stages can be distinguished: basic re-
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search and clinical development/approval. In the basic research stage a biomolec-
ular target is identified; this is often a biological molecule thought to be involved
in a specific disease. Potential new drug-like molecules which are able to modulate
the biological function of the target are then designed and synthetised. Subse-
quently tests are performed in vitro and in vivo in the Preclinical Development
stage to assess efficacy, pharmacology and toxicity. These studies are usually
based on models that are thought to be predictive of the Clinical Development
stage where, new candidate compounds are assessed in different phases on human
beings and, finally are approved for the market. The whole drug discovery path
lasts about 12 - 15 years and the total cost is on average 1.0 - 1.2 billion dol-
lars (10). It is interesting to observe the percentages of failures along the critical
path. Sams et al. (11) analysed the limitations of the target-based drug discovery
approach showing the dramatic falling of new drug approval. The main factors
for these failures are related to poor pharmacokinetics, lack of efficacy, animal
toxicity, side effects on human beings and market issues (Figure 1.3). This has
naturally led to the question as to whether this approach is efficacious and more
importantly if new and alternative optimisation methods can be developed.
Along the critical path, the design/discovery of new drug-like molecules that
are able to bind macromolecule targets activating or inhibiting specific biological
functions is an important point and it is highlighted in Figure 1.3. In this stage,
the quick and correct design of potent and selective ligands could drastically
reduce failures and cut down costs and time and, for this reason, it is the main
research area of this study.
The design of new-drug like molecules can be performed using different ap-
proaches. In the High Throughput Screening (HTS) a large number of biological
modulators and effectors are screened and assayed against selected and specific
targets by using different types of libraries including combinatorial chemistry, ge-
nomics, protein, and peptide (12). The main goal is to accelerate drug discovery
by screening large compound libraries at a rate that may exceed a few thousand
compounds per day or per week and for this reason is frequently used by the phar-
maceutical industry (12). Other popular approaches are the Ligand-Based and the
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Structure-Based. In the first case (indirect drug design) a model of the biological
target is inferred based on the knowledge of binders to the specific target and this
model is used to design new ligands. On the other hand, in the second approach
ligands are designed using structural information of the target, usually known
from crystallographic or NMR data and, this methodology has also been used in
this investigation. In Structure-Based Drug design, promising selected hits un-
dergo more extensive optimisation steps known as the lead-optimisation stage. In
it an important aspect is to quantify the affinity between candidate ligands and
a target protein by determination of dissociation constant Kd. This constant is
linked to the change of the Gibbs free energy through the equation:
∆G = RT ln Kd
c0
, (1.1)
where R is the ideal constant gas, T the temperature and c0 the standard state
concentration. In equation 1.1 the free energy change is evaluated between the
thermodynamic state where the biomolecular target P and the drug-like molecule
L are in a solvent environment, and the state where the biomolecule and the
drug-like molecule form the solvated complex PL. It is possible to represent this
dynamic equilibrium using the process:
P + L
 PL (1.2)
The optimization of protein-ligand interactions relies most of the time on struc-
tural modifications of previously identified promising ligands. In this stage, known
as Structural Activity Relationship (SAR), the binding affinity is often optimised
by trying to improve its components i.e. enthalpy ∆H and entropy ∆S:
∆G = ∆H − T∆S . (1.3)
Many different factors influence enthalpy and entropy. Enthalpy contributions
are related to inter- and intra- molecular interactions such as electrostatic or
ionic bonds, hydrogen bonds, Van Der Waals (VdW) interactions, dipole-dipole
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interactions and hydrophobic interactions (13). Entropy components are connected
with the fixations of molecular degrees of freedom and solvation/desolvation of
polar groups (13). The optimisation of all these components is not an easy task.
For example VdW forces are optimised by the shape complementarity between
the biomolecular target and the drug-like molecule (13), while hydrogen bonds are
optimised when hydrogen bond donors and acceptors have optimal geometries
in the complex. Entropy changes are related to the reduction of translational,
rotational and internal degrees of freedom of ligand and protein in complexation
and the release of water molecules from the binding site. Freire et al. (13) have
shown how the pharmaceutical industry developed inhibitors of HIV protease from




















Indinavir Saquinavir Nelfinavir Ritonavir Amprenavir Lopinavir Atazanavir Tipranavir Darunavir
Figure 1.4: The thermodynamic signature of all HIV-1 protease inhibitors devel-
oped and approved by FDA from 1996 to 2006. Although the free energy of binding
did not change considerably, the newest inhibitors, which have a better efficacy,
are often optimised in entropy, enthalpy or both components. Figure adapted from
Freire et al.(13).
earlier HIV-PR drugs was dominated by entropy, whereas the binding affinity of
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the later and, also, more effective had a stronger enthalpic component.
The previous analysis has shown the importance of the entropic and enthalpy
components in the design of new drugs. However, a deep understanding of these
contributions cannot be achieved without considering the protein-ligand dynam-
ics. Indeed, it is notorious that in some cases ligand binding can produce sig-
nificant conformational changes to the ternary or quaternary structure of a pro-
tein (14), therefore a full understanding of the binding process cannot be achieved
without accounting for the dynamic aspect. As a consequence, it is not only im-
portant to consider the average structure of a molecule in drug design but also
consider where dynamic fluctuations take place, their nature and their scale. This
is a quite modern view of the topic, probably related to the dominant X-ray
crystallographic methods used in the past to provide structural information on
bimolecular systems. Indeed, in these methods a static image of a biomolecule
is generated with atoms fixed in space. However, this view was abandoned dur-
ing the “decade of rigid macromolecules” (14) (1965-1975), in favour of a dynamic
picture of the bio-molecular systems. A fundamental insight in the problem has
been achieved by atomistic simulations where proteins and molecules are repre-
sented by a set of interacting particles according to a specified force field. This
description often requires many assumptions and limitations due to complexity
of the biological systems, indeed their introduction is necessary for a practical
use of the model. Despite these drawbacks and limitations, atomistic simula-
tions have been increasingly and successfully used on biological systems in the
last thirty years and are expected to become even more prevalent in the future,
with the improvements in numerical methods and, at the same time, the in-
crease in computational power. As a consequence, it is important to quantify the
level of precision required for any computational method to significantly affect
the lead-optimisation efforts of the pharmaceutical industry in a typical workflow
in structured based drug design (15). Usually in the workflow, a computational
chemist selects promising ligands for synthesis from a proposed list of hits that
lack sufficient affinity. For example a medicinal chemist team might propose 100
ligands and the computational chemist might need to select 10 for synthesis (15).
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It has been showed (16) that even a very modest level of computational accuracy
can significantly affect the lead-optimisation stage as illustrated in Figure 1.5. In
it, the free energies of binding of more than 84.000 compounds against 30 protein
targets were examined (17). It turns out that the distribution of affinities changes
in actual compounds proposed by medicinal chemists is very close to a Gaussian
distribution centred at zero. If the computational method used to screen the
compounds for the synthesis yields correct affinity prediction with a given level
of Gaussian random noise then, it is possible to question what level of noise it is
possible to tolerate (15). Screening a fixed number of compounds with this com-
putational methods will find more potent compounds as the computational noise
decreases and, therefore, it would be possible to reduce the number of molecules
that need to be effectively synthesised. Assuming that it is possible to screen 10
molecules per week how many molecules must be screened to gain a factor of 10 in
affinity after filtering by using the computational method? It turn out that with a
0.5 kcal/mol of noise level the number of screened is reduced by a factor of 8; with
1.0 kcal/mol of noise a factor of 5 and even with 2.0 kcal/mol of noise a factor of
3 (15). Therefore, a computational method that could screen 10-100 molecules per
week with even 2.0 kcal/mol of noise would improve the lead-optimisation stage
by reducing the synthesis needed in a lead series of a factor of 3 (15). So even
relatively small numbers of moderately accurate computational predictions may
be able to give significant advantage to the pharmaceutical workflow. However,
computational prediction to be useful has to be quick. In order to address this
aspect, many computational methods based on algorithmic-hardware solutions
have been developed such as parallel computing techniques used in this thesis. In
addition, the prediction of the binding affinity is in reality just one consideration
in lead optimisation. Improvements must be balanced against other main factors
such as solubility, permeability, bio-availability (15) to cite only few, which are
important physicochemical parameters highly relevant for drug-like performance.
Furthermore, drug-like molecules need to be safe and other parameters relevant
to toxicology need to be addressed.
The impact of computational methods in drug development and in particular
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Figure 1.5: The probability of synthesis of a compound as a function of the bind-
ing free energy change for different levels of computational errors. Filled regions
indicate those compounds with at least a factor of 10 gain in binding affinity, and
are labeled (1x, 3x, 5x, 8x) with the reduction in the number of compounds which
would need to be synthesised (on average) to gain this factor of 10 in affinity(15).
Blue represents the approximated Gaussian distribution observed experimentally
analysing more than 84.000 small compounds against 30 protein targets at Abbot
Laboratories(17). Orange, green and red are the distributions generated by filtering
the compounds with a hypothetical computational method, which respectively gives
correct free energy values with 2.0,1.0, and 0.5 kcal/mol of error noise(15). Even
with moderate errors a computational filtering method could drastically improve
the efficiency of synthesis in the lead-optimisation stage. Picture adapted from
Mobley et al.(15)
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in drug discovery and design has been significant in the last 25 years. Meaningful
contributions have been made in lead generation, lead optimisation, prediction of
drug likeness, de novo design, ligand docking, binding affinity prediction and mod-
ulation of ADME (Absorption, Distribution, Metabolism, Excretion) properties
and toxicity (18). Many examples can be found in literature where computational
methods played a significant role in drug development. For instance, the ligand-
based approach was used to modelling the pharmacophore of benzodiazepine re-
ceptor ligands and to design nicotinic agonist using shape matching algorithm (19).
Quantum Mechanics calculations revealed an angiotensin-converting enzyme in-
hibitor QSAR (19). Schames et al. (20) by using MD simulations on HIV integrase
revealed an unidentified trench that was not evident from available X-ray crystal-
lography and later on was demonstrated that known inhibitors do in fact bind in
this cryptic trench (21). These are just few examples of effective use of computa-
tional methods in drug discovery. This thesis has explored relatively new methods
in molecular simulations to calculate binding affinities by merging different the-
oretical methods with the latest hardware technologies and providing new freely
available tools to the scientific community. In order to fully understand the ap-
proach and the details, the next paragraphs will build up the necessary Statistical
Mechanics tools and the computational methods used.
1.3 A brief introduction to Statistical Mechanics
The properties of a macroscopic system which exchanges heat and work with its
surrounding are described by the discipline of Classical Thermodynamics. Histor-
ically, the development of this science was quite troubled and its general principles
were empirically discovered most of the time. A complete and satisfactory theory
was only achieved in the 18th century when “heat” was shown to be a form of
energy. With the development of modern atomistic theories, a connection was
sought between microscopic states of matter and thermodynamic properties. The
early attempts tried to apply the classical mechanic method to the atomic de-
scription however, this strategy paused difficult problems to overcome. First of
all, the relatively high number of degree of freedoms involved in the system de-
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scription and the non-linear system interactions between particles. Secondly, the
mere use of a classical and “deterministic” description of the atomic dynamics can-
not explain many natural facts driven by the second thermodynamic principle. E.
Majorana (22) wrote in a broader context:
“Determinism, which does not leave any rule to human freedom and
forces one to consider all the phenomena of life as illusory, implicates
a real cause of weakness”
The reconciliation between micro and macro description has eventually been
achieved with the description of Statistical Mechanics. A significant understand-
ing was that macroscopic properties could not be strongly dependent on the deter-
ministic dynamic of each single system particle but, rather, on averages through
the statistical mechanic notion of “ensemble”. The modern view presents a given
thermodynamic system characterised as a set of points in the phase space. Each
point is known as a microstate and it is modelled with the multidimensional vari-
ables:
q = (q1, · · · , qn) ,
p = (p1, · · · , pn) ,
(1.4)
where qi is the generic generalised coordinate, pi the related momentum and n the
degree of freedom of the considered system. In the phase space, different starting
conditions will generate different trajectories. However, many different trajectories
in phase space will have the same macroscopic properties. A set of phase space
points that share the same macroscopic properties is called an ensemble. If the
thermodynamic system visits all its configurations in an infinity amount of time
i.e. the system is ergodic then, the physical-chemical thermodynamic observable
A can be computed as time averaged in the phase space trajectory as follows:







where the symbol <> denotes the average of the interested property A and T is
the time interval. Usually, dynamic systems are a powerful approach to gener-
ate an ensemble and its associated average and they form the basis of the MD
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method which is one of the most popular methods to tackle statistical mechanics
problems (23). In the hypothesis of an ergodic system, Gibss (24) suggested that




A(q,p)ρ(q,p, t)dqdp , (1.6)
where ρ(q,p, t) is the ensemble probability density function and, its determina-
tion is a key problem in statistical mechanics. Relevant observables are always
in thermodynamic equilibrium i.e. variables that do not change in time. As a
consequence, the equation 1.6 must lead to a time independent result and this
is possible only if ∂ρ/∂t = 0 which will be assumed from now on. In order to
completely define a thermodynamic system in equilibrium it is necessary to spec-
ify a set of three intensive or extensive properties. Interesting conditions are the
NVT (Canonical ensemble), the NPT (Isothermal-isobaric ensemble), the NVE
(Microcanonical ensemble) and the µVT (Grand canonical ensemble) where, N
is the constant particle number, V the constant system volume, P the constant
pressure, T the constant temperature, E the constant energy and µ the constant
chemical potential. For each one of these ensembles it is possible to determine the
probability density function ρ(q,p) and in particular for the NVT ensemble is:












In the equations 1.7 and 1.8, H(q,p) is the system Hamiltonian, β = 1/kBT where
kB is the Boltzmann’s constant and T the temperature, h the Plank’s constant
and the term N ! is introduced for quantum mechanical reasons to take into ac-
count the number of indistinguishable particles in the system. It is interesting to
observe that H cannot be time dependent otherwise the observable A will be time
dependent, therefore in this statistical framework are excluded systems where are
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present external time dependent forces. If the system potential energy U(q) is a
function of the generalised coordinate q only, then, the expression of the partition
function can be simplified expressing the system Hamiltonian H as sum of kinetic
K(p) and potential energy U(q) terms. In this case the integral can be decoupled
into two independent parts, one dependent on the generalised coordinates and the








where m is the mass of each particle. The integral on the momentum part can be
solved in a closed form and the simplified version of the partition function is:
QNV T =
1
N !Λ3N ZNV T , (1.10)











From a computational point of view this expression is very attractive, it specifies
how to construct the ensemble average of a given thermodynamic observable that
can be compared to experimental measurements. An important quantity in Sta-
tistical Mechanics is the Helmholtz free energy F linked to the partition function
by the equation:
F = −kBT lnQNV T . (1.13)
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In terms of free energy component analysis, it is convenient to rewrite the previous
equation in terms of ensemble average:








= +kBT ln〈exp(+βH(q,p))〉NV T
(1.14)
In the context of this study a significant ensemble is also represented by the
NPT ensemble. Indeed, chemistry experiment are most of the time conducted
at constant pressure, temperature and constant number of particles. In these
conditions the expression of the Gibbs free energy is:
G = −kBT lnQNPT , (1.15)





exp(−β(H(q,p) + pV ))dqdpdV , (1.16)
and where p is the pressure and V the system volume.
From now on all the relevant thermodynamic equations useful to this study
will be referred and derived in the canonical ensemble, unless otherwise stated,
because in it proofs have a convenient notation in this ensemble.
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1.4 Mechanical Potential Energy: a very brief introduction
In order to extract interesting macroscopic properties from a system in thermo-
dynamic equilibrium using the ensemble average (equation 1.12), it is necessary
to evaluate the system Hamiltonian at different phase space coordinates and, this
usually translates in the calculation of the system potential energy U(q). Conse-
quently, the specification of the potential energy and its parameters is a key point
especially in molecular simulations. It defines the microscopic interaction laws
and the agreement with experimental data strongly dependent on its reliability.
An accurate description of the interaction laws would require the explicit use of
Quantum Mechanics however, the use of this theory is frequently restricted to
hundreds of atoms and its application to biological macromolecules is ordinarily
impracticable due to the high number of atoms involved in the system description.
In the Bohr-Oppenheimer approximation (25) the electron and nuclei motion in a
molecule can be separated by splitting the total atomic wave function as product of
the electron wave function Ψe(ri,Ri) and the nuclei wave function Ψn(Ri) where
ri, and Ri are respectively the electron and nuclei positions. This approach relies
on the physical fact that the electrons are considerably lighter than the nuclei.
The Schrödinger equation for the nuclei is then replaced by Newton’s law. The
nuclei are then moved according to classical mechanics by using potentials that
result from the solution of the Schrödinger equation for the electrons and, many
approximations have to be employed (26). For example, these approximations are
derived by using ab-initio methods such as the Hartree-Fock or density functional
theory. However, the complexity of the model and the related algorithms en-
forces limitations on the system size. A further drastic simplification is the use of
parametrised analytical potentials that are function of the nuclei positions only.
This representation is known as mechanical or atomistic representation. In it the
whole atomic system is described as as a charged point mass particle without
any internal structure. This approximation suits biomolecular studies where the
exact solution of the whole quantum mechanic atom dynamics is numerically im-
practicable. The functional form of the mechanical potential is usually divided
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into two main terms called the “non-bonded” and “bonded” interactions in this
context. Three concomitant effects characterised the non-bonded interactions. A
repulsive contribution related to the exclusion volume of the VdW forces caused
by the inter-atomic repulsions between atomic nuclei. A second contribution de-
scribes the dispersion forces or London forces, which is caused by atomic charge
fluctuations produced by the presence of another atom creating an attractive











where rij is the atomic distance between the atom i and j, εij and σij are re-
spectively the well energy depth and the collision diameter. These parameters
are usually determined using experimental and computational approaches such
as viscosity data, scattering data and quantum mechanic calculations (14). Often
these parameters are refined also using crystallographic and liquid structures (14).
The final contribution to the non-bonded interactions is related to the elec-
trostatic between particle atoms. These interactions are modelled by using the
Coulomb potential providing partial charges to each atom in the system. The







where qi is the atom charge of atom i and ε0 the vacuum dielectric constant.
The sign and the magnitude of the Coulomb parameters may be obtained by de-
termining the electronic density function of the system from quantum mechanic
calculations of the ground state by using first principle methods such as Mul-
liken (27) and AM1-BCC (28). Usually the results are basis set dependent and they
are improved with experimental data fitting (14). Coulomb forces are notoriously
stronger compared to the Lennard-Jones interactions and, as a consequence, they
have a longer-range and are responsible for very relevant hydrogen bond forma-
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tions in biomolecular simulations. The intra non-bonded interactions are not
usually applied on atoms that are separated by less than three (known as 1-
2, 1-3 terms) or four bond lengths. A reasonable explanation is related to the
overlapping between the non-bonded interactions and the bonded terms used to
delineate the covalent bonding (14). In molecular simulation, the non-bonded term
calculations are expensive with a complexity of O(N2) where N is the number of
particles in the system. In order to reduce their computational cost these are fre-
quently estimated by only considering the atoms in a given cut-off distance only.
This approximation is usually improved adding long range correction terms to the
Coulomb expression such as the reaction field (29), or using a non cut-off scheme
such as the Ewald summation (30). In addition, in order to avoid discontinuities
in energy and/or forces at the cut-off distance, switching functions are regularly
used (31).
The bonded contributions to the potential energy are related to vibrational
bond terms and energetic rotational terms around bonds. The vibrational terms
model the bond and angular stretching dynamics and they are usually accounted
by a simple harmonic potential or other anharmonic terms. In biomolecular sys-
tem, this approximation is motived by constant fluctuations around equilibrium
positions at conventional temperatures. The harmonic potential form of the bond
Ub and angular Ua vibrational terms are:
Ub + Ua =
cb
2 (rij − r0)
2 + ca2 (θklm − θ0)
2 , (1.19)
where cb and ca are respectively the bond and angle force constants while, r0
and θ0 are respectively the equilibrium bond distance and the equilibrium angle.
Furthermore, the terms rij and θklm are respectively the atomic distance between
the generic atoms i and j and the angle between the generic atoms k, l and m.
The rotation around bond contributions are modelled by using energetic ro-
tational barriers along bonds. These potential terms Ud are represented by using
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An(1 + cos(nφijkl − φ0)) , (1.20)
where An is the height of the torsional barrier, n the multiplicity, φijkl the di-
hedral angle formed by the atoms i, j, k and l and φ0 is the equilibrium dihedral
angle. This functional form correctly describes two fold barriers such as in amide
group and three fold barriers such as in hydrocarbon chains (14). However for more
complex molecule such as sugars, it is necessary to consider other potential expres-
sions (14). The potential bonded parameters may be determined using quantum
mechanics calculations and experimental data. For example the force constant de-
terminations can be performed calculating the minimal structural configuration
and then performing a normal vibrational analysis and fitting the results with
experimental data (14).
The classical mechanical potential expression in a system can therefore be
written as a sum of bonded and non-bonded contributions as follows:

























)6+ 14πε0 qiqjrij ,
(1.21)
and excluding from the non bonded terms the 1-2 and 1-3 interactions. Nowadays,
different force fields mainly based on the presented force field have been developed,
usually for different purposes. The most popular are MM2 (32) and its extensions,
AMBER (33), CHARMM (34), GROMOS (35) and OPLS (36). However, many sig-
nificant physical phenomena are completely ignored in this framework such as
polarizability, π-stacking interactions or creation and destructions of chemical
bonds. To address these limitations, mixed quantum mechanical-molecular me-
chanical force fields are under development in a number of laboratories and first
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results seem to be encouraging. The thesis author would like to rewrite a quote
from the Halgren’s paper (37) which, nowadays to some extent is still valid:
“Some day, consensus on the form and manner of parameterisation
of molecular force fields may exist, but for now much remains to be
learned. This is as it should be, for the problem being addressed is a
hard one: to capture faithfully in a computationally tractable model
enough of the real, quantum-mechanical physics to insure that a bio-
molecular simulation, properly carried out, will yield a correct answer
to useful precision. The way would be clearer if we knew how much
physics ’enough’ is”
1.5 An introduction to the force field parametrisation
As we have seen, in the context of molecular simulations an important aspect
is the force field used to model the molecular system. Usually, force fields are
specified by using a potential energy function and a set of parameterisation con-
stants. In the previous paragraph a particular form of the mechanical potential
and its parameters was examined but, it is not unique and force fields can differ
in the potential energy functional form and the parameters. Usually, the func-
tional form tries to mediate between accuracy and computational efficiency and it
is often chosen for its mathematical properties such as the derivability up to the
second order, to enable use of MD simulations and minimisation techniques. Gen-
erally, force fields are designed to model and predict specific properties for specific
classes of molecules e.g. structural or thermodynamic properties and, they could
in principle fail to predict other properties when they are applied to molecular
systems that differ from a training set (31). This aspect is know as transferability
of the force field parametrisation and it is an important property in the prediction
process. The force field parameterisation is usually performed as follows (38):
• a set of reference data related to chemical and physical properties relevant
for the force field application target are selected. These properties have to
be computable and, in many cases, these are computed by using coordinates
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and particle momenta. Examples of reference data are (38): chemical struc-
tures determined by using X-ray crystallography, microwave spectroscopy
and electron diffraction; electrostatic properties such as dipole moments;
physical properties such as density; thermodynamic quantities such as en-
thalpy of formation, hydration free energy and heat capacities;
• divide the data in training and validation set;
• set a starting value for each parameter to be optimised accordingly to their
chemical and physical meaning in the training set. During the optimisation
a check on the parameter values is required to ensure that the parameters
are still meaningful;
• refine the parameter values until an optimal parameterisation is reached.
Usually in this process, the minimisation of a selected scoring function is




wl(Ocalcl (p)−Orefl (p))2 , (1.22)
where p is the vector parameter, N0 the number of reference data points,
wl are the reference data weights, Ocalcl (p) and O
ref
l (p) are respectively the
calculated data and the reference data value itself;
• the optimised parameters are then validated on the validation set to predict
the reference data. This step enables evaluation of the force field transfer-
ability.
The parameterisation of a force field by using all possible available reference
data and the potential energy function parameters is computationally unfeasible.
For instance, if the considered potential energy is the mechanical potential energy
1.21 and N is the number of atoms in a system then, the total number of unique





The same number is required for the optimisation of each LJ parameters ε and
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are required for each angle equilibrium distance and angle amplitude. Finally,(N+4−1
4
)
optimised parameters are required for each dihedral angle amplitude and
phase. If the previous analysis is restricted to the first N = 100 elements of the
periodic table (39), then the total number of required parameters is > 109, which
is hardly feasible to obtain. In order to make parametrisation tractable, it is
possible to select a subset of significant atoms present in many organic molecules
such as: H, C, N, O, F, Si, P, Cl, Br and I (39). However, results are often
not satisfactory because it is necessary to take into account the local chemical
environments to derive accurate force fields (31). Thus, many force fields rely on
concept of “atom type”. For example, in the MM2 (32), MM3 (40) and MM4 (41)
force fields, eight carbon atomic types are distinguished: sp3, sp2, sp, carbonyl,
cyclopropane, radical, cyclopropene and carbonium ion (31). In two widely used
bio-molecular force fields such as OPLS (36) and AMBER (33), 41 atomic types are
defined (39) and in the UFF (42) force field, which includes most of the elements
of the periodic table, 126 atom types are described (39). Another frequently used
strategy to reduce the parametrisation effort is to exclude some parameters from
the optimisation process. For instance, the atomic charges can be computed by
using quantum mechanics calculation methods prior to runnig a MD simulation.
A disadvantage of this approach is that atomic partial charges are no longer
transferable and must be computed for every new molecule to model. Finally,
another interesting method is the approach where parameters that depend on
more than one atom are re-defined as function of a single per atom parameter.
For example, in the LJ potential the parameter σAB is function of the two atoms




where σA and σB are single per atom parameters, the total number of optimised
parameters required is N instead of the original N(N + 1)/2.
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1.6 Free Energy Calculations
The rigorous theory of free energy calculation was developed many years ago and
due to the limited computational resources at that time numerical applications
to the theory were very limited (43). The roots of the early method can be as-
cribed to John Kirkwood (44) when in his work on the derivation of the integral
equation in liquid state theory he introduced the the notion of order parameter to
infer free energy difference between two thermodynamic states. Nearly 20 years
later, Zwanzig (45) showed how to calculate free energy changes by using ensemble
averages, which forms the theoretical basis of the popular Free Energy Pertur-
bation (FEP) method. The initial applications of free energy calculations had
to wait to more computational power to be extended to physical and chemical
relevant systems and therefore, the calculations were originally domain of analyt-
ical studies (43). A remarkable non trivial success of these starting attempts was
the explanation of the hydrophobic effect in the work of Pratt and Chandler (46)
which was subsequently confirmed by numerical simulations. When computa-
tional power became available, a plethora of free energy calculations applied to
increasingly complex molecular systems began to flourish (43). Most of the initial
efforts were based on MMC approaches e.g. initial applications to Lennard-Jones
fluids (47), study of atomic clusters (48) and ion hydration investigations (49). In
1979 two studies faced the nature of the hydrophobic effect by using free energy
calculations. Susumu Okazaki et al. (50) used MMC to estimate free energy of
hydrophobic hydration. They found that the hydrophobic hydration was accom-
panied by a decrease in internal energy and large entropy loss in agreement with
the conventional picture of the phenomenon (43). In the second, study Bruce Berne
et al. (51) investigated a multistage approach applied to model system formed by
Lennar-Jones spheres in a bath of water molecules and they successfully recovered
the results of Pratt and Chandler (46) related to the hydrophobic interactions (43).
In the 1980s new research directions were explored. Tembe and McCammon (52)
applied the FEP method to model ligand-receptor assemblies. Jorgensen and
Ravimohan (53) estimated the hydration free energy of ethane and methanol by
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applying a common topology shared between the transformation end points. An-
other remarkable example of calculation (43) was the study of the SN2 chemical
reaction of Cl− + CH3Cl in gas phase and solution by Chandrasekhar et al. (54),
which laid out the basis of modern QM/MM calculations. In the same year Koll-
man et al. opened new paths to in-silico modelling of site-directed mutagenesis
by using the FEP approach to calculate free energy changes associated with point
mutations in amino acid side chains (55;56;57;43). They employed a first attempt
of slow-grow method, which was rigorously theoretical formulated 10 years later
by Jarzynski (58). It is also worth to mention the approached developed by Fleis-
chmand and Brooks (59) to calculate entropy and enthalpy differences (43). They
showed that the error associated with these two thermodynamic quantities in cal-
culations were about one order of magnitude higher that the corresponding free
energy error. In contrast to FEP the Thermodynamic Integration (TI) method
was used only in the late 1980s when Straatsma and Berensden (60) successfully
used the method to calculate ionic hydration by mutating neon to sodium and,
nowadays, this technique is one of the most common free energy approaches.
The initial studies reported very good agreement between experimental and
predicted free energy data however, after the starting enthusiasm it was soon re-
alised that these successes were probably due to good fortune rather than precise
computer simulations (43). For example, in many cases it was observed that pre-
dicted free energy deviates from the related experimental value as soon as more
sampling was accumulated. In addition, many systems appeared to be non-ergodic
showing slow-convergence issues. These and other observations have mainly driven
the different research paths in the last 20 years and many successes were achieved
relaxing the “theoretical rigour” (43) by using “well-motivated” (43) approximations.
For example, in many stratification free energy calculation strategies, the path
connecting the end points of the simulation was divided into sub-paths and, of-
ten, numerical instabilities occured at the reference and target states. Beutler et
al. (61) introduced the concept of soft core potential to mitigate the problem and,
nowadays, it is frequently used in alchemical free energy calculations where cre-
ation and annihilation of chemical groups are involved. Another common problem
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was the free energy dependence on the system size in cases where significant elec-
trostatic interactions were present (43). The use of reaction field (29) and Particle
Mesh Ewald lattice (30) considerably mitigated the problem in neutral systems. On
the other hand, in charged systems, Hummer et al. (62) showed that the system-
size dependence can be faced if a self-interaction term is taken into account in
the simulation. This term is associated with the interaction of charged particles
with their periodic images. Hummer in his paper was able to correctly calculate
the hydration free energy of a sodium ion in a water box consisting of 16 water
molecules only. Another problem that caused concern in the field was the use of
holonomic constraints. In numerical calculations these are often used to remove
high frequency vibrations allowing the equation of motions to be integrated by
using larger time steps. In the early years of free energy calculations the effect
of frozen internal degree of freedom was ignored (63) however, it was showed that
constraints could significant alter the accessible volume phase space and, there-
fore, influence free energy simulations (43). Stefan Boresch and Martin Karplus (64)
showed the importance of the metric tensor corrections that can be analytically
estimated in many systems.
Practical applications of free-energy calculations to the pharmaceutical con-
text were limited due to the computational cost and accuracy. The primary line
of research in this direction targeted drug design applications. Eric Duffy and
W. Jorgensen (65) simulated a set of 200 pharmaceutical organic compounds in
aqueous environment calculating their solvation free energy. With the increase of
computational power W. Jorgensen used the FEP method in the lead-optimisation
stage to design new potent anti-HIV-1 agents (66). A compromise between ac-
curacy and high throughput was proposed by David Perlman and Paul Charif-
son (67) suggesting that one step FEP simulation on a grid surround the ligand
gives a roughly estimate of the binding constant. A significant boost to reach
throughput was also achieved with the introduction of reliable implicit solvent
models. Simonson et al. (68) showed how to approximate long range interactions
in a continuum solvent environment without sacrificing accuracy, which led to a
significant reduction of the computational cost in atomistic simulations. More
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recently Andrew McCammon et al. (69) employed the Poisson-Boltzmann surface
area (MM/PBSA), successfully facing the problem of estimating conformational
changes in free energy upon binding of a ligand to its receptor (43). An aspect
in free energy calculation that causes considerably difficulty has been the system
sampling. In the 1990s different approaches based on the treatment of an order
parameter as dynamic variable were developed (43). The idea was to construct a
series of MD trajectories or MC walks with a different value of the order param-
eter. The probability of visiting the different system states characterised by a
different value of the order parameter can be significantly different. Occasionally,
a configuration swap is attempted between the systems, accepting or rejecting the
swapping based on a Metropolis criterion. A suitable parameter used to increase
the smoothing of the probability distribution function is the temperature and, this
method known as parallel tempering has became increasingly popular to tackle
difficulty problems where high-energy barriers are present between the different
system states (43). Another technique was proposed by Laio and Parrinello (70)
in 2002. They developed the metadynamics approach based on the definition of
collective variables to efficiently explore the free energy surface. In it, a memory
kernel guaranties that the different visited free energy minima in the free energy
landscape are progressively filled as the simulation progresses in the long run (43).
As previously seen one of the most concerning problem in free energy calcula-
tions performed on biomolecular systems with a high number of degree of freedoms
is the necessity to efficiently search the phase space. One common characteristic of
such systems is the presence of energy barriers lower or higher than the simulated
system thermal energy (43). In an ergodic system every point in the phase space
have to be accessible from every other point. This requirement for complex sys-
tems simulated along conventional time scales could produce disconnected phase
space regions and, therefore, systems are often trapped in “un-escapable states”.
Hodel et al. (71) showed how errors produced by insufficient sampling could impact
free energy calculations (43). It turn out than, even for relatively small systems
such a nine-residue peptide improper sampling resulted in errors of the order of 1
kcal/mol, which accounted for about 50% of the total calculated free energy (43).
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Many methods have been designed to enhance the sampling to yield more accu-
rate results than conventional approaches such as MD and MMC. However, the
development of new algorithms, often based on new mathematical approaches is
just one possible way to tackle the problem. It is believed (43) that this strat-
egy lead to non “perfect” methods but, rather methods that perform better for
particular applications of problems (43). Nonetheless, a simplest approach to en-
hance the sampling exists and it significantly emerge from the previous brief free
energy history i.e. the use of brute force methods based on the enhancement of
computational power. In the last 25-30 years many progresses have been made in
the computational field e.g. the processor performance exponential growth. This
growth is the result of two main factors: increase in the processor complexity
related to higher device density (number of transistor per chip) and the introduc-
tion of new architectural features such as large cache memories, large instruction
buffers, multiple instructions per cycle, multi-threading, branch predictions to cite
only few (72). However, nowadays, there are physical limits that have be reached
in the computational development such as the finite speed of signal propagation
along a wire and heat dissipation issues. One possible path settled to tackle these
problems by the semiconductor industry has been the use of multiple processors.
Since 2003, the semiconductor industry has followed two main directions to
designing microprocessors: the multicores and the many-cores (73). The multicores
began as two-core CPU processors, with the number of cores approximately dou-
bling with each semiconductor process generation (73). A current exemplar is the
recent Intel Core i7 microprocessor, which has four processor cores, each of which
support multiple-instructions, hyperthreading and is designed to maximise the ex-
ecution speed of sequential programs (73). In contrast, the many-core architecture
focuses more on the execution throughput of parallel applications and a current
exemplar is the GPU GeForce GTX Titan X with more than 3000 cores, each
of which is a heavily multithreaded (73). The development of this technology has
been driven by the market demand for high-quality, real-time graphics computer
applications such as video games and animated movies and ad-hoc microproces-
sors named Graphic Processing Unit (GPU) were developed to this end. There
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is a large computational gap between CPUs and GPUs in particular in numerical
applications. The design of a CPU is made by sophisticated control logic units to
deal with the operating system requests. On the other hand, the design philoso-
phy of the GPUs is shaped by the video game industry, which exerts tremendous
economic pressure for the ability to perform a massive number of floating-point
calculations per video frame. In addition, graphics chips have been operating at
approximately 10 times the memory bandwidth of contemporaneously available
CPU chips (73). GPUs are designed as numeric computing engines and therefore
they have been adopted in many scientific fields where to validate scientific hy-
potheses TFLOPS performance is often required and PFLOPS performance would
be highly desirable (72).
As previously seen the sampling in biomolecule systems is one of the main
concerning problems. This thesis has explored and applied the computational
power of the modern GPU processors to face the sampling problem in biomolecular
simulations. We have seen that it is very useful to quantify the relative binding
affinities between prominent ligands in the lead-optimization stage. With this aim
a fast relative free energy implementation based on alchemical transformations
and the FDTI method has been developed. The implementation merged two
existing piece of software Sire (74) and OpenMM (75) gaining flexibility from the
advanced Sire molecular modeling framework and speed from the OpenMM APIs
performing molecular dynamics simulations directly on the modern GPUs. The
produced implementation is the starting point to perform new science merging
flexibility and computational power in a simple, efficient and effective way. This
is often missing in many competitor software restricted to predefined and rigid
schemes, which do not fit in a flexible frame so important in the scientific research
context.
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1.7 FEP and TI
As described in the previous paragraphs, the binding free energy is a relevant prop-
erty to improve the drug efficacy at the early steps of drug discovery. Molecular
simulations are nowadays used to support rational drug design but, the predic-
tion of free energy of binding and its components, still remains the “Holy Grail”
of Computational Chemistry (76). In the last thirty years, many computational
methods have been developed to compute binding affinities, usually balancing a
trade-off between accuracy and computational cost. In order to fully understand
the difficulties related to free energy calculation, it is necessary to examine how
free energies are computed. The evaluation of the absolute Helmholtz free energy
involves the numerical calculation of equation 1.13, which is rewritten here for
clarity:
F = −kBT lnQ .
This equation is extremely important. It describes the link between macroscopic
and microscopic worlds evaluating the macroscopic observable F througth the
calculation of the partition function Q, which is involved the microscopic descrip-
tion. The effective determination of Q is unworkable for realistic cases, because it
requires the calculation of the system accessible phase space volume integral, for
example by using molecular simulations. On the other hand, in molecular systems
we are frequently interested in the calculation of free energy differences between
two thermodynamic states A and B. In this case from equation 1.13 it follows:




which by using the simplification described in § 1.3 can be rewritten as ratio of
configurational partition functions:




In general the two thermodynamic states A and B can differ in many ways, such
as extensive and intensive variables e.g. temperature, pressure or volume, or
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they can be modelled by two different Hamiltonians HA and HB e.g. a residue
mutation in a protein or functional groups in a ligand. The determination of the
ratio QB/QA can be simplified as follows:


















= −kBT ln < exp(−β(HB −HA)) >A
(1.26)
In the previous proof, it is assumed that the temperature between the two states
A and B is the same, but it is straightforward to generalise this condition. The
expression of ρA in the previous equation is the probability to find the system A in
the microstate (q,p) in the NVT ensemble. Due to its importance, equation 1.26
is named the free energy perturbation formula (44;45) and it allows the calculation
of ∆F monitoring the factor exp(−(HB − HA)/kBT ) e.g. by using molecular
simulations. This methodology is known as FEP because the Hamiltonian of the
system B can be written as a perturbation of the Hamiltonian of the system A:
HB = HA + ∆H , (1.27)
where ∆H is the perturbed energy term. However, this approach could present
a substantial issue i.e. the configurational phase spaces related to the thermo-
dynamic states A and B could not truly overlap. This effectively means, that
the configurations generated during the sampling of the state A, for example us-
ing molecular simulations could not be significant configurations of the state B
and the Hamiltonian change in the equation 1.26 could be large, producing a low
contribution to the exponential term and, therefore, a possible poor convergence
in the calculation of ∆F . In general, this issue can be tackled by dividing the
thermodynamic path A → B in closer intermediate steps where the Hamiltonian
changes are expected to be small and the whole free energy change between the
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end states is computed as sum along the path steps.
Another popular method used to compute free energy change is the TI method.
In this approach a thermodynamic system in the state A is transformed into the
thermodynamic system B by changing a coupling parameter λ defined in a given
range [λA, λB] where, λA and λB respectively represent the system in the states A
and B. The coupling parameter can control the change of extensive and intensive
properties or can mutate the Hamiltonian of system A into B (HA → HB), or
it could control structural changes between A and B such as values of torsional
angle. If the Hamiltonian depends on a coupling parameter then, the free energy





























> dλ . (1.30)
In the TI method the calculation of ∆F is evaluated using the ensemble average
< ∂H/∂λ > in contrast with the FEP approach where is evaluated the ensemble
average < exp(−β∆H) >. The TI method should not suffer of the FEP problem
related to the poor sampling of the final state and, as a consequence, it is expected
to produce better convergence. However, the TI method also requires the integral
calculation and usually this is numerically performed by using quadrate rules or
polynomial regression and, these techniques could bias the method. In addition,
the numerical integral accuracy depends on the shape of < ∂H/∂λ > producing
acceptable results if it is smooth enough. In particular transformations, known
as Alchemical transformations, the LJ and Coulomb interactions can be abruptly
turned on or off, simulating the appearance or disappearance of particles in a
system and, therefore, the change < ∂H/∂λ > could be significant producing
poor numerical integration. Due to their importance in this study, alchemical
1.8. Sampling methods: MD and MC 42
transformations and the TI methods are further discussed in Chaper two where
will be presented an implementation of the TI free energy method.
1.8 Sampling methods: MD and MC
As previously seen, the determination of macroscopic thermodynamic properties
using microscopic quantities relies on the calculation of the ensemble averages eval-
uated on different phase space configurations, usually generate by using Molecular
Dynamics or Monte Carlo sampling methods. In these methodologies the simula-
tion frequently begins by selecting a set of initial conditions and then the system
is evolved to produce new phase space configurations. Generally, the first simu-
lation segment corresponds to an equilibration stage and, at the point where the
equilibrium is numerically achieved (steady fluctuations), the previous history is
discharged. Subsequently, significant physical properties are calculated from the
ensemble average and, finally, the simulation is allowed to proceed until there
is no significant variation among the investigated physical properties. The main
characteristics of MD and MC are briefly detailed below.
1.8.1 Molecular Dynamics
In an atomistic simulation, atoms are identified as a set of N interacting particles
in a given force field and, in this case, the system can be modelled by using the
Cauchy’s problem related to Newton’s second order linear differential equations:











∀i = 1, · · · , N . In the previous system F i is the generic force acting on particle i,
mi its mass, ri the particle position as function of the time parameter t, r0i and v0i
are respectively the particle position and velocity at the starting time t0. In the
MD method the force acting on each particle can be derived from the potential
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energy function as follows:
∇riU = −F i . (1.32)
Using the previous equation it is possible to prove that the total system energy is
constant and, therefore, the natural ensemble suitable to MD is the microcanonical
ensemble NVE. Equations 1.31 are known as the N-body problem and, in the
general case, it is not possible to find a solution in a closed form. Numerical
methods are then used to find approximate solutions. A very näıve method to
integrate the system 1.31 is to evaluate the acceleration a(t) of each particle
by using the potential U(r(t)) and, subsequently, it is possible to update the
velocities v(t + ∆t) and the positions r(t + ∆t) supposing that the acceleration
is constant between t and t + ∆t where ∆t is the time step. The procedure is
then reiterated. This very simple algorithm suffers of many issues producing poor
sampling without conserving the total system energy. More suitable integrators
are the Verlet schemes i.e. Verlet-Störmer (78) and velocity Verlet (79). MD can also
be performed in other frequently used ensembles. In the NVT case, it is necessary
to control the temperature in the system. This can be achieved in many ways
and, a very simple approach is offered by the velocity scaling techniques (80). The








2NkbT (t) . (1.33)
In order to control the temperature at a reference temperature Tref , it is possible





2 = 32NkbTref . (1.34)
Therefore, the difference in temperatures obtained subtracting the two previous
equations can be written as:
∆T = (λ2 − 1)T (t) . (1.35)
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Multiplying at each time step the velocities by the factor
λ = (Tref/Tcurr)1/2 , (1.36)
it is possible to keep the temperature constant at Tref while Tcurr is the tem-
perature at the selected step calculated by using equation 1.33. Another scaling
technique is to couple the system to a thermal bath (81). In this case the rate of






(Tbath − T (t)) , (1.37)
where τ is the parameter that describe how tightly the system is coupled to the
bath and Tbath is the bath temperature. Therefore, ∆T in this case is:
∆T = ∆t
τ
(Tbath − T (t)) , (1.38)
and the scaling factor λ using the equation 1.35 is:




T (t) − 1
)
. (1.39)
However, the previous two scaling approaches are not able to correctly sample the
NVT ensemble producing poor averages. Other approaches have been developed
based on stochastic processes (82) or extended system methods (83) and analogue
methodologies have been developed to control the pressure.
1.8.2 Monte Carlo
The effectively determination of the equation 1.12 requires the calculation of mul-
tidimensional integrals that, for practical system cannot be evaluated using stan-
dard techniques e.g. quadrature rules. For example the Trapezium and Simpson’s
rules to integrate an n-dimensional function f on a given volume require to eval-
uate m3n points where, m is the number of selected approximation points in each
dimension (31). Hence, if we just select a 50-dimensional function evaluated with
3 points per dimension this would require 3150 ∼ 1071 calculations, which is cur-
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rently unachievable by any computational machine (31). The Monte Carlo method
and its variations have been developed to calculate multidimensional integrals.
The basic idea is to generate many random points in the multidimensional space
and count the number of points that fall inside the integral volume. In particular
this technique applied to the equation 1.12 leads to the following algorithm (31):
1. randomly generate 3N space coordinates;
2. calculate the potential energy function Ui(q) at step i on the 3N coordinates
and then evaluate exp(−βUi(q));
3. accumulate the previous values and return to step 1.







However, this approach is not very efficient. Indeed, most of time random ar-
rangements of atoms will have a negligible Boltzmann factor exp(−βUi(q)). As
a consequence, the low-energy states, which weight more in the ensemble aver-
age sum, are not efficiently sampled. The Metropolis Monte Carlo approach (6)
is a significant improvement to the original Monte Carlo method. In this tech-
nique, the low-energy states are efficiently explored (importance sampling) by
using Markov Chains. In the canonical ensemble, the algorithm evolves molecu-
lar systems from a state where the particles have positions q to a new randomly







The acceptance criteria is based only on the variation in the potential energy in-
volved in the specific move. If the potential energy change is positive the move
is accepted with probability one otherwise, it is accepted with a probability that
exponentially decreases with the increase in the potential energy change (23). How-
ever, the displacement of all the particles in a single move could lead to a low
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acceptance rate, and this problem becomes more severe as soon as the particle
number increases (23). An immediate solution is to move one particle at a time
in a move randomly selected among all the particles. This strategy also has a
positive effect on the potential energy calculation. It is only necessary to update
the potential energy with the contribution related to the new particle position in
the case of a positive acceptance test.
1.9 Chapter summary and thesis overview
This chapter introduced the main theme of this thesis, which is related to modern
and new computational methods used to help and speed up the drug discovery
process. A brief overview of the novel drug development process was detailed
and in particular the importance of the drug discovery and design process was
highlighted to cut down cost and time along the critical path. The importance
of the binding affinity as one of the key parameter used by medicinal chemists to
improve drug efficacy was described and how computational predictions of this
quantity could significantly help the synthesis of new potent drugs. An intro-
duction of relevant thermodynamic quantities was explained to connect the micro
atomic world with macroscopic observables through the use of the ensemble av-
erage notion. Finally, computational methods to predict free energy change were
introduced. The FEP and TI approaches were explained together with molecular
simulation techniques such as MD and MMC.
The following chapter will present an implementation of the single topol-
ogy and the FDTI methods used in conjunction to calculate relative free energy
changes. Applications of the implemented code will be used to compute relative
and absolute hydration free energy by using the single and the dual topology meth-
ods. Chapter three will detail the importance of the flexibility in a simple molec-
ular system and how the force field parameterisation can impact on the molecular
flexibility; a comparison with experimental data will be detailed. In Chapter four
the non-additivity phenomenon in drug design will be investigated. The relative
free energy implementation will be used to predict the relative binding affinities of
series of congeneric Thrombin inhibitors and to estimate the non-additivity level
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present in the systems. The final chapter will try to explain the non-additivity
origins selected Thrombin inhibitors. Finally, conclusions will summarised the
whole thesis work.
“Given for one instant an intelligence which could comprehend all the
forces by which nature is animated and the respective positions of the
beings which compose it, if moreover this intelligence were vast enough
to submit these data to analysis, it would embrace in the same formula
both the movements of the largest bodies in the universe and those of
the lightest atoms; to it nothing would be uncertain, and the future as
the past would be present to its eyes”
— Pierre-Simon Laplace. Introduction to Oeuvres vol. VII, Théorie
Analytique de Probabilités
2
Free energy calculations using Alchemical
Transformations
2.1 An Introduction to Alchemical Transformations
I
N the first chapter the FEP and TI methods were introduced to calcu-
late free energy changes between two selected thermodynamic states
and the notion of coupling parameter λ was introduced. This param-
eter is used to transform a given thermodynamic system between two end states
e.g. changing the intra- and inter molecular interactions, structural modifications
or even extensive or intensive parameters. In general, in the free energy context,
transformations where the coupling parameter is used to convert a thermodynamic
system between different chemical states are known as alchemical transformations.
This is in part due to the fact that these transformations could also involve changes
in molecular species and therefore, in a sense, this is the realisation of the inacces-
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sible dream of the proverbial alchemist to transmute matter (43) chased during the
middle age. Historically alchemical transformations are grounded in the works
of Kirkwood (84;44) and Zwanzig (45). The former introduced the coupling param-
eter technique, and described how to use it in conjunction with the TI method
to calculate the free energy change. Later on, Zwanzig showed how to calculate
changes in the free energy by evaluating exponentials of potential energy differ-
ences over an ensemble average of system configurations. From a computational
point of view the coupling parameter is introduced in the system Hamiltonian H
and the Hamiltonian shape is changed between the selected end states along the
alchemical transformation. The coupling parameter is usually selected in a given
range [λA, λB] with the constraint that H(λA) and H(λB) respectively describe
the starting and the final thermodynamic states involved in the transformation.
The choice of the lambda dependence in the system Hamiltonian, and therefore,
the alchemical path between the end states is arbitrary. However the transition
could be computationally very different among the paths. Indeed, the selection of
a path with high-energy barriers between the starting and final states could lead
to a very inefficient calculation. Figure 2.1 (a-c) illustrates some specific alchem-
ical mutations and Figure 2.1 (d) elucidates the concept of thermodynamic paths
between two end states.
In the alchemical paradigm another important aspect is the notion of thermo-
dynamic cycle. Free energy is indeed a thermodynamic state function and its total
variation along a closed thermodynamic path must equate zero (∆FA→A = 0).
This fact is frequently used to evaluate free energy changes between thermody-
namic states separated by high-energy barriers. Indeed, in principle, it is possible
to introduce new thermodynamic states along a closed cycle where it is easier
to calculate free energy changes and then, indirectly calculate the free energy
change between the original states (Figure 2.2). Thermodynamic cycles are re-
versible, and therefore, forward and backward transformations can be considered.
The thermodynamic cycle closures are frequently used as quality check for free
energy calculations and the discrepancy from zero measures the transformation
hysteresis (43). If the hysteresis is greater than the statistical uncertainties then










Figure 2.1: (a) The coupling parameter λ can be used to mutate a molecule
into another molecule. In this case an ethane molecule is mutated into a methane
molecule. (b) The coupling parameter can also be used to control structural modifi-
cation. In this case a deca-alanine molecule is forced to unfold by changing torsion
angles during an “alchemical” mutation. (c) λ can also be used to change the in-
teractions between molecules. In this case the inter-molecular interactions between
a solute and a solvent are progressively switched on from a non-interacting to a
full-interacting case. This technique can be used to compute a hydration free en-
ergy. (d) The free energy surface of a thermodynamic system can be represented
as a hyper dimensional surface. In this case the free energy is function of two
variables only and two minima A and B are highlighted. The minimum in B is
a stable state while A is a meta-stable state. The system can switch between the
two states using different thermodynamic paths. Although the free energy differ-
ence is the same between the two states, the path used to switch between A and B
could present different computational demand and therefore can be less or more
efficient.













Figure 2.2: Free energy changes along a closed thermodynamic path must be zero.
Therefore, the free energy change between two thermodynamic states A and B can
be indirectly evaluated as follows: ∆FA→B = −(∆FB→1 +∆F1→2 + · · ·+∆Fk→A).
a potential ergodic issue could be present along the calculation. In addition, low
hysteresis and low statistical uncertainties do not guarantee that the transforma-
tion is correct; the alchemical transformation could be still biased by incorrect
force field parameterization (43).
An example of alchemical transformation, which will be further investigated in
this chapter is represented by the alchemical transformation used to compute the
hydration free energy. This important quantity measures the free energy change
required to hydrate a molecule from the gas phase to an aqueous environment.
Figure 2.3 (a) represents the starting and final thermodynamic states usually
needed to calculate the hydration free energy (Gibbs Free energy). In the first
thermodynamic state the molecule is in the gas phase while in the final thermo-
dynamic state the molecule is fully interacting with the solvent. Along this path
the intermolecular interactions between the solute and solvent are progressively
switched on. An alternative path used to compute the hydration free energy is
also presented in Figure 2.3 (b). In this case the hydration free energy is evaluated
as difference between two annihilation free energy changes. The first is the free
energy change required to switch-off the solute intramolecular interactions in the
gas phase while the latter is the energy change required to switch-off the solute
intra- and the solute-solvent inter-molecular interactions.
The absolute free energy of binding between two molecules can be calculated
in a very similar fashion. In the protein-ligand binding context the binding affinity
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Figure 2.3: Different thermodynamic paths can be used to compute free energy
changes. (a) The hydration free energy of a molecule can be calculated progres-
sively switching on the intermolecular interactions between a solute and a solvent.
(b) The hydration free energy is calculated using a double annihilation in this case.
is the free energy change required to form a complex in an aqueous environment
starting from an unbound state Figure 2.4 (a). The direct calculation of the
absolute binding affinity is particularly difficult by using the path in Figure 2.4
(a). Effectively, it is necessary to simulate a binding event where the ligand
and the protein meet during their diffusive motions in a solvent environment
and then start the binding process; overall this requires the dehydration of the
binding site and configurational changes of the protein and the ligand and the
whole process could be very difficult to simulate in-silico. An alternative path
P:S + L:S (P:L):S
P:S + L P:S + L
ΔGL ΔGPL
ΔG = 0




Figure 2.4: (a) Absolute binding affinity can be computed simulating a direct
biding event. However, this is very computationally demanding and alternative
paths are usually used. (b) The binding affinity can be calculated performing a
ligand (L) de-solvation and decoupling the ligand from the solvent (S) and the
protein (P) binding site environment. The ligand decoupling could potentially be
difficult and distance harmonic restraints are usually required.
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used to calculate the absolute binding affinity between a ligand and receptor is
shown in Figure 2.4 (b). In this case the binding affinity is calculate as free
energy difference required to de-solvate the ligand and to decouple the ligand
from the solvent and the receptor. It interesting to observe that in both final
states where the free energy change is zero (Figure 2.4 (b)) the intra-molecular
ligand interactions are not annihilated. The selected pathway could also present
some issues. Indeed, the ligand decoupling from the protein could potentially
lead the ligand to stick in different protein parts when close to its full decoupling
state producing difficult free energy convergence. In order to overcome this and
other issues, it is useful to constraint the orientational configuration of the ligand
related to the receptor applying distance harmonic constraints in the decoupling
and de-solvation transformations and analytical corrections are required to the
free energy calculation to take into account these contributions (85;86).
Absolute binding affinity is an important property as discussed in the first
chapter, but more often medicinal chemists are interested in the relative binding
affinity between ligands. Indeed, there is often the need to compare free energy
of bindings between two ligands L1 and L2. The problem can be represented





The free energy change ∆∆G = ∆G2−∆G1 is the relative free energy of binding.
The thermodynamic cycle in Figure 2.5 is frequently used to compute relative
binding affinity between two ligands L1 and L2 with a given host protein P.
The relative binding affinity is evaluated as difference between two alchemical
transformations. In the first the ligand L1 is mutated in the ligand L2 in a
solvent environment (∆GL) while, in the latter, the ligand L1 is mutated in the
ligand L2 in the binding site (∆GPL). Because of their importance in rational
drug design this thesis mainly focused on relative binding affinity calculations.
In order to perform alchemical transformations, generally two different method-
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Figure 2.5: The thermodynamic cycle used to calculate the relative free energy
of binding between two ligands L1 and L2. In this case ∆∆G = ∆G2 − ∆G1 =
∆GPL −∆GL
ologies are implemented: the dual and single topology. In the dual topology (87)
method a system where two complete versions of two changing molecules respect
to the coupling parameter λ coexist at all the time. One version of the molecule
represents the initial state and the other the final end point. The atoms of the two
molecule versions interact with the rest of the system in an appropriate weighted-
mix however, the topologies do not interact each other. In the method the atom
types and internal coordinates of the coexisting molecules never change (87). The
coupling parameter λ is usually introduced in the potential energy function of the
system Hamiltonian U(r) and represents the scaling constant defining the topol-
ogy mixtures at any intermediate point. Usually the weighted-mix is defined as
follows (23):
U(r, λ) = f(λ)UA(r) + g(λ)UB(r), (2.1)
where UA and UB are the potential energies of the end states A and B, and
the functions f and g satisfy the constraint: f(λB) = g(λA) = 0 and f(λA) =
g(λB) = 1 (23). Frequently λA and λB are respectively selected as 0 and 1 and
in this thesis it will be assumed from now on otherwise explicitly stated. The
two functions f and g are also completely arbitrary but they are often selected as
linear: f = (1− λ) and g = λ.
In contrast with the dual topology approach, in the single topology paradigm
the change is formulated in terms of a system where the atom types and target
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internal coordinates are modified to reflect the end states. The transformation
is practically implemented changing per-atoms, bonds, angles and dihedral force
field parameters controlled by using the coupling parameter. A shared topology is
used between the alchemical end points and, usually the larger topology involved
in the mutation is used as common scaffold for the end states. The eventually
omitted structural atoms between the starting and final end states are treated as
vanishing particles and are often referred as “dummy particles”.
It has been proved that in alchemical mutations where bond lengths are
changed as a part of a free energy calculation a contribution from those changes
could be necessary to include by using the so called PMF contribution (63). Bond
changes are frequently involved in the single topology method and it could be
necessary to take into account these corrections. On the other hand, in the dual
topology method the target bond lengths in the hybrid analytic potential function
do not change with λ and therefore free energy calculations could be simplified
in this schema. However, the dual topology approach could require greater con-
formational rearrangement of the system at every increment in λ, since a greater
number of atoms interact with the system compared to the single topology method
and therefore, the single topology method could result in less abrupt changes at
the endpoints and possibly lead to faster convergence.
Pearlman (87) compared both the approaches in free energy calculation by using
FEP and TI for different alchemical transformations. The study clearly indicates
that the free energy simulations performed by using the single topology approach
converge more quickly than those using dual topologies. The difference is partic-
ularly acute when relatively short calculations are carried out or when the FEP
method is used (87). Comparing TI and FEP for the same system, it appears that
the two methods are approximately comparable with the single topology model
but that TI is appreciably more efficient with the dual topology system (87). In
addition, there are cases where the dual topology method is preferable e.g. in
systems where closed ring changes (purine and pyrimidine nucleic acid bases or
where an aromatic to aliphatic substitution is performed for a protein side chain).
In such cases the slower rate of the dual topology method must be adjusted and
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the sampling performed accordingly.
As previously described, in alchemical transformations, atoms can frequently
appear or disappear and often this could lead to the so called end point catas-
trophe issue. Indeed, the inter-atomic interactions between atoms that vanish
and the surrounding environment could become extremely intense due to possi-
ble steric clashes generated by the short interatomic distances. This fact could
potentially lead to severe numerical instabilities during the simulations which it
is necessary to correctly handle in a practical implementation of the single and
dual topology method. The next paragraphs will detail the implementation of a
relative free energy calculation code by using the FDTI method and the single
topology paradigm.
2.2 The FDTI method
The FEP and TI methods were briefly introduced to calculate free energy changes
between two thermodynamic states in Chapter one. In particular the TI method
describes how free energy differences can be evaluated by calculating the ensemble







> dλ . (2.2)
Due to the high number of degrees of freedom the previous equation cannot be an-
alytically resolved in realistic systems and numerical techniques are often applied.







In the method equation 2.3 is numerically approached by opportunely selecting a
set of N values of the coupling parameter in a range [λA, λB] and the integral in the
equation 2.3 is approximated by using quadrature rules or polynomial regression.
For example the integral can be approximated by using the simple trapezium





















In order to perform the numerical integration, it is generally required the evalua-
tion of the integrand function on a set of selected values of the coupling parameter,






In the FDTI method these values are numerically estimated by using the finite
difference central derivate formula:
∂G
∂λ
' ∆G(λ→ λ+ ∆λ)−∆G(λ→ λ−∆λ)2∆λ , (2.6)
where ∆λ is a selected parameter, which controls the precision of the gradient
calculation. In the literature (88) it is possible to find better approximations for
the gradient but the computational cost is usually higher and the improvements
are often negligible. In order to compute the free energy differences in the equation
2.6 the Zwanzig’s formula (45) is used in the FDTI method:
∆G(λ→ λ±∆λ) = −1/β ln〈exp[−β(U(λ±∆λ)− U(λ))]〉λ , (2.7)
where the symbol <> represents the ensemble average generated by using MMC
or MD. Algorithm 1 and Figure 2.6 represent an implementation of the FDTI
method.









Figure 2.6: In order to calculate free energy change between two thermodynamic
states the algorithm 1 can be used. An ensemble of configurations for a selected
value of the coupling parameter λ can be generated by using MD. At beginning the
system potential energy is calculated on the starting configuration. Subsequently,
the value of λ is perturbed in λ ± dλ. The system potential energy function is
then calculated on these values U(λ ± dλ) and the exponential differences can be
computed exp[U(λ± dλ)−U(λ)] and stored. The value of the coupling parameter
is then set to its original value and the system in evolved in time by using MD
for a selected number of steps. The new positions of the atoms in the space will
define new values for the potential energy U(λ) and its variations U(λ± dλ) and,
therefore, new exponential differences. The procedure can be iterated and all the
exponential values can be used to compute the ensemble average and, as a con-
sequence, the value of the free energy gradient at the selected coupling parameter
value.
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Algorithm 1 The FDTI algorithm
1: Select a set of λ values: {λA = λ1, λ2, · · · , λn = λB}, λk ∈ [λA, λB]
2: λ← λ1
3: for i 6= n do
4: Generate an ensemble of configurations {C1, C2, · · · Cl}λ for the selected λ
5: for j 6= l do
6: Evaluate and save the exponentials: exp[−β(U(λ±∆λ)− U(λ))]
7: end for
8: Compute the ensemble average: −1/β ln〈exp[−β(U(λ±∆λ)− U(λ))]〉λ





12: Go to step 3:
13: end for




2.3 An Implementation of the Single Topology Method
The FDTI method can be used in conjunction with the single topology method to
calculate relative binding free energy. Two alchemical mutations (Figure 2.5) are
usually required to calculate relative binding affinity between two ligands L1 and
L2. However, it is necessary to explain what “mutation” means in this context
and how a molecule can be transformed into another molecule. Following the
Born-Oppenheimer approximation (25), atoms can be represented as point particles
interacting with each other in a given force field described by using an appropriate
potential energy function. In principle, an atom species can be mutated into
another atom species and, therefore, a molecule can be mutated into another
molecule, if the intra- and inter- molecular interactions between the two species
are changed between the end points of two thermodynamic states. In the single
topology method this is achieved by introducing the coupling parameter lambda
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in the total mechanical potential energy function (equation 1.21) as follows:



























where each force field parameter is explained in Chapter one §1.4. The functional
form of the force field parameters respect to the coupling parameter λ can be
arbitrary and in the implemented code was selected as linear:
cb(λ) = c1bλ+ c0b(1− λ) ,
rb(λ) = r1bλ+ r0b (1− λ) ,
ca(λ) = c1aλ+ c0a(1− λ) ,
θa(λ) = θ1aλ+ θ0a(1− λ) ,
An(λ) = A1nλ+A0n(1− λ) ,
φd(λ) = φ1dλ+ φ0d(1− λ) ,
εij(λ) = ε1ijλ+ ε0ij(1− λ) ,
σij(λ) = σ1ijλ+ σ0ij(1− λ) ,
qi(λ) = q1i λ+ q0i (1− λ) .
(2.9)
The superscript indexes “0” and “1” respectively denote the force field parameters
in the starting and final states.
In an alchemical mutation between two molecules it is possible to distinguish
three categories of atoms. If L1 and L2 are respectively the starting and the final
molecule it is possible to have:
• atoms that are in L1 but not in L2. This category of atoms is called “to
dummy” atoms;
• atoms that are in L2 but not in L1. This category of atoms is called “from
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dummy” atoms;
• atoms that are both present in L1 and L2. This category of atom is called
“hard” atoms.
During the mutation in the “to dummy” atom group the intra- and inter-molecular
interactions are progressively turned off between these atoms and the rest of the
system. In the final state these atoms are “to dummy” or “ghost” particles, they
do not present any charges and Lennard-Jones parameters. On the other hand,
in the “from dummy” atom group the intra- and inter- molecular interactions are
progressively turned on. The “hard” atom group describes cases where atoms do
not change between the end states or if they change they mutate into different
atom types. During the mutation for this group the intra- and inter- atomic
interactions are progressively changed between the starting and the final atom
configurations. Figure 2.7 shows the three atom groups considering alchemical
mutations between the ethane and methane molecules.
The “to dummy” and “from dummy” atom groups are introduced to deal with
cases where particles appear or disappear along an alchemical transformation.
From a computational point of view these atoms can lead to numerical instability if
they are not correctly handled. In particular near the end points of the mutations
the interatomic distances between “to dummy” or “from dummy” atoms and other
system atoms e.g. solvent molecules could become relatively small (steric clashes)
producing high variation in the inter-molecular potential energy and therefore
possible computational failures. In order to mitigate the problem the use of the




















where σij and εij are the Lennard-Jones parameters of a pair of particles i and
j whose distance is rij while qi, qj are the atomic charges; δ and the integer








































Figure 2.7: (a) Mutation of ethane to methane. The purple atoms are “to
dummy” atoms because they are present in the starting molecule but not in the
final one. (b) Mutation of methane to ethane. The red atoms are “from dummy”
atoms because they are present in the final molecule but not in the starting one.
(c) Same mutation as in (a). The green atoms are “hard” atoms because they
are present in the starting and in the final molecules. In this case one of the two
carbons is mutated into a hydrogen atom.
2.3. An Implementation of the Single Topology Method 63
n are used to control the softening. From this equation it is clear that when
the distance between atoms is zero (steric clashes) the potential is numerically
computable (finite) because of the presence of the term λδσij . It is interesting to
observe that the coupling parameter λ needs to vary differently between the three
groups of atoms. For example in the “to dummy” group, for increasing values of
coupling parameter the interactions are progressively turned off in contrast with
the “from dummy” group where they are progressively turned on.
In the implemented code, the coulomb interactions were also evaluated by us-
ing the reaction field potential (90;91). The use of this potential simulates the pres-
ence of a medium of constant dielectric εsolvent to partially correct the Coulomb
long-range interactions computed with cut-offs. Although this method is not as
accurate compared to other methods such as the Ewald summation (30) it is very
easy to implement and very computationally efficient. The Coulomb interactions







































In the previous equations rcutoff is the cutoff distance and εsolvent is the dielectric
constant of the solvent.
The “to dummy” and “from dummy” atom groups also require a special treat-
ment for the intra-bonded molecular interactions. Indeed, the creation and de-
struction of atoms, leads to the creation and destruction of bonds, angles and
dihedrals angles. Actually, the dihedral angle annihilations are not particularly
difficult to implement. Indeed it is possible to set to zero the amplitude and
phase of the angle dihedral to produce a null dihedral. On the other hand, set
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to zero the force constants in the harmonic potentials related to the bond and
angle terms in the mechanical potential (equation 2.8) could potentially produce
unstable and noisy sampling. Indeed, for example, the progressively annihilation
of the force constant in the potential bond term could lead to problematic bond
shrinking which could produce difficult convergence problems. In order to over-
come the problem it is interesting to observe that the free energy change between
two thermodynamic states where the amplitude and the equilibrium constant of
a harmonic potential are changed produces a variation equal to (92):




where, ki and kf are respectively the starting and the final force constant, kB the
Boltzmann constant and T the temperature. As a consequence, in an alchemical
transformation where the creation or destruction of bond and angle terms are
involved, free energy changes will annihilate if it is set ki = kf . This strategy was
implemented in the developed code.
In the single topology method, a common topology between two mutant
molecules is used to perform the alchemical transformation; the topology is mor-
phed between the end states using the coupling parameter opportunely intro-
duced into the system Hamiltonian. In this method, an important aspect is the
determination of the topology parts that change between the end states. This is
extremely important because it allows the detection of the different atom groups:
“to dummy”, “from dummy” and “hard”. In order to detect structure changes
between the end states, graph matching algorithms were used. These algorithms
have been extensively applied in the analysis of chemical molecules and chem-
ical reactions (93). In these algorithms a molecule is treated as a mathematical
graph. Briefly a graph G is made with a collection of N nodes (the atoms in a
molecule), and a set E of arcs connecting pair of nodes E = N × N (the bonds
in a molecule) (93). Two nodes are adjacent if they are connected by one arc. A
labeled graph is a graph where each node and arc has a label. A molecule can be
effectively seen as a labeled graph where the atoms are labeled with atom names
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and arcs with bond types. A subgraph of G is defined as a subset P ⊆ N of
nodes of G with a subset of its arcs F ⊆ P × P (93). In addition, two subgraphs
are isomorphic if there is a mapping between the nodes such as adjacent nodes in
the first subgraph are mapped in adjacent nodes in the second subgraph (93). A
common subgraph of two graphs G1 and G2 consists of two subgraphs H1 of G1
and H2 of G2 such that H1 is isomorphic to H2 (93). The Maximum Common Sub-
graph (MCS) of two graphs is the common subgraph which contains the largest
possible number of arcs (93). In order to detect changes between the end states of
an alchemical transformation and detect the common topology, algorithms based
on the detection of the MCS can be used. Most of the time these algorithms are
bases on backtracking techniques (94) in conjunction with alpha-beta pruning (95).
These algorithms have a non polynomial complexity on the number of atoms and
they are frequently applied between small molecules only such as ligands. Figure
2.8 shows the construction of the MCS between benzene and aniline molecules us-
ing an unlabelled MCS algorithm. In the implemented code, the MCS algorithm
was not directly implemented but, an external computer program FeSetup (96) was
used to generate an appropriate input file where all the mutations between the
end states were detected, an therefore, to create the common topology.
The relative free energy code based on the FDTI and the single topology meth-
ods was developed extending Sire (74) through the use of the OpenMM APIs (75).
Sire is a molecular modelling framework developed in the C++ programming lan-
guage. In order to simplify the programming to non-expert users, the Sire public
class interface has been exposed to a more friendly programming language such as
Python. Sire allows the creation of molecular systems using different approaches
e.g. using Amber (97;98) topology files. It was originally developed to sample
molecular systems by using the MMC algorithm and more recently by using MD
(implemented by the same author of this thesis) through the use of the OpenMM
APIs. These APIs are able to implement MD algorithms by using the modern par-
allel architectures present on the latest GPU and gain significant computational
power compared to more conventional approaches. Furthermore, these APIs do
not explicitly require the knowledge of dedicated GPU programming languages






























Figure 2.8: (a,b) The benzene and aniline molecules are considered as two math-
ematical graphs. The nodes of each graph are labelled using integer numbers. The
MCS algorithm finds the isomorphism between the largest common parts of the
two chemical structures. In this case for example, the atom with index 6 in the
benzene molecule is mapped into the atom with atom number 12 in the aniline
molecule and so on. (c) The MCS graph is highlighted in light blue. The compar-
ison of the MCS with the starting molecules allows the detection of the mutating
parts in an alchemical mutation. In this case, these parts are highlighted in red.
such as CUDA or OpenCL. Figure 2.9 illustrates the linking between Sire and its
extension using OpenMM. In the relative free energy implementation OpenMM
was used to code the mechanical potential described in the equation 2.8 with the
use of soft core potential 2.10 and reaction field 2.12. The implementation of
bonded and non-bonded terms was performed using custom potential expressions
in OpenMM. In particular the inter-molecular potential applied to the different
atom groups was implemented as follows:
• hard - hard interactions: Coulomb with reaction field and Lennard-Jones
potential;




Figure 2.9: The direct use of the Sire APIs could be difficult for scientists not
expert in advanced programming because of the high abstracted interface imple-
mented in C++. As a consequence, an easier front-end has been developed using
Python wrappers. In Sire the system sampling is performed by using the MMC
algorithm. Sire was linked with the OpenMM APIs to perform MD simulations us-
ing the capability of the latest GPUs. This has a dramatic impact on the speed-up
of the MD simulations because of the huge number of cores and the high memory
bandwidth present on these architectures.
• to dummy - to dummy interactions: soft core potential with reaction field;
• from dummy - from dummy interactions: soft core potential with reaction
field
• hard - to dummy: soft core potential with reaction field;
• hard - from dummy: soft core potential with reaction field;
• to dummy - from dummy: soft core potential with reaction field.
Figure 2.10 reports a summary of the inter-molecular potential used. The 1-4
intra-molecular non bonded interactions were implemented with custom bonded
OpenMM expressions using the same schema represented in Figure 2.10. This
potential was not applied to atom particles separated by one or two covalent bonds
(1-2, 1-3 interactions). The intra-molecular bonded terms were implemented by
using custom OpenMM potential expressions for the bond, angle and dihedral
terms.
In order to test and calibrate the implementation, single point energy calcu-
lations were performed on different systems for selected values of the coupling














Figure 2.10: The implemented inter-molecular interactions between a mutant
solute and a system composed by solvent molecules and a protein. The inter-
molecular interactions between “hard” atoms are evaluated using the standard LJ
potential (equation 1.17) and reaction field potential (equation 2.11) and named
in figure as ULJ and RF . The other inter-molecular interactions are evaluated by
using soft core potential with reaction field (equation 2.10 where the Coulomb term
is replaced by equation 2.12) and named in figure as Usoft with RF .
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parameter. The total potential energy for different alchemical mutations in vac-
uum was computed by using the implemented code in OpenMM and then com-
pared with the same potential energy implemented in Sire only without using
OpenMM. The OpenCL platform was selected in OpenMM on GPU with mix
precision while the calculation in Sire were performed on CPU in double preces-
sion. A total of 100 mutations involving different polar and non polar molecule
groups were considered and the software package FEsetup (96) was used to set
the different systems and to generate the common topology used to perform the
alchemical mutation and table (2.1) reports all the selected mutations. The point
atomic charges were assigned by using the Amber module Antechamber (97;98), se-
lecting the AM1-BCC method (28) and GAFF (97;98) was used for the generation of
the other force field parameters. The total system potential energy was computed
for eleven values of the coupling parameter λ equally spanned over the range
[0,1]: (0.0, 0.1, 0.2, 0.3, 0.4, 0.5, 0.6, 0.7, 0.8, 0.9, 1.0). The statistical agreement
between the different window values was assessed evaluating the absolute error
between the calculated potential energy in Sire and OpenMM. On average the
Mean Unsigned Error (MUE) recorded considering all the mutations was ' 10−5,
which is in agreement with similar tests used to compare CPU vs GPU potential
energy errors (99)
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Table 2.1: The total potential energy for eleven windows in 100 alchemical mu-
tations was calculated with OpenMM and compared to the same potential im-
plemented in Sire only. The statistical agreement for each system was assessed
evaluating the absolute error for each single point energy calculation between Sire
and OpenMM. On average the overall MUE ' 10−5
System number Transformation System number Transformation
1 acetamide to acetone 51 methylbenzene to benzene
2 acetamide to methylethene 52 methylbenzene to methane
3 acetone to acetamide 53 methylbenzene to phenol
4 acetone to dimethylether 54 methylethene to acetamide
5 acetone to formaldehyde 55 methylethene to formaldehyde
6 acetylbenzene to aniline 56 methylethene to methylacetylene
7 acetylbenzene to methylacetatebenzene 57 methylfuran to methane
8 aniline to acetylbenzene 58 methylfuran to methylpyrrole
9 aniline to methylbenzene 59 methylfuran to methylthiene
10 aniline to nitrobenzene 60 methylfuran to methyltriazole
11 aniline to pyridine 61 methylfuryltriazole to methyltriazole
12 benzene to chlorobenzene 62 methylindole to methane
13 benzene to cyclopropylbenzene 63 methyloxadiazole to methyloxazole
14 benzene to ethynebenzene 64 methyloxadiazole to methyltriazole
15 benzene to methylbenzene 65 methyloxazole to methyloxadiazole
16 benzene to nitrilebenzene 66 methyloxazole to methylpyrrole
17 benzene to pyridine 67 methyloxazole to methyltriazole
18 benzene to triazine 68 methylphenyltriazole to methyltriazole
19 chlorobenzene to benzene 69 methylpyrrole to methylfuran
20 chlorobenzene to nitrilebenzene 70 methylpyrrole to methyloxazole
21 chlorobenzene to phenol 71 methylpyrrole to methylthiene
22 cyclopropylbenzene to benzene 72 methylthiene to methylfuran
23 dimethylether to acetone 73 methylthiene to methylpyrrole
24 dimethylether to dimethylsulfide 74 methyltriazole to methylfuran
25 dimethylether to methanol 75 methyltriazole to methylfuryltriazole
26 dimethylether to propane 76 methyltriazole to methyloxadiazole
27 dimethylsulfide to dimethylether 77 methyltriazole to methyloxazole
28 dimethylsulfide to propane 78 methyltriazole to methylphenyltriazole
29 ethane to methane 79 neopentane to ibutane
30 ethane to methanol 80 neopentane to methane
31 ethane to propane 81 nitrilebenzene to benzene
32 ethynebenzene to benzene 82 nitrilebenzene to chlorobenzene
33 ethynebenzene to nitrilebenzene 83 nitrilebenzene to ethynebenzene
34 formaldehyde to acetone 84 nitrobenzene to aniline
35 formaldehyde to methylethene 85 nitrobenzene to pyridine
36 ibutane to neopentane 86 nitrobenzene to triazine
37 ibutane to propane 87 phenol to chlorobenzene
38 methane to ethane 88 phenol to methylbenzene
39 methane to methanol 89 propane to dimethylether
40 methane to methylbenzene 90 propane to dimethylsulfide
41 methane to methylfuran 91 propane to ethane
42 methane to methylindole 92 propane to ibutane
43 methane to neopentane 93 propane to methane
44 methane to propane 94 pyridine to aniline
45 methanol to dimethylether 95 pyridine to benzene
46 methanol to ethane 96 pyridine to nitrobenzene
47 methanol to methane 97 pyridine to triazine
48 methylacetatebenzene to acetylbenzene 98 triazine to benzene
49 methylacetylene to methylethene 99 triazine to nitrobenzene
50 methylbenzene to aniline 100 triazine to pyridine
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2.4 Relative Hydration Free Energy calculation. Ethane to
Methanol a case study
The relative free energy implementation was tested on many systems. In this
section, results related to the calculation of the relative hydration free energy be-
tween the ethane and methanol molecules are reported. The alchemical path used








ΔΔGHyd = ΔGHyd2 - ΔGHyd1 = ΔGsol - ΔGvac
Figure 2.11: The relative free energy of hydration between two molecules L1 and
L2 can be computed performing two alchemical mutations. In the first simula-
tion the molecule L1 is mutated into the molecule L2 (∆Gvac) and in a second
simulation the same mutation takes place in a solvent environment (∆Gsol). The
differences between these two free energy changes equates the relative hydration
free energy: ∆∆GHyd = ∆Gsol −∆Gvac .
to perform two alchemical mutations between the two molecules respectively in
an aqueous environment and in vacuum. The software package FEsetup (96) was
used to set the systems and generate the common topology used to perform the
alchemical mutations. The point atomic charges were assigned by using the Am-
ber module Antechamber (97;98) selecting the AM1-BCC method (28). GAFF (97;98)
was used for the generation of the other force field parameters and the system
was also solvated in a box of water selecting TIP3P as water model by using
the Amber module LEaP (97;98). Before the production run, the system was min-
imized for 100 cycles by using the steepest descent method and equilibrated a
298K and 1 atm pressure for 200 ps - 2 fs time step by using the Amber module
Sander (97;98). In this process harmonic restraint were set on the common topology
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by using a restraint force constant of 10 kcal mol−1 Å−2 and selecting the starting
atom positions as restraint positions. The hydrogen bonds were constrained to
their equilibrium distances in this stage. In order test the implementation the
system sampling was performed using MD through OpenMM and using the stan-
dard MMC in Sire. Sixteen values of the coupling parameter λ were selected in
the range [0,1]: (0.0000, 0.0109, 0.0432, 0.0955, 0.1654, 0.2500, 0.3455, 0.4477,
0.5523, 0.6545, 0.7500, 0.8346, 0.9045, 0.9568, 0.9891, 1.0000). These values were
calculated by using the Chebyshev nodes to improve the numerical stability of
regression techniques used to estimate the TI integral. Indeed recent studies have
shown that the use of polynomial regression using equidistant values could lead to
convergence problems when the interpolation is performed with high polynomial
orders (100). Chebyshev nodes have been proven to mitigate this issue especially
in the TI method when the interpolated curve is not smooth enough. The cou-
pling parameters λ were generated using the following equation derived from the
Chebyshev nodes (100):
λ = 12 | cos(ψπ)− 1| (2.15)
where ψ ∈ [0, 1]. The MD production run was performed for 5 ns constraining
all the bonds and selecting a time step of 2 fs. During the simulation 25 × 104
gradient values were collected and used to compute the gradient for each window
in the solvent and in the vacuum simulation. In addition in the solvent simula-
tions the pressure and the temperature were kept constant respectively using the
Monte Carlo Barostat algorithm (101;102), setting the Monte Carlo frequency to 25
steps, and using the Andersen thermostat (82) with a collision coefficient of 1/ps.
The coulomb power and the delta shift soft-core parameters were respectively set
to 0 and 2. All the bonds containing hydrogens were constrained to their equilib-
rium distance and the non-bonded interactions were evaluated by using an atom
based cut off scheme setting the cutoff distance to 10 Å . In the solvent simula-
tion, the electrostatic interactions were calculated by using reaction field with the
medium dielectric constant set to the water dielectric constant (εsolvent = 78.3).
The sampling by using the MMC method was performed in the solvent state se-
lecting 200 × 5 · 105 moves. In each move the solvent molecules were allowed to
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perform a maximum translation of 0.15 Å and a maximum rotation of 15 degrees.
The solute was allowed to move with a maximum translation of 0.192 Å and a
maximum rotation of 15 degrees. In addition the maximum volume move was set
to 360 Å3. For the vacuum state by using MMC method the number of internal
Monte Carlo moves was set to 200 × 1000. The simulation in vacuum and sol-
vent were repeated three times for both sampling methods and the uncertainties
were calculated as standard deviation of the mean over the three independent
runs. Figure 2.12 reports the free energy gradient variations along the alchemical
mutations in vacuum and solvent sampling the system by using MD and MMC.
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Figure 2.12: Free energy gradient evaluated for the vacuum and solvent muta-
tions using MD and MMC. The free energy gradient was computed for 16 windows
selected in the range [0,1]. The difference between the highlighted areas represents
the relative hydration free energy for the MMC case only.
regression and the computed values for the relative hydration free energies by
using MD and MMC were respectively −6.270± 0.003 kcal/mol and −6.49± 0.03
kcal/mol. The experimental value calculated by using the solvation free energy
database reported by Mobley (103) was: -6.93 kcal/mol.
The relative ethane to methanol hydration free energy calculation was histor-
ically simulated for the first time by using the single topology method, FEP and
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MMC by Jorgensen et al. (53) and nowadays it is often used as horse test for new
single topology implementations. It is interesting to observe that the calculated
value was -6.93 kcal/mol in the original paper, which is in very close agreement
with the experimental value just using few windows. The discrepancy with the
calculated values here could be blamed to the force field. In the Jorgensen paper
the calculation was performed by using the OPLS force field to parameterise the
ethane and methanol molecules while TIP4P water model was selected for the
solvent and it could be the luckily reason for the experimental discrepancy.
Our results show that the hydration free energies computed by using MD
and MMC are not consistent in error bars. Theoretically, in the limit of infinite
sampling time the results have to be the same but, practically, this often does not
happen. It is well known, that one of the main differences between the methods
is related to the efficiency in exploring the configurational space. In the MMC
method, the system is evolved using random moves and therefore the method is
ergodic by construction. On the other hand, by using MD to generate moves
the system tends to move in regions of configuration space with lower energy
and, therefore climbing high energy barriers could be very problematic. In the
considered system, due to the relatively small number of particles and the selected
setting to perform the simulations the sampling should not be the cause of the
discrepancy. It is possible that this is related to the thermostat and/or barostat
schemes used and their setting to perform the MD simulations, which did not
correctly sample the NPT ensemble.
2.5 Absolute Hydration Free Energy calculation.
1,2-Dichloroethane a case study
A flavour of dual topology method was also developed to calculate absolute hy-
dration free energy using the alchemical path illustrated in Figure 2.3 (a). The
implementation was applied to the calculation of the absolute hydration free en-
ergy of 1,2-dichloroethane molecule. In the selected alchemical path, the inter-
molecular interactions between the solute and solvent were progressively switched
on by using the soft core potential. The switching was performed in two different
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stages. In the first stage the VdW interactions were turned on and subsequently,
in a second stage, the Coulomb interactions were turned on. In particular, twenty
coupling parameters λ were selected in the range [0, 2]. In this range when the λ
values were varying between [0, 1] the VdW forces related to the soft-core term,
were progressively switched on while the Coulomb forces were kept off (first stage).
For higher values of λ ∈ (1, 2] the VdW terms were kept on and coulomb forces
were progressively switched on (second stage). This approach was used to avoid
steric clashes between the solute and solvent atoms with opposite charges at the
beginning of the simulation. The 1,2-dichloroethane molecule was parameterised
using GAFF (97;98) and the point atomic charges were assigned using the Am-
ber module Antechamber (97;98) selecting the AM1-BCC method (28). In addition,
TIP3P water model was used for the solvent. Before the production run the
system was minimized for 100 cycles by using the steepest descent method and
equilibrated at 298K and 1 atm pressure for 200 ps - 2 fs time step by using the
Amber module Sander (97;98). In this process harmonic restraint were also set on
the solute molecule by using a restraint force constant of 10 kcal mol−1 Å−2 and
selecting the starting solute atom positions as restraint positions. The system was
sampled by using two different methodologies: MMC and MD. For each method
the simulations were repeated three times and statistical uncertainties were cal-
culated using the standard deviation of the mean. The MD simulations were
performed for a total time of 1 ns using a time step of 1 fs. During the production
run using MD all bonds and angles containing hydrogen atoms were constrained
and the temperature was set to 298 K while the pressure was kept constant at
1 atm. The pressure and the temperature were controlled respectively using the
Monte Carlo Barostat algorithm (101;102), setting the Monte Carlo frequency to
25 steps, and using the Andersen thermostat (82) with a collision coefficient 1/ps.
The coulomb power and the delta shift soft-core parameters were respectively
set to 0 and 2. All the bonds containing hydrogens were constrained to their
equilibrium distance and the non-bonded interactions were evaluated by using an
atom based cut off scheme setting the cutoff distance to 10 Å . The electrostatic
interactions were calculated by using reaction field with the medium dielectric
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constant set to the water dielectric constant (εsolvent = 78.3). During the MD
sampling 50 · 104 gradient values were collected and used to calculate the ensem-
ble average. The sampling by using the MMC method was performed selecting
100 × 106 moves. In each move the solvent molecules were allowed to perform
a maximum translation of 0.15 Å and a maximum rotation of 15 degrees. The
solute was only allowed to have a maximum rotation of 15 degrees. In addition
the maximum volume move was set to 122.25 Å3. Twenty windows were selected
in the range [0,2]: (0.0000, 0.0145, 0.0573, 0.1257, 0.2160, 0.3227, 0.4397, 0.5603,
0.6773, 0.7840, 0.8743, 0.9427, 0.9855, 1.0000, 1.1090, 1.2830, 1.5000, 1.7170,
1.8910, 2.0000). These values were calculating by using the Chebyshev technique
previously described Chebyshev equation (2.15). With the aim of further improv-
ing the integral calculation, 14 out of 20 points were selected in the λ range [0, 1].
In this range the average gradient undergoes higher variations because of the rela-
tive short distances between water molecules and the 1,2-dichloroethane molecule
with significant contributions related to the VdW forces. The TI integral was
calculated interpolating the gradient data with a polynomial regression of order
seven. In addition, trapezium integration was also carried out and compared with
the polynomial integration. The results related to the evaluation of the gradient
for both methods are shown in Figure 2.13. Table 2.2 reports a comparison of
the calculated hydration free energy sampling the system by using the MD and
MMC methods and Figure 2.14 shows a comparison between the convergence time
Table 2.2: Values of free energy of hydration related to the 1,2-dichloroethane
molecule at 298K sampling the system by using the MD and MMC methods. The
numerical integration was carried out using a polynomial regression of order seven
and using the trapezium integration quadrature rule. Data is reported in kcal/mol
along with the experimental data. Three independent runs were performed for MD
and MMC and uncertainties were calculated propagating the standard deviation of
the mean of the recorded binding affinities.
MD MMC
Polynomial Regression -0.18 ± 0.06 -0.3 ± 0.1
Trapezoid -0.15 ± 0.07 -0.3 ± 0.1
Experimental data -0.17 ± 0.01
of the cumulative gradient by using both methods. The agreement between the
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MD MMC
λ ∂G∂λ ± δ ∂G∂λ ± δ
0.0000 -0.7 ± 0.2 -0.9 ± 0.1
0.0145 0.3 ± 0.2 0.1 ± 0.1
0.0573 3.4 ± 0.2 3 ± 0.3
0.1257 6.3 ± 0.5 6.1 ± 0.2
0.2160 5.4 ± 0.8 5.4 ± 0.3
0.3227 3.5 ± 0.3 3.4 ± 0.4
0.4397 2.3 ± 0.4 2.4 ± 0.3
0.5603 1.3 ± 0.6 1.9 ± 0.4
0.6773 0.6 ± 0.2 0.8 ± 0.3
0.7840 0.1 ± 0.2 0.2 ± 0.5
0.8743 -0.1 ± 0.2 0.2 ± 0.3
0.9427 -0.486 ± 0.007 -0.1 ± 0.3
0.9855 -0.66 ± 0.05 -0.4 ± 0.2
1.0000 -0.30 ± 0.07 -0.2 ± 0.1
1.1090 -0.37 ± 0.03 -0.47 ± 0.02
1.2830 -0.95 ± 0.02 -1.08 ± 0.02
1.5000 -1.87 ± 0.05 -2.07 ± 0.07
1.7190 -3.2 ± 0.1 -3.5 ± 0.1
1.8910 -4.5 ± 0.1 -5.2 ± 0.2









Figure 2.13: Values of the free energy gradient per each coupling parameter λ
used for the MD and MMC methods. The values are expressed in kcal/mol. The
gradient values are the arithmetic average over three runs and δ represents the
related standard deviation of the mean.
two methodology was quite satisfactory and assessed calculating the determina-
tion coefficient: R2 = 0.99. It is interesting to observe that the binding affinity
calculated with MD method was closer to the experimental value compared to
MMC. Figure 2.13 shows that the difference is mainly originated when the 1,2-
dichloroethene molecule is nearly fully decoupled from the solvent environment.
As previously described, it is notorious that the dual topology method is hard to
converge especially at the end states of alchemical mutations and longer sampling
is usually required. Figure 2.14 shows convergence problem for one of the selected
window for the MMC method compared to the MD method and this could explain
the discrepancy between the two approaches in this particular calculation.
2.6 Chapter Conclusions
In this chapter was presented an implementation of the single topology alchemical
method and the FDTI method used in conjunction to calculate relative binding
affinities. The implementation was performed merging two pieces of software
Sire and the OpenMM APIs. The former is a molecular modelling framework
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Figure 2.14: Variations of the cumulative gradient at the temperature of 298K
for the value of the coupling parameter λ = 0.0145 versus the total simulation
time. The sampling of 100×106 MMC moves required about 35 hours for the case
study. On the other hand, the MD time required to perform 1 ns simulation was
18 minutes. The final convergent value is different between the two methods and
overall the MMC sampling seems to be more problematic than the MD sampling.
This could suggest that longer sampling is required for the MMC method for the
selected window.
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extremely flexible in bio-molecular modelling, definition and editing of molecular
parameters and implementation of new molecular simulation methods. On the
other hand, the OpenMM APIs allows the simulation of molecular system by using
MD accelerated by using the latest piece of hardware such as GPU. In order to test
the code, the implemented potential energy function by using the OpenMM APIs
was compared to the same potential energy function implemented in Sire only
and single point calculation energy were performed on 100 alchemical mutations.
Results were in excellent agreement with a MUE error of ' 10−5. Subsequently,
the relative hydration free energy of ethane to methanol was calculated by using
the implemented code and MMC. The results were in good agreement with the
experimental value (< 1 kcal/mol) although, the MMC result was closer to the
experimental value compared to the MD based implementation. The discrepancy
could be caused by a not correct sampling of the selected NPT ensemble. Finally,
the absolute hydration free energy of 1,2-dichloroethene was calculated. In this
case, the MD based implementation result was in excellent agreement with the
experimental data compared to the MMC method. The problem seems to be
related to the sampling of few windows closer to the fully decoupled end state that
are not sampled enough by using the MMC method. In Chapter four the code
will be validate on a more significant bio-molecular system such as the Thrombin
protein.
“There are two possible outcomes: if the result confirms the hypothe-
sis, then you’ve made a measurement. If the result is contrary to the
hypothesis, then you’ve made a discovery”
— Enrico Fermi
3




or a long time chemists and biochemists considered molecules just in
terms of their atomic constituents and two dimensional structure. The
importance of three dimensional conformations was only discovered
later on by semiochemists, when they became interested in the interactions be-
tween fragrant substances with receptors (104). This led to the notion of a molecu-
lar shape that reflects a given arrangement of the atoms of a molecule in space. In
general, different molecular conformations need to be considered to explain many
chemical-physical properties that cannot be explained with just a single conforma-
tion. Conformers are stereoisomers in dynamic equilibrium that could differ from
each other through stretching and bending of bonds or rotations around covalent
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bonds (105). Classes of molecules that may readily adopt different conformers are
often named “flexible” molecules. Molecular flexibility has been studied for long
time because of its importance in many contexts such as polymers, protein folding
or protein-ligand binding. For instance, in the latter, ligand functional groups fre-
quently need to adopt specific spatial arrangements to match the complementary
shape of the protein binding site.
In the next paragraphs of this chapter, an experimental and computational
study performed on the influence of molecular flexibility on the preferred confor-
mations of a set of related molecules will be detailed. The focus was to collab-
orate with the experimental group of Dr Cockroft (University of Edinburgh) to
reproduce in-silico the experimental data derived from NMR measurements. As
the computational models used were relatively inexpensive, the influence of force
field parameters on the resulting conformational equilibria was investigated. Such
studies are important to validate the accuracy of forcefields used in simulations
of large biological molecules.
3.2 The experimental systems
With the aim of studying the effect of molecular flexibility on conformational
equilibria, a set of molecules with two main moieties linked together by flexible
chains were experimentally synthesised. The two groups named here α and β
were designed to interact with each other by forming intra-molecular interactions
in solution. These molecules can adopt different conformers as schematically il-
lustrated in Figure 3.1. Many molecules were synthesised with different chain
lengths and Figure 3.2 represents the whole set of synthesised molecules. In each
molecule the α group is a 4-fluorophenol group, β an amide group and the linker
chain an alkyl chain. The hydrogen of OH in the 4-fluorophenol group is able
to form an intra-molecular hydrogen bond with the oxygen atom in the amide
group. In order to investigate how this intra-molecular hydrogen bond was af-
fected by the chain length, each linker molecule was solvated in a solution made
of chloroform and, a tributylphosphine at selected concentrations. Following the
experimental setup, the thermodynamic process can be represented as illustrated







Figure 3.1: Schematic representation of the synthesised molecules. In solu-
tion each molecule can adopt different conformations and can also form an intra-
molecular hydrogen bond between the groups α and β. The chain length has a
































Figure 3.2: The set of synthesised molecules. The alkyl amide substituent con-
tains 1, 2, 3, 4, 5, 6 and 8 carbon atoms excluding the two terminal methyl group.
The chain links a 4-fluorophenol group with an amide group. The two groups are
able to form an intra-molecular hydrogen bond between the hydrogen of OH in the
4-fluorophenol group and the oxygen of the amide carbonyl group.
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Figure 3.3: The thermodynamic process in solution can be represented by three
thermodynamic states. Each linker molecule is able to form intra- and inter-
molecular hydrogen bonds. The intra-molecular hydrogen bond defines the folded
and unfolded states. The inter-molecular hydrogen bond is formed with the trib-
utylphosphine oxide molecule. ∆Ginter and ∆Gintra are respectively the inter- and
intra- molecular complexation free energies.
namic states in dynamic equilibrium. A first state named the “unfolded” state
where the linker molecule is not forming either intra- or inter- molecular hydrogen
bond with itself or another solute. A second state named the “folded” state where
the linker molecule can form intra-molecular hydrogen bond interactions. Finally,
a third thermodynamic state where the linker molecule can form an hydrogen
bond between the hydrogen of OH in the 4-fluorophenol group and the oxygen of
tributylphosphine oxide molecule. Experimentally, the change in chemical shift of
the 31P signal of the tributylphosphine oxide was measured by using NMR titra-
tion and, just one chemical shift was observed. Therefore, the process illustrated
in Figure 3.3 seems to be a fast equilibrium process. The observed strength of
the tributylphosphine oxide bound complex is in direct competition with the in-
termolecular complex and, therefore, the measured energy of complexation ∆Gobs
is:
∆Gobs = ∆Ginter −∆Gintra . (3.1)
In the previous equation, ∆Gintra is the intra-molecular complexation energy
required to form the intra-molecular hydrogen bond and ∆Ginter is the inter-
molecular complexation energy required to form the inter-molecular hydrogen
bond. In order to indirectly measure ∆Gintra, the direct measurement of the
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∆Ginter contribution was performed by using NMR titration. To do this a molecule
similar to those depicted in Figure 3.2 was synthesised but lucking the amide
group. In this case, the thermodynamic process in solution can be described as














Figure 3.4: The amide group present in the original molecules was removed. In
this case, the thermodynamic process can be represented by two thermodynamic
states. This new molecule can only form inter-molecular hydrogen bond with
the tributylphosphine oxide molecule. The inter-molecular complexation energy
∆Ginter was measured by using NMR titration.
independent from the alkyl chain length and experimentally its measured value
was: ∆Ginter = −2.15 kcal/mol. Figure 3.5 reports the overall measured com-
plexation energy ∆Gobs and the indirect estimation of ∆Gintra for the different
linker molecules. The intra-molecular complexation energy can be decomposed
into an entropic and an enthalpic component. The former is associated to the
entropy related to the different conformations produced by rotations around the
alkyl chain and the latter is the change due to the enthalpy related to the intra-
hydrogen bond formation. It is clear from the experimental results that increasing
the alkyl chain length produces an increase in ∆Gintra and, therefore, an increase
in the entropic component.
3.3 The computational systems
The main goal of this research project was to calculate in-silico the intra-molecular
complexation energy ∆Gintra for the different linker molecules. In particular, this
study highlighted the importance of the force field parameterisations. The se-
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Figure 3.5: The overall experimental complexation energy ∆Gobs and the related
intra-complexation energy ∆Gintra.
lected molecular systems are indeed relatively small to enable extensive sampling
and precise calculations of ensemble averages at low compuatational cost. This
permits the evaluation of different parameter sets in a timely manner. The compu-
tation of the intra-molecular complexation energy can be performed by using the
















Figure 3.6: The thermodynamic process used to calculate ∆Gintra.
TI methods were introduced to calculate free energy changes. However, the his-
togramming technique is another popular method used to calculate a free energy
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change ∆G. This approach relies of the following thermodynamic equation:




where kb is the Boltzmann constant, T the temperature and P1 and P0 are respec-
tively the probabilities to find the system in the final and starting thermodynamic
state. In this particular case, P1 and P0 are respectively the probability of the
“folded” and “unfolded” state. From a computational point of view, it is possible
to estimate these probabilities by sampling the systems conformations by molec-
ular simulations and, by computing the relative frequencies of the two states
recorded along the simulation. In the limit of sufficiently large sample size, the
relative frequencies approach the equilibrium state probabilities. However, this
approach requires to discriminate between folded and unfolded state by using an
appropriate criteria. In the examined systems the folded state is related to the
intra-molecular hydrogen bond formation. A reasonable threshold distance to ob-
serve hydrogen bond is 2.5 Å between acceptor (oxygen atom in amide group) and
the hydrogen atom of the donor (phenolic hydroxyl) and it will be assumed from
now on. Although the systems are not computationally demanding in this case,
the force field parameterization was quite crucial to reproduce the experimental
results. Indeed, the experimental set up solvated the different linker molecules in
a solution made of chloroform and tributylphosphine oxide molecule. The evalua-
tion of the intra-complexation energy using the thermodynamic process in Figure
3.6 requires the modeling of the system in a solution of pure chloroform. In the
molecular simulation literature, this solvent is quite unusual and in principle, it
could have a significant impact on the linker molecule parameterization. In par-
ticular the atomic charge calculations. In order to find a suitable protocol to
perform MD simulations on each linker molecule, two atomic charge computation
methods were considered: AM1-BCC (28) and the Charge Model 5 (CM5) (106).
The AM1-BCC method is used to quickly produce high quality atomic charges
for computer simulation of organic molecule in polar media (28). The method em-
ulates the quantum electrostatic potential derived using the HF/6-31G* level of
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theory. This theory level has been shown to reproduce hydration free energies of
organic molecules with good accuracy and, therefore, it is adequate for aqueous
simulations (28). In the AM1-BCC method the atomic charge qAM1−BCCj of an
atom j is evaluated as follows (28):
qAM1−BCCj = qAM1j + qBCCj , (3.3)
where qAM1j is the charge evaluated by using the AM1 (107) semi-empirical method
and qBCCj is the correction charge calculated by using the Bond Charge Correc-






where γ is the total number of bond types present in the molecule, Tjα is the
bond connectivity template matrix and pα is the bond charge correction term.
In the AM1-BCC method, the pα parameters are estimated fitting a training set
of more than 2700 molecules with the electrostatic potential generated by using
HF/6-31G* level theory.
CM5 is a computational method used to calculate atomic charges designed
to accurately reproduce the dipole moment of a molecule by mapping the Hir-
shfeld (108) population charges onto a new set of charges (106). The model can be
applied to charged and uncharged molecule in gas or in solution. CM5 is a class
IV charge model i.e. the atomic charge are calculated to accurately reproduce
charge-dependent observable e.g. the dipole moment by using experimental data
or high level quantum mechanics calculations. CM5 is the successor of the CMx
models that were introduced to overcome the classes I,II and III charge model
problems such as the charge dependence on the molecular system orientations,
the dependence on the theory level and the selected basis set (106). CM5 is based
on the Hirshfeld population, which is less sensitive to basis set size and the basis
set choice compared to the CMx models (106). The CM5 charge qCM5k is calculated
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by using the following equation (106):




where qHPAk is the Hirshfeld charge, Bkk′ are constant values function of tab-
ulated atomic covalent radius and Tkk′ are the parameters to optimise. In the
optimisation process the MG3S basis set is used along with a training set of 614
molecular configurations with ether experimental reference dipole moments (388
data) or, theoretical reference dipole moments (226 data) (106). The latter are
density based dipole moments averaged over five theoretical methods (106). The
charges produced by the CM5 model are used for force field parameterisation in
MD simulations, for computing solvation free energy and for generating realistic
potentials and multipole moments (106).
In order to estimate the impact of the selected charge methods on the calcu-
lations the intra-molecular complexation energy was initially calculated for the
linker molecule with three carbon bonds along the alkyl carbon chain. The linker
molecule was modelled by using Schrödinger Maestro (109) and the following pro-
tocols named here AM1-BCC and CM5 were set to calculate the atomic charges
and to assemble the relative molecular systems:
• AM1-BCC protocol
– The atomic charges were assigned by using the Amber module An-
techamber (98) and selecting the AM1-BCC method;
– GAFF (97;110) was used for the generation of the other force field pa-
rameters of the solute;
– the linker molecule was solvated in a buffer of chloroform by using the
Amber module LEaP (98). The solvation in chloroform was performed
by selecting the keyword CHCL3BOX during the solvation process.
– the solvated system was minimised for 100 cycles by using the steepest
descend method and equilibrated at 300 K and 1 atm pressure for
105 MD steps with 2 fs time step (200ps) using the Amber module
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Sander. During the equilibration the linker molecule was restrained to
its starting position by using harmonic potential with a force constant
of 10 kcal mol−1 Å−2 and constraining bonds involving hydrogen atoms
to their equilibrium distance.
• CM5 protocol
– The linker molecule was geometrically optimized by using Gaussian
09 (111) and selecting the basis set M06-L/MG3S. The calculation was
performed until stationary point on the potential surface was found
using the eigenvalue-following algorithm;
– the Hirshfed population charge was calculated by using Gaussian 09 (111)
in the basis set M06-L/6-31+G(d,p) selecting as solvent environment
the chloroform (Gaussian keyword scrf=(solvent=chloroform));
– the Hirshfed charge were corrected in CM5 charges by using the CM5PAC
software package (112);
– GAFF (97;110) was used for the generation of the other force field pa-
rameters;
– the molecule linker was solvated in a buffer of chloroform by using the
Amber module LEaP (98). The solvation in chloroform was performed
by selecting the keyword CHCL3BOX during the solvation process.
– the solvated system was minimised for 100 cycles by using the steepest
descend method and equilibrated at 300 K and 1 atm pressure for
105 MD steps with 2 fs time step (200ps) using the amber module
Sander. During the equilibration the molecule linker was restrained
to its starting position using harmonic potential with a force constant
of 10 kcal mol−1 Å−2 and constraining the hydrogen bonds to their
equilibrium distance.
Figure 3.7 shows the assembled system.
The previous two generated systems were simulated by using the MD module
of the Sire-OpenMM software package (74). Sire-OpenMM was in part detailed
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Figure 3.7: The molecular system generated for the linker molecule with three
carbon bonds along the alkyl carbon chain.
in the second chapter for the calculation of the relative free energy of binding.
However, this piece of software was also extended to perform fast MD simulation
on GPUs by using the OpenMM APIs (75). In particular, the mechanical poten-
tial 1.21 detailed in Chapter one was implemented, adding support for the long
range electrostatic correction by using a reaction field (90;91). The MD simulations
were performed for 100 ns in the NPT ensemble setting the pressure and the tem-
perature respectively to 1 atm and 300 K. The pressure was regulated by using
MonteCarlo barostat (101;102) with isotropic scaling and an update frequency of 25
steps. The Andersen thermostat (82) was used to keep the temperature constant
selecting a coupling coefficient of 10 ps−1. The simulations were carried out by
using the Leap-Frog Verlet integrator with a 2 fs time step. All the bonds were
constrained to their equilibrium distances and the PME (113) cutoff scheme was
used selecting a cutoff-distance of 10 Å and a tolerance error of 10−4. During
the simulations, the intra-molecular distance between the hydrogen of the OH in
the 4-fluorophenol group and the oxygen atom in the amide group was monitored
(Figure 3.8) and, the intra-molecular complexation energy was calculated by using
equation 3.2. The histograms related to the intra-molecular distances by using
the two previous protocols for the charge calculations and related to the linker
molecule with thee carbon bonds are reported in Figure 3.9 along with the cal-






Figure 3.8: In order to calculate the intra-molecular complexation energy, the
intra-molecular distance Dintra was monitored along the MD simulations.
culated intra-molecular complexation energies. The results have shown that the
calculated binding energy are very different. The AM1-BCC method produces
a free energy change of -4.35 kcal/mol preferring the folded state. On the other
hand, the CM5 charge method produces a binding energy of +1.00 kcal/mol pre-
ferring the unfolded state. As previously described, the AM1-BCC method has
been optimised for polar media simulations where TIP3P, SPC and TIP4P water
model are frequently used. The CM5 method is a more robust charge method for
force field parametrisation and the defined CM5 protocol allows the selection of
the chloroform as solvent environment. Overall, the agreement between experi-
mental and predicted data was considered closer by using the CM5 methods and,
therefore, in this research project this protocol has been selected as standard pro-
tocol for the charge calculations and the linker molecule setting. The described
CM5 protocol used to set the linker molecule system and the MD setting will be
extensively used in the rest of this chapter with small changes where stated. As a
consequence, this two protocols will be often referenced as the CM5 protocol and
the MD settings or protocol.
In the CM5 protocol the linker molecule was solvated in a buffer of chloroform
by using the Amber module LEaP and, specifying, the keyword CHCL3BOX (114)
during the solvation process. A simulation test was conducted to highlight if the
predefined chloroform atomic charges used by LEaP could significantly change
the simulations. With this aim, a chloroform molecule was sketched by using
Schrödinger Maestro (109) and the atomic charges were calculated as described in
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Figure 3.9: The intra-hydrogen bond formation was monitored recording the
intra-molecular distance Dintra shown in Figure 3.8 along a MD simulation. The
threshold to have hydrogen bond formation was set to 2.5 Å (red vertical lines).
The distance histograms obtained by using the AM1-BCC and the CM5 protocols
are shown for the linker molecule with three carbon bonds along the alkyl chain.
The intra-molecular complexation energy for both methods was calculated by using
the equation 3.2. The probability of the folded state was estimated counting the
frequency to observe the monitored intra-molecular distance to be less or equal to
the selected threshold distance (Dintra 6 2.5 Å).
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the CM5 protocol. Subsequently, the linker molecule with three carbon bonds
along the chain was solvated in a box of chloroform by using the new chloroform
molecule, without using the predefined LEaP chloroform model. A new MD
simulation was conducted on the assembled system with the MD setting previously
detailed. A comparison between the intra-molecular distance histograms produced
by using the predefined chloroform model and the optimised version are shown
in Figure 3.10 along with the calculated intra-molecular complexation energies.
Significant differences were not observed and the standard LEaP chloroform model
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Figure 3.10: In the CM5 protocol the solvation stage was executed by using a pre-
defined model for the chloroform molecule. An optimised version of this molecule
was modelled by using the CM5 atomic charge calculation. The intra-molecular
distance histograms related to the linker molecule with three carbon bonds show
that there are no significant differences between the optimised version (right his-
togram) and the standard parametrisation used by LEaP (left histogram).
The CM5 and MD protocols previously used to set and simulate the linker
molecule with three carbon bonds were also used to set and simulate all the
linker molecules shown in Figure 3.2. Each simulation was repeated three times
and the uncertainties were calculated as standard deviation of the mean over
the three independent runs. For each system, the intra-molecular complexation
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energy was calculated by using the equation 3.2 and results are reported in Figure
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Figure 3.11: (a) A comparison between the experimental and predicted intra-
molecular complexation energies for the different linker molecules illustrated in
Figure 3.2. (b) Experimentally the probability to observe 50% the folded state and
50% the unfolded state is measured between four and five carbon chain lengths. As
a consequence, a correct comparison between the experimental and predicted data
should shift the experimental measurements to have zero intra-molecular complex-
ation energy when the carbon chain length is 4.5 carbon bonds.
experimental and predicted data, a problem to face is the measured zero free
energy point in the experimental data. Indeed, experimentally the probability
to observe 50% the folded state and 50% the unfolded state was measured when
the carbon length l is between l = 4 and l = 5 approximately. Therefore, a
correct comparison should shift the experimental data to have zero binding affinity
when the carbon length l = 4.5. To this end, the experimental intra-molecular
complexation energy of the system with l = 4 and l = 5 were averaged and
the resulting value of +0.8 kcal/mol was used to shift all the experimental intra-
molecular complexation energies. Figure 3.11 (b) reports the shifted values. The
predicted results validate the starting hypothesis that the increase in the carbon
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chain length decreases the intra-molecular complexation energy. This is due to
an increasingly favourable entropic contribution owing to the increased number of
conformations available to longer linker groups in the “unfolded” state. However,
there are discrepancies between the predicted and measured data especially for
the extreme values of the carbon chain length. A plausible explanation could
be the different “sensitivity” between the experimental measurements and the
computational model. In Figure 3.11 (b) the experimental measurements show a
plateau when the chain length l > 5 . On the other hand, the computational model
is significantly variable in this area. The unfolded population probability Po have
a difference of 0.8% between the systems with l = 6 and l = 8 however, this small
variation in the probability population produces a change in the calculated intra-
complexation energy of 1 kcal/mol which is significant in this context. In a similar
way, the experimental intra-complexation energy between l = 1 and l = 2 does
not significantly change while, the predicted value change is nearly 4 kcal/mol. In
this case, the folded population probability Pc presents a difference of nearly 18%.
To summarise, it should be possible to state that the experimental measurements
at the extremes of the carbon chain length are not able to record small population
changes between the unfolded and folded states; probably because they are lost
within the experimental noise. It is also interesting to observe the presence of a
local minima in the experimental and predicted data. However, the experimental
minima is recorded when the carbon chain length l = 3 while, it is predicted when
l = 4.
In order to improve the agreement between experimental and predicted data
the LJ parameters related to the linker molecule systems assembled by using the
CM5 protocol were modified to asses their impact on the simulations. In the MD
module of Sire-OpenMM the LJ potential was implemented by using the equation
1.17 described in Chapter one. In this equation, the well depth parameter εij
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where εi is a defined per atom force field parameter. In this case, the εi parameter
of each linker molecule with two, three, four and five carbon bonds were multiplied
by the factors 0.8 and 1.2. Each system was then simulated in a single run by
using the MD setting previously detailed and the intra-comlexation energy was
calculated. Results are reported in Figure 3.12. The impact on the simulation
was not significant and no further investigations were performed.
Predicted
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Figure 3.12: The per-atom well depth parameter εi was multipled by the factors
0.8 and 1.2 for the linker molecules with two, three, four and five carbon bonds
to check their impact on the calculated ∆Gintra values. The change in the intra-
complexation energy is shown along with the previously predicted. No significant
discrepancies were found and no further investigations were conducted.
Another important factor that could affect the simulations is the carbon chain
flexibility. This is mainly controlled by the force field parameters related to the
dihedral angles along the carbon chain. In the MD module of Sire-OpenMM,
the implemented dihedral potential energy is described by equation 1.20. The
dihedral flexibility is mainly regulated by the amplitude parameter An in the
cosine expansion. With the aim of improving the agreement between experimental
and predicted data, the amplitude parameter An of each dihedral angles along
the alkyl carbon chain was multiplied by the factors 0.3 and 0.8 for the system
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with two, four and six carbon bonds. Again, each system was then simulated in a
single run by using the MD protocol previously detailed and the intra-comlexation
energies were calculated; results are reported in Figure 3.13. In addition different
starting condition were tested with the chain starting in the folded and unfolded
states but no significant differences were recorded (data not shown). The results
highlighted that the simulations are not considerably affected by this change and
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Figure 3.13: The amplitude parameter of each dihedral angles along the alkyl
carbon chain was multipled by the factors 0.3 and 0.8 for the linker molecules with
two, four and five carbon bonds to check their impact on the calculated ∆Gintra.
The change in the intra-complexation energy is shown along with the previously
predicted. No significant discrepancy were found and no further investigations
were conducted.
In the experimental setup the different linker molecules were solvated in a so-
lution of chloroform and tributylphosphine oxide in selected concentrations. As a
consequence, in solution is present another molecule, the tributylphosphine oxide,
which has not been considered so far in the molecular simulations. The rea-
soning behind this experimental hypothesis was that the thermodynamic process
described in Figure 3.6 was not significantly affected by the tributylphosphine ox-
ide molecule. Actually, the whole thermodynamic process is instead described as
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Figure 3.14: In the experimental setup the full thermodynamic process can be
described by using four thermodynamic states. The states 2 and 3 are respectively
the “unfolded” and “folded” states previously introduced. In the state 0 the linker
molecule can form intra-molecular hydrogen bond and inter-molecular hydrogen
bond with the tributylphosphine oxide molecule while in the state 1, just the inter-
molecular hydrogen bond is formed. One of the experimental hypothesis was that
the state 0 was unlikely and, therefore, the tributylphosphine oxide molecule was
ignored in the simulation setup considered so far.
dynamic equilibrium, the “folded” and “unfolded” state previously introduced and
two other states where the linker molecule is able to form or not inter-molecular
hydrogen bonds with the tributylphosphine oxide molecule. For future references,
these four states were named state 0, state 1, state 2 and state 4 as reported in
Figure 3.14. The experimental hypothesis i.e. the fact that the tributylphosphine
oxide molecule is not considerably affecting the thermodynamic process in Fig-
ure 3.6 and, therefore, the correctness of the computational models tested so far,
could be proved or disproved if the state 0 is an unlikely state. In order to test
this hypothesis, a model of the tributylphosphine oxide molecule was sketched by
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using Schrödinger Maestro. Subsequently, its atomic charges were calculated by
using the CM5 charge method and the molecule was assembled with the linker
molecules in chloroform. Figure 3.15 illustrates an example of the produced sys-
tem. In order to check the effect of the tributylphosphine oxide molecule in the
Figure 3.15: The tributylphosphine oxide molecule was modelled by using the
CM5 protocol and assembled with the linker molecules. The systems were also
solvated in a box of chloroform.
system simulations the linker molecules with two and six carbon bonds along the
chain were simulated by using the MD protocol previously introduced. The intra-
and inter- molecular distances reported in Figure 3.16 were recorded along the
MD simulations and were used to discriminate between the four thermodynamic
states as follows:
• state 0 : Dintra 6 2.5 Å and Dinter 6 2.5 Å
• state 1 : Dintra > 2.5 Å and Dinter 6 2.5 Å
• state 2 : Dintra > 2.5 Å and Dinter > 2.5 Å
• state 3 : Dintra 6 2.5 Å and Dinter > 2.5 Å
The MD simulations were repeated three times and the uncertainties were calcu-
lated as standard error of the mean over the three independent runs. Figure 3.17
reports the results for the simulated systems. In addition, Figure 3.18 shows an
example of the intra- and inter- molecular distances recorded during a selected
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Figure 3.17: The probability to find the system in the four thermodynamic states.
The system with two carbon bonds along the chain (left figure) was mainly in the
folded state 3 forming intra-molecular hydrogen bond. On the other hand, the
system with six carbon bonds (right figure) preferred the unfolded state 2. In both
simulations the state 0 was unlikely.
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Figure 3.18: The intra- and inter- molecular distances recorded during a selected
MD run for the systems with two and six carbon bonds. The monitored distances
are reported in Figure 3.16. The light coloured areas are the different four ther-
modynamic states while, the black shaded points are the recorded distances. The
system with two carbon bonds (left figure) preferred the state 3 while the system
with six carbon bonds (right figure) preferred the state 2.
run. Figure 3.17 seems to confirm the experimental hypothesis that the state 0
was unlikely.
The previous results could be however biased by a tributylphosphine oxide
concentration artefact. Indeed, the diffusive motions of the linker molecules and
the tributylphosphine oxide molecule during the MD simulations could limit the
binding event in the considered simulation time scale. In order to simulate the trib-
utylphosphine oxide molecule in higher concentrations and, therefore, limiting the
diffusive motion in solution, a restraint distance was implemented. The restraint
distance was applied between the hydrogen atom of OH in the 4-fluorophenol
group and the oxygen atom in the tributylphosphine oxide molecule. A special
custom potential was implemented in Sire-OpenMM and applied to the selected
atoms. The designed potential energy function UOH used is:
UOH = USOH + θ(r −Dmax)(r −Dmax)2 , (3.7)
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UOH = USOH + θ(r −Dmax)(r −Dmax)2
Figure 3.19: The potential energy function used to constraint the tributylphos-
phine oxide molecule in a given sphere. The sphere has a radius Dmax and it is
centred on the hydrogen of OH in the 4-fluorophenol group. The potential was
implemented to simulate the different tributylphosphine oxide concentrations in
solution.
atoms, Dmax a selected distance threshold, θ the Heaviside function and r the
distance between the selected atoms. Figure 3.19 illustrates these parameters.
When the inter-atomic distance between the selected atoms is less than Dmax,
the implemented potential equates the standard mechanical potential otherwise,
an harmonic contribution is added. As a consequence, the tributylphosphine ox-
ide molecule is approximately enclosed in a sphere of radius Dmax and, in the
implemented case centred on the hydrogen of OH in the 4-fluorophenol group.
Molecular simulations were performed by using the MD protocol and adding the
defined UOH potential. The systems with two and six carbon bonds with the
tributylphosphine oxide molecule were simulated using different values of the pa-
rameter Dmax: 4 Å, 8 Å and 12 Å. For each of this value, the simulation was
repeated three times and the uncertainties were calculated as standard deviation
of the mean over the three independent runs. Results are reported in Figures 3.20
and 3.21. In addition the system with four and five carbon bonds were simulated
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with the same setting but in a single run without repetitions (data not shown).
The state 0 was unlikely to happen for all the simulated systems and with
the range of considered tributylphosphine oxide concentrations. Therefore, the
tributylphosphine oxide and the linker molecules do not bind at the same time.
This result proved the correctness of the experimental hypothesis and the best
agreement between the predicted and experimental data reached in this research
project is shown in Figure 3.11.
3.4 Chapter Conclusions
This chapter investigated the effect of molecular flexibility on conformational equi-
libria of a set of molecules with two main moieties linked together by flexible
carbon chains. The molecules can experimentally adopt different conformers in
chloroform solution and, in particular, two thermodynamic conformations were
defined the “folded” and “unfolded” states. In the “folded” conformation an intra-
molecular hydrogen bond was formed and an in the “unfolded” state the hydrogen
bond was broken. The intra-molecular complexation energy between these two
states was computed by using molecular dynamics simulations and compared to
the experimental data. The agreement was not optimal but in many cases it was
possible to find reasonable explanations. With the aim of improving the agree-
ment, force field parameters were changed. The partial charges were computed by
using the AM1-BCC and the CM5 methods. The latter approach was preferred
because of closer results to the experimental values. Other force field parameters
were changes such as LJ and dihedral parameters but not significant changes were
observed. The partial charge seems to have the major impact in the calculations.
It would be possible to improve the agreement, for instance studying the effects of
the CM5 charge scaling or by using more advanced force fields such as polarizable
force fields or QM/MM methods.
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State 0 State 1 State 2 State 3
Dmax = 12Å
Figure 3.20: The probability to observe the four thermodynamic states for the
linker molecule with two carbon bonds and for different values of Dmax (equation
3.7) parameter is shown. This parameter is used to simulate the tributylphosphine
oxide concentrations. Low values of Dmax simulate high concentrations. The
results show that if the simulated tributylphosphine oxide concentration is in the
selected range Dmax = 4 Å, the tributylphosphine oxide binds the linker molecule.
On the other hand, if the concentration is Dmax = 12 Å the intra-molecular folded
state is preferred. The state 0 was unlikely for all the simulated tributylphosphine
oxide concentrations.
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Dmax  = 4Å
Dmax = 8Å
Dmax = 12Å
Figure 3.21: The probability to observe the four thermodynamic states for the
linker molecule with six carbon bonds and for different values of Dmax (equation
3.7) parameter is shown. This parameter is used to simulate the tributylphosphine
oxide oxide concentrations. Low values of Dmax simulate high concentrations.
The results show that if the simulated tributylphosphine oxide concentration is
high in the selected range (Dmax = 4 Å), the tributylphosphine oxide binds the
linker molecule and this happened also for lower concentration values. Also in
this case the state 0 was unlikely for all the simulated tributylphosphine oxide
concentrations.
“I still remember the day when my father gave me my first computer.
I was only ten, and at the time it was just an extraordinary machine
to play with. For me, the computer is still that remarkable toy that I
had as a child, but now I have changed game. It is a fantastic box that
can bring ideas and dreams to life, and to understand where all those







s shown in Chapter 1.2 a significant aspect along the critical path
for drug discovery is the optimization of the non-covalent binding be-
tween a disease-involved protein and small organic molecules. To this
end, free energy of binding is frequently used to quantify the protein-ligand in-
teractive strength and iterative SAR studies are performed on promising hits to
improve the binding affinity. Unfortunately, nowadays, the SAR stage seems to
be more an art to master than a standardised protocol to be routinely applied
by medicinal chemists. The main difficulties are correlated to the optimisation
of enthalpy and entropy components. Binding enthalpy changes are notoriously
difficult to improve, and they are related to two concomitant effects: the VdW
forces/hydrogen bonds and desolvation of polar groups (13). VdW forces are opti-
mised by the perfect shape complementarity between the biomolecular target and
106
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the drug-like molecule, while hydrogen bonds are maximised when the distances
and angles between hydrogen bond donors and acceptors are optimal in the com-
plex (13). The desolvation of polar groups reflects the strength of the interactions
between the solvent-target and solvent-ligand before the formation of the complex.
A favourable enthalpy change is an indication of a sufficiently strong interaction
between the target and the ligand that compensates for the unfavourable enthalpy
change related to desolvation (13). On the other hand, entropy changes are driven
by two major terms: conformational entropy changes and solvation entropy. The
former is related to the reduction of translational, rotational and internal degrees
of freedom of ligand and protein after the binding while the latter depends on the
release of water molecules from the binding site (13) and ligand in solution.
In this intricate framework, a complex task is to rationalise and simultane-
ously optimise all the different contributions at the atomic level and to find gen-
eral rules to translate into protocols and guidelines. In recent years, meaningful
improvements have been achieved in the structure determination of protein-ligand
complexes using X-ray crystallography and NMR spectroscopy and, a plethora of
computational methods based on static structures such as AutoDock Vina (115) or
idock (116) have been applied to the prediction of the binding free energy. In order
to find “hits” with sufficient affinity to be considered interesting, these methods
usually need to screen thousand compounds per day and, therefore, the approxi-
mations introduced to achieve throughput cause the predicted binding free energy
to be frequently inaccurate (117;118).
One of the main simplifications introduced by these approaches is the addi-
tivity of the binding free energy i.e. the assumption that free energy and free
energy changes can be decomposed into sum of independent components ascribed
to specific parts in a system. The extent to which this hypothesis can be con-
sidered valid is a question that is of central importance in many chemical and
biochemical contexts. In general, if the cruel question is: “Can the free energy
or entropy and their changes be decomposed into a sum of independent compo-
nents ascribed to specific parts in a system”, then the answer is negative. Free
energy and entropy are indeed global properties of the whole phase space and
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their component decompositions hold in the hypothesis that the phase space is
divisible into uncorrelated parts. This result has been clearly proved in Statistical
Mechanics (119). In equation 1.14, the Helmholtz free energy is given by:
F = kbT ln〈eβH〉NV T .
A minimum requirement to express the total free energy as sum of components is
to express the system Hamiltonian into sum of components e.g. two parts H1 and
H2 related to two different system interactions. In this case it is always possible
to state that the total system energy E is equal:
E = 〈H〉 = 〈H1 +H2〉 = 〈H1〉+ 〈H2〉 . (4.1)
However, this property is not transferred to the Helmholtz free energy:
F = kbT ln〈eβH1eβH2〉NV T , (4.2)
where the terms in the ensemble average cannot be further factorized. However,
if the system Hamiltonian H can be broken down into two components i.e.:
H(q1, q2, p1, p2) = H1(q1, p1) +H2(q2, p2) , (4.3)
where q1, p1, q2 and p2 are uncorrelated phase space coordinates, then the property
holds:
F = kbT ln〈eβH1〉NV T + kbT 〈eβH2〉NV T = F1 + F2 . (4.4)
Despite this result, the additivity of free energy has been observed in many chem-
ical systems where covalent interactions are involved. In this cases the additivity
assumption has been validated and it is used to predict chemical equilibria and
kinetic (120). However, in systems such as protein-ligand or protein-protein where
the relevant interactions are non-covalent most of the time this hypothesis cannot
be taken for granted. As a result, in drug design, the non-additivity or cooper-
ativity could significantly affect the structural-activity stage. Indeed, two ligand
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fragments linked together can result in a ligand with a binding affinity that could
be greater (positive cooperativity) or lower (negative cooperativity) than the sum
of its parts (76). This fact has been conveniently ignored for many years in the
protein-ligand binding context in favour of the simpler additivity model. Patel
and co-workers (121) investigated 19 different biological systems to examine the ex-
tent of non-additive substituent effects on binding affinities and they found that
only half exhibited additive behaviour.
An in depth study of non-additivity of functional groups in protein-ligand in-
teractions was performed by Baum et al. (76) and is central to this thesis. In the
case study the Thrombin protein and series of congeneric inhibitors were con-
sidered. Thrombin is a serine protease of the chymotrypsin family (122) involved
in the hemostasis, the delicate balance between bleeding and thrombosis, which
is essentially maintained by the localisation and rapid amplification of coagula-
tion proteinases and their cofactor complexes at the site of vascular injury (123).
Thrombin once is generated in the blood from its inactive precursor prothrombin,
plays two important and paradoxically opposing functions. It acts as a procoag-
ulant factor when it converts fibrinogen into an insoluble fibrin clot that anchors
platelets to the site of lesion and initiates processes of wound repair (124). In this
cascade prrocess thrombin cleaves fibrinogen to fibrin, activates the fibrin-cross-
linking transglutaminase factor XIII (FXIII), catalyzes its own generation through
activation of FXI, FVIII, and FV, and stimulates platelet aggregation via cleav-
age of the membrane-bound protease-activated receptors (PARs) 1, 3, and 4 (122).
In contrast, thrombin acts as an anticoagulant through activation of protein C.
This function unfolds in vivo upon binding to thrombomodulin, a receptor on the
membrane of endothelial cells. Binding of thrombomodulin suppresses the ability
of thrombin to cleave fibrinogen and PAR1, but enhances >1000-fold the speci-
ficity of the enzyme toward the zymogen protein C (124). Hijacking of thrombin
by thrombomodulin and activation of protein C in the microcirculation constitute
the natural anticoagulant pathway that prevents massive intravascular conversion
of fibrinogen into an insoluble clot upon thrombin generation (124;125;126).
There are several indications for an allosteric behaviour of thrombin. First,
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prothrombin undergoes large conformational changes during activation (122). Sec-
ond, the Basic Pancreatic Trypsin Inhibitor (BPTI), in spite of its relatively bulky
reactive site loop, can tightly bind to the thrombin Glu192 Gln mutant (122). The
structure of the BPTI complex with this thrombin mutant (1BTH) explained
the improved binding through favourable interactions of the Gln 192 carboxam-
ide group with BPTI but also revealed a dramatic opening of the active site
cleft, allowing accommodation of the bulky inhibitor (122). Third, Na+ has been
found to be an important allosteric modulator of α-thrombin (122). Kinetically,
two allosteric states, a “slow” and a “fast” α-thrombin form, have been defined,
which are characterised by the absence and presence, respectively, of an Na+ ion,
bound in the range of the physiological Na+ concentration (122). For example, the
fast thrombin form cleaves fibrinogen as well as the protease-activated receptors
(PARs) more efficiently, i.e., displays procoagulant, prothrombotic, and prosig-
naling properties, while the slow form preferentially cleaves protein C and thus
exhibits more anticoagulant properties (122;127).
Many diseases including stroke and myocardial infarction involve thrombo-
sis; therefore, thrombin is a preferred target of antithrombotic drugs (128). Drugs
available to block thrombin action include heparins, hirudins (lepirudin and bi-
valirudin), vitamin K antagonists and a new generation of direct thrombin in-
hibitors such as dabigatran and argatroban (128). In addition, the association
of idiopathic venous thrombosis with occult cancer is generally recognized. How-
ever, it has not been fully appreciated that thrombin generated during thrombosis
can augment the malignant phenotype (129). Indeed, Thrombin protein activates
tumor cell adhesion to platelets, endothelial cells, and subendothelial matrix pro-
teins, it enhances tumor cell growth and increases tumor cell seeding and sponta-
neous metastasis (129).
The complexity of thrombin function and regulation have captured the inter-
est of many investigators over the years and therefore many studies have been
conducted. Therefore, it is an easily accessible protein with well established and
accurate crystallographic structure. A three dimensional representation of this
protein with its binding site is reported in Figure 4.1. Structurally the protein
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Figure 4.1: (a) Tertiary structure of the modelled Thrombin protein and one of
its inhibitors. (b) A representation of the binding site of Thrombin and (c) its
exposition to water molecules represented as red spheres.
presents three aligned sub-pockets illustrated in Figure 4.2 along with the main
protein residues involved in the binding and shows the main protein inhibitors
considered in this study.
As previously mentioned, the Baum and co-workers (76) investigation of Throm-
bin and its non-additivity with specific inhibitors was significant to this research
project. In the investigation, the Isothermal Titration Calorimetry (ITC) was
used to measure the free energy of binding of four series of congeneric inhibitors
of Thrombin. The inhibitors differ in three main structural modifications. The
first modification is the presence or absence of a terminal amino group (X = H,
X = NH2) that interacts with the carbonyl oxygen of Gly216, forming hydrogen
bonds. A second modification is related to the group that secures the ligand in the
S1 pocket. Either a meta-chlorobenzyl or para-benzamidine moiety is attached to
the L-prolyl portion via an amide bond (76). Finally, a third modification concerns
the side chain R2 anchored to the sub-pocket S3. A series of methyl to benzyl
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Figure 4.2: (a) The Thrombin protein and the main residues involved in the
binding with series of congeneric inhibitors. (b) The ligands present three main
modifications at the position X (X = H or NH2), the group R2 anchored in the
sub-pocket S3 and the group R1 anchored to the sub-pocket S1. When the group R1
is m-chlorobenzyl the modification related to the position X divides the inhibitors
into two groups named 3 (X = H) and 5 (X = NH2) series. Figure adapted
from Baum et al.(76).
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positive linear correlation between the hydrophobic contact surface area of the R2
groups with the protein and the free energy of binding (Figure 4.3). The increase
in affinity is caused by the increase in size of the hydrophobic occupants of the S3
pocket. In addition, the presence of the amino group produces a further reduction
of the binding free energy due to the additional hydrogen bond with the Gly216.
However, the amino group also seems to interact cooperatively with the hydropho-
bic binding pocket S3. Assuming independence of the contributions added by the
single interactions, the presence or absence of the amino group should produce a
translation of the correlation line but not a slope change (76) (Figure 4.3). This
X = H - 3 Series
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Figure 4.3: The correlation of hydrophobic ligand surface area in contact with
the protein is plotted against the Gibbs free energy of binding. The plot shows the
ligands where the functional groups in the X and R2 positions are changed and R1
is the meta-clorobenzyl group. A linear correlation is obtained for the 3 (X = H)
and 5 series (X = NH2) but the different line slopes suggest the presence of non
additivity in the system. Figure adapted from Baum et al.(76)
suggests that there is cooperativity between the hydrophobic free energy com-
ponent related to the sub-pocket S3 and the free energy component related to
the hydrogen bond formation with the Gly216. The effect is also confirmed by
the thermodynamic analysis. For example in Figure 4.4 the binding free energy
change measured for the ligand 5K (3B → 5K), which includes the modification
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of both ligands 3K and 5B is -4.6 kcal/mol while, the single contributions are
respectively for the ligands 3K (3B → 3K) and 5B (3B → 5B) -0.9 kcal/mol and
-1.6 kcal/mol. For this ligand a binding free energy change of -2.5 kcal/mol would

























Figure 4.4: Binding free energy differences ∆∆G between selected thrombin in-
hibitors. The compound 5K presents the modification of both the ligands 3K and
5B. However, the binding free energy differences ∆∆G(3B → 5K) 6= ∆∆G(3B →
3K) + ∆∆G(3B → 5B). This is an experimental evidence that free energy is not
an additive property.
The previous case study is an example where the additivity assumption could have
misdirected medicinal chemists in the lead optimization stage. In the Baum and
coworkers (76) investigation a possible interpretation of the cooperativity effect
was explained by the dynamic properties of the inhibitors bound to the active
site. An analysis of the B-factor measured for the different thrombin inhibitors
in complex was performed by using X-ray diffraction. This parameter reflects the
average atomic fluctuations and is frequently used to gain information related to
the mobility of residues in crystalline structures. Figure 5.3 illustrates B-factor for
the 3L and 4L ligands. The colour scale changes from dark blue to red, indicating
low and high values, respectively, of the B-factor (76). The results show that the
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presence or absence of the amino group produces a rigidification of the pocket
S3 (dark blue in Figure 5.3). The entropy change (−∆∆TS) increases by +3.3
kcal/mol, which is partially balanced by a decrease in enthalpy change (∆∆H) of
-5.3 kcal/mol.
Figure 4.5: The crystallographically determined binding mode of 3L and 4L in
complex with thrombin. Colors are assigned to all atoms according to their tem-
perature factors, from blue (low B-factor) to green to yellow and to red (high
B-factor).The ratio of the mean B-factor of ligands with respect to the active site
residues is indicated. The binding free energy change and its enthalpic and en-
tropic components are also given. The ligand 4L forms a charge-assisted hydrogen
bond (3.1Å) and a slight reduction of the adjacent hydrogen bond (distance 3.3Å
vs 2.8Å) between the ligand carbonyl and the nitrogen of Gly216 is observed. A
significant decrease in B-factor ratio between the ligand and the binding site from
1.26 to 1.06 was observed. (Figure adapted from Baum and coworkers.(76))
The previous analysis highlighted the importance of dynamics in the protein-
ligand binding process to rationalise and explain the sources of non-additivity.
Indeed, protein and ligand fluctuations around average structures are very im-
portant to capture entropic effects that cannot be accounted using solely rigid
structures produced by crystallographic methods. Despite their computational
cost compared to docking and scoring function methods, free energy calculations
account for enthalpy and entropy changes in protein-ligand binding, usually pro-
ducing improved results (117;130). The final two chapters of this thesis had two
main goals: reproduce in-silico the non additivity of binding free energy in the
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Thrombin system obtained by Baum and coworkers (76), which is described in this
chapter and, explain the possible non-additivity sources in the system, which is de-
tailed in Chapter five. The investigation was performed by using the implemented
free energy code described in Chapter two and based on the alchemical transfor-
mation method accelerated with the latest General Purpose Graphic Processing
Unit (GPGPU) technology.
4.2 Thrombin Molecular Modelling and Setup
In this study the non-additivity of the Thrombin inhibitors in the 3 and 5 series
was considered. In particular these series are obtained changing the hydropho-
bic group R2 anchored to the sub-pocket S3, the hydrogen with an amino group
and selecting the functional group R1 to the m-chlorobenzyl in the sub-pocket
S1 (Figure 4.2 (b)). In order to reproduce the non-additivity in-silico the crys-
tallographic structure of human thrombin in a complex with a thrombin ligand
structurally related to the ligands simulated in this study was downloaded from
the PDB databank (PDB code 2ZC9 (76)). The protein was inspected and revised
using Schrödinger Maestro (109). The hirugen chain was removed from the struc-
ture. The side-chain of Arg75 in chain H was completed in a solvent exposed
conformation. The incomplete light chain was capped before Glu1C with an ACE
residue and after Ile14L with an NME residue. The incomplete heavy chain was
capped after Gly246 with an NME residue. Missing residues Trp148, Thr149,
Ala149A, Asn149B, Val149C, Gly149D, Lys149E in chain H were modelled in
the structure using the FALC-Loop web server (131). Standard protonation states
were assumed for protein side-chains. On the basis of visual inspection of hydrogen
bonding patterns, His57 and His71 were modelled in their uncharged, δ-tautomer.
His91, His119 and His230 were modelled in the δ-tautomer (132). Disulfide bridges
were modelled between Cys42-Cys58, Cys1-Cys122, Cys168-Cys182 and Cys191-
Cys220 (132). The ligands in the 3 and 5 series were modelled by using Maestro
and manually placed inside the binding site in a starting conformation selected
according to the crystallographic data and visual inspection. In addition, all the
amino groups related to each ligand in the 5 series were protonated. In order
4.2. Thrombin Molecular Modelling and Setup 117
to assemble input files for all the different complexes the FE-Setup (96) software
package was used. This piece of software is able to automatically create the sol-
vated complexes and ligands starting from their PDB structures. In particular the
following protocol was set in FE-Setup for the preparation of the ligands, protein
and complexes:
• Ligands
– The atomic point charges were assigned by using Antechamber (98) se-
lecting the AM1-BCC (28) method;
– GAFF (97;110) was used for the generation of the force field parameters;
– the ligands were solvated in a buffer of water selecting TIP3P water
model using the Amber module LEaP. In addition, for the ligands in
the 5 series the solution was also neutralised adding Cl− counter ions
due to the positive net charge after the ligand protonation;
– the solvated systems were minimised for 100 cycles by using the steepest
descent method and equilibrated at 300 K and 1 atm pressure for 105
MD steps with 2 fs time step (200 ps) using the Amber module Sander.
During the equilibration stage, the ligands were also restrained to their
starting positions using a harmonic potential with a force constant
of 10 kcal mol−1 Å−2 and constraining the hydrogen bonds to their
equilibrium distances.
• Protein
– Amber ff99SB (133) force field parameters were used to parametrise the
protein;
– the protein was minimized in vacuum for 500 cycles of steepest descent
method using the Amber module Sander.
• Complexes
– The ligands were combined with the Thrombin protein and solvated in
a buffer of water selecting TIP3P water model by using the software
LEaP. Counter ions were also added to neutralise the solution;
4.2. Thrombin Molecular Modelling and Setup 118
– the complexes were minimised for 500 cycles by using the steepest de-
scent method and equilibrated at 300 K and 1 atm pressure for 105 MD
steps with 2 fs time step (200 ps) using the Amber module Sander. Dur-
ing the equilibration stage, the protein and the ligands were restrained
to their starting positions using a harmonic potential with a force con-
stant of 10 kcal mol−1 Å−2 and constraining the hydrogen bonds to
their equilibrium distances.
In order to quantify the Non Additivity (NA) level for each ligand presents in
the system it is convenient to consider the Figure 4.6. The generic ligand 5X ′′
presents the functional group R′′ and the amino group NH2 compared to the
generic base scaffold 3X ′ . Therefore, the ligand exhibits both the modifications
of the ligands 3X ′′ and 5X ′. As a consequence, the level of non-additivity can be
defined as:
NA = ∆∆G3X′→5X′′ − (∆∆G3X′→5X′ + ∆∆G3X′→3X′′) . (4.5)
The thermodynamic equation can be rewritten by using the thermodynamic cycle
with the end states 3X ′, 5X ′ and 5X ′′:
NA = ∆∆G5X′→5X′′ −∆∆G3X′→3X′′ . (4.6)
If NA equates zero then the system is additive, otherwise it quantifies the non-
additivity level.
To compute non-additivity, the relative binding free energy between the differ-
ent ligands in the two series was calculated using the thermodynamic cycle shown
in Figure 4.7. This cycle shows that in order to calculate the relative free energy
of binding between two ligands, it is necessary to perform two distinct alchemical
simulations. A first simulation where a ligand L1 is mutated into a ligand L2
while both interact with the solvent environment (∆GL), and a second simula-
tion where the ligand L1 is mutated in the ligand L2 in the binding site while
they interact with the solvent and the protein (∆GPL). The relative binding free






Base scaffold + H
Base scaffold + NH2





























Figure 4.6: The ligand 5X ′′ presents both the modifications of the ligands
5X ′ and 3X ′′. Therefore, the non-additivity can be evaluated subtracting from
∆∆G3X′→5X′′ the sum between ∆∆G3X′→5X′ and ∆∆G3X′→3X′′ . Using the high-
lighted thermodynamics cycle the non additivity equates the difference between the
relative free energy of binding ∆∆G5X′→5X′′ and ∆∆G3X′→3X′′





Figure 4.7: The thermodynamic cycle used to calculate the relative free energy
of binding (∆∆G = ∆G2 − ∆G1 = ∆GPL − ∆GL) between two ligands L1 and
L2.
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energies calculated for the 3 and 5 series are reported in the relative free energy










































































































Figure 4.8: The relative free energy map used to calculate relative free energy of
binding between the ligands in the 3 (X = H) and 5 (X = NH2) series.
because this scaffold is central to the web of defined alchemical transformations.
The free energy changes related to the complex state ∆GPL and the solvent state
∆GL (Figure 4.7) were calculated using the implemented free energy code de-
scribed in the Chapter two and based on the alchemical transformation method.
The coupling parameter λ used to mutate a ligand into another was modulated
in the range [0, 1] where 0 denotes the state where the ligand is the starting state
and 1 denotes the final ligand. The transformations were performed selecting 16
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λ values: (0.00000, 0.00616, 0.02447, 0.07368, 0.11980, 0.19045, 0.28534, 0.40631,
0.57822, 0.70755, 0.80955, 0.88020, 0.92632, 0.97553, 0.99384 and 1.00000). These
values were generated by using the Chebyshev technique described in the second
chapter by using equation 2.15. Figure 4.9 shows the generated windows for the
selected value of ψ (equation 2.15) and it is interesting to observe how the point
density increases nearby the boundaries of the integration region where high vari-
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Figure 4.9: The selected values of the coupling parameters λ. The values were
generated by using the Chebyshev node technique (§ 2.4) with the aim of reducing
the polynomial regression instability as the degree of the polynomial is increased.
The bonded and non-bonded force field parameters involved in the mutations
were linearly interpolated between the starting and final ligand parameters. In
order to circumvent steric clashes at the end points of the simulations the soft
core potential (134) was used between atoms that can be created or annihilated
as described in Chapter two. The coulomb power and the delta shift soft-core
parameters were respectively set to 0 and 2. Free energy changes were calcu-
lated by using the FDTI method and setting the delta increment to ∆λ = 10−3.
The TI integral was numerically estimated by using a polynomial interpolation
of seventh-order. For each window the ensemble average was calculated by sam-
pling the system using MD. In the production run each window was sampled for 5
and 10 ns using the NPT ensemble and setting the pressure and the temperature
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respectively to 1 atm and 300 K. The pressure was regulated by using Monte
Carlo Barostat (101;102) with an update frequency of 25 MD steps. The Andersen
Thermostat (82) was used to keep the temperature constant, selecting a collision
frequency of 10 ps−1. The simulations were performed by using the Leapfrog-
Verlet integrator with a 2 fs time step. All the bonds were constrained to their
equilibrium distance and the non-bonded interactions were evaluated by using an
atom based cut off scheme setting the cutoff distance to 10 Å . The electrostatic
interactions were calculated by using reaction field with the medium dielectric
constant set to the water dielectric constant (εsolvent = 78.3). A total of 5 · 104
gradient values were collected in 10 ns simulation and each complex state calcula-
tion was repeated three times. At the beginning of each run the particle velocities
were randomly generated accordingly to the Maxwell-Boltzmann distribution at
300 K temperature. The uncertainties were estimated as standard error deviation
of the mean over the three independent runs. The calculation in the solvent state
were performed for 5 and 10 ns one time and the uncertainties were estimated
using block averaging. In order to circumvent steric clashes at beginning of the
production run due to the equilibration stage performed on the starting mutant
only (λ = 0), each window was re-minimized for 500 steps and re-equilibrated.
This stage was performed by changing the coupling parameter between 0 and the
selected window in steps of 0.1. For each one of these values an equilibration of
2 ps with 0.5 fs time step was performed setting the pressure and temperature
respectively to 1 atm and 300 K. At the end of the re-equilibration stage the
time step was re-set to 2 fs and no data was collected during this period. All the
production runs were performed on a GPU cluster using nVidia K20 and M2090
graphic card units. During the runs the OpenMM release 5.2 was used by setting
the GPU platform to OpenCL.
4.3 Free energy prediction
Predicted relative free energies of binding are reported in Table 4.1, along with
the experimental data. In order to validate the correct convergence, 5 ns and 10
ns MD simulations were performed for each relative binding affinity calculation.
4.3. Free energy prediction 123
Table 4.1: Experimental (Exp) and Predicted (Pred) relative free energy of bind-
ing between the ligands in the 3 and 5 series. The predictive relative free energies
are shown for 5 and 10 ns MD simulation time used to sample the systems. Results
are reported in kcal/mol.
Exp Pred 5ns Pred 10ns
3B → 3A 0.7 ± 0.4 0.52 ± 0.08 0.59 ± 0.02
3C → 3B 0.2 ± 0.2 0.50 ± 0.07 0.63 ± 0.04
3D → 3A 1.3 ± 0.4 1.2 ± 0.2 1.3 ± 0.1
3D → 3B 0.6 ± 0.2 0.9 ± 0.2 1.2 ± 0.1
3D → 3C 0.4 ± 0.2 0.4 ± 0.1 0.49 ± 0.06
3E → 3C −0.24 ± 0.06 0.8 ± 0.1 0.80 ± 0.06
3E → 3D −0.7 ± 0.2 0.8 ± 0.2 0.48 ± 0.05
3F → 3C 0.6 ± 0.2 0.7 ± 0.1 1.07 ± 0.05
3G → 3A 1.8 ± 0.4 2.4 ± 0.5 2.9 ± 0.1
3H → 3A 2.2 ± 0.4 2.9 ± 0.5 3.0 ± 0.2
3I → 3B 0.9 ± 0.2 3.5 ± 0.5 2.47 ± 0.03
3J → 3B 1.6 ± 0.2 4.4 ± 0.5 4.3 ± 0.2
3K → 3B 0.9 ± 0.2 2.5 ± 0.7 2.4 ± 0.5
5B → 5A −0.8 ± 0.1 −0.6 ± 0.2 0.0 ± 0.2
5C → 5B 0.9 ± 0.1 1.1 ± 0.2 0.7 ± 0.02
5D → 5A 0.7 ± 0.2 1.4 ± 0.3 2.4 ± 0.1
5D → 5B 1.5 ± 0.1 1.6 ± 0.3 1.49 ± 0.08
5D → 5C 0.6 ± 0.1 0.37 ± 0.08 0.99 ± 0.03
5E → 5C 1.2 ± 0.1 1.0 ± 0.1 1.17 ± 0.03
5E → 5D 0.6 ± 0.1 0.7 ± 0.1 0.98 ± 0.03
5F → 5C 1.5 ± 0.2 0.1 ± 0.2 0.84 ± 0.09
5G → 5C 1.7 ± 0.1 0.26 ± 0.04 0.28 ± 0.03
5G → 5F 0.2 ± 0.2 0.0 ± 0.3 0.7 ± 0.3
5H → 5A 1.7 ± 0.2 3.6 ± 0.4 3.2 ± 0.2
5I → 5A 2.4 ± 0.2 5.1 ± 0.4 4.9 ± 0.2
5J → 5B 3.4 ± 0.2 4.6 ± 0.3 4.4 ± 0.4
5K → 5B 3.1 ± 0.2 3.9 ± 0.8 2.7 ± 0.3
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Table 4.2 reports the relative free energy of binding selecting the ligand B as
reference state in both series which will be assumed from now on unless otherwise
stated and Figure 4.10 shows the comparison between experimental and predicted
results. For some ligands the calculation of the relative free energy of binding
Table 4.2: Experimental and Predicted relative free energy of binding selecting B
as reference state in both series (3B → 3X and 5B → 5X). The predicted values
are shown for 10 ns only. For some ligands the relative free energy was averaged
using different thermodynamic paths and reported where needed. Data is shown
in kcal/mol
Exp Pred
3A 0.7 ± 0.4 0.59 ± 0.02
3B 0.0 ± 0.0 0.0 ± 0.0
3C −0.2 ± 0.2 −0.63 ± 0.04
3D −0.6 ± 0.2 −1.2 ± 0.1
3E (B→D→E ; B→C→E) 0.0 ± 0.2 −1.53 ± 0.07
3F (B→C→F) −0.8 ± 0.2 −1.70 ± 0.07
3G (B→A→G) −1.1 ± 0.6 −2.3 ± 0.1
3H (B→A→H) −1.5 ± 0.6 −2.4 ± 0.2
3I −0.9 ± 0.2 −2.47 ± 0.03
3J −1.6 ± 0.2 −4.3 ± 0.2
3K −0.9 ± 0.2 −2.4 ± 0.5
5A −0.8 ± 0.1 0.0 ± 0.2
5B 0.0 ± 0.0 0.0 ± 0.0
5C −0.9 ± 0.1 −0.76 ± 0.02
5D −1.5 ± 0.1 −1.49 ± 0.08
5E (B→C→E ; B→D→E) −2.1 ± 0.1 −2.20 ± 0.05
5F (B→C→F) −2.4 ± 0.2 −1.60 ± 0.09
5G (B→C→G ; B→C→F→G) −2.6 ± 0.2 −1.7 ± 0.2
5H (B→A→H) −2.6 ± 0.2 −3.1 ± 0.3
5I (B→A→I) −3.2 ± 0.3 −4.9 ± 0.3
5J −3.4 ± 0.2 −4.4 ± 0.4
5K −3.1 ± 0.2 −2.8 ± 0.3
was calculated averaging the relative free energy changes along different possible
paths in the relative free energy map Figure 4.8. For example for the ligand 3E
two paths were selected: 3B → 3D → 3E and 3B → 3C → 3E. Table 4.2
reports the selected paths for each ligand where needed. In order to quantify
the level of agreement between experimental and predicted data, three different
statistical quantities were calculated: the Coefficient of Determination (R2), the
Mean Unsigned Error (MUE) and the Predictive Index (PI). The Predictive
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Figure 4.10: Experimental versus Predicted relative free energy of binding se-
lecting B as reference state in both series. The predicted values are shown for 10
ns only. Three different statistical quantities were calculated to assess the agree-
ment between the data: R2, MUE and PI. The continue line represents the perfect
theoretical agreement.
















−1 ⇐⇒ E(j)−E(i)P (j)−P (i) < 0
0 ⇐⇒ P (j)− P (i) = 0
+1 ⇐⇒ E(j)−E(i)P (j)−P (i) > 0
(4.9)
In the previous equations, the term E(i) is the experimental binding affinity of
compound i and P (i) its predicted value. In case of perfect ranking the PI index
is +1 while in case of completely wrong ranking is -1 and a value of 0 represents
a totally random ranking. The overall agreement between experimental and pre-
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dicted data was quite satisfactory as shown in Figure 4.10 and on average the
predicted data underestimates the experimental data. In addition the agreement
is slightly better with the 5 series compared to the 3 series as shown by R2, MUE
and PI calculations.
In molecular simulation one of the most significant aspects to monitor is the
poor system sampling which could potentially lead to wrong convergence and re-
producibility issues. In order to check the result convergence, the relative binding
free energy calculations were simulated in complex for 5 and 10 ns three times per
each window. The result analysis showed that the the variations between 5 and
10 ns did not produce significant changes in the calculated binding free energies in
most systems excepted for some more problematic transformations. In addition,
the solvent simulations produced very close results extending the situation time,
in some cases up the second decimal place and, therefore, the solvent simulations
were simulated one time only and estimating their uncertainties using block av-
eraging with a confidence interval of 95%. Overall, the maximum uncertainty on
the relative binding affinity calculated as standard error of the mean along the
triplicates was less than 0.5 kcal/mol produced in some problematic simulations.
The higher discrepancy in the relative free energy of binding in the 3 series is
produced by the ligand J while in the 5 series by the ligands J and I. In most
of the cases in these simulations the alchemical transformation involved a rela-
tively high number of atoms such as for the ligand 5J. In this mutation 14 atoms
were simultaneously transformed from a full interactive to a non-interactive atoms
producing poor convergence issues.
With regard to correctly quantify the level of agreement between experimen-
tal and predicted data an error analysis was conducted on the selected statistical
quantities R2, MUE and PI. In this analysis the experimental ei and the pre-
dicted pi relative binding free energies related to the ligand i ∈ {1, . . . , N} (N is
the total number of the ligands) can be represented as the sets {. . . , ei±∆ei, . . . }
and {. . . , pi±∆pi, . . . }, where ∆ei and ∆pi are respectively the experimental and
predicted statistical uncertainties. It is often assumed that the relative binding
affinity is normal distributed and, therefore, for each data point ei and pi it is
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possible to generate new data points ẽi and p̃i drawing from a normal distribution
N(µ, σ2) i.e. ẽi ∼ N(µ = ei, σ2 = ∆ei) and p̃i ∼ N(µ = pi, σ2 = ∆pi). For
each pair sets {. . . , (ei, ẽi), . . . } (Experimental-Experimental), {. . . , (pi, p̃i), . . . }
(Predicted-Predicted) and {. . . , (ei, p̃i), . . . } (Experimental-Predicted) it is possi-
ble to determine R2, MUE and PI and, the procedure can be re-iterated n times
drawing new ẽi and p̃i values from a normal distribution. Therefore, R2, MUE and
PI can be represented as statistical variables themselves with probability distri-
butions fR2 , fMUE and fPI . The drawing procedure aims to numerically simulate
both the experimental and computed binding affinity measurements for each lig-
and many times. This is useful to quantify the experimental and predicted result
reliability by estimating, for instance, an error interval to quantify the spread of
these distributions. A possible interval can be computed by using the cumulative
probability F related to each one the previous distribution. The interval:
a ≤ X̄ ≤ b , (4.10)
where a = F−1(0.03), b = F−1(0.98) and X̄ is the average value calculated for
R2, MUE and PI was considered for this error analysis. In it, the probability
to find one of the selected statistical variables is 95%, which represents nearly
the entire population. The described error analysis procedure selecting n = 106
generates the results shown in Table 4.3 and Figure 4.11 The error analysis on
the Experimental-Experimental data (Figure 4.3 (a)) showed that the 5 series
presents improved statistics (R2, MUE and PI) compared to the 3 series. This
could indicate that the 5 series is experimentally more reliable than the 3 series.
The error analysis conducted on the Predicted-Predicted data (Figure 4.3 (b))
showed that there are not significant discrepancies between the 5 and 3 series
while the most significant result obtained from the error analysis conducted on
the Experimental-Predicted data (Figure 4.3 (c)) showed that the MUE error is
higher in the 3 series compared to the 5 series while the PI index in the 5 series
is higher than the 3 series. In addition, the R2, MUE and PI values calculated
from the experimental and predicted data and shown in Figure 4.10 are in the
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Figure 4.11: The probability distributions of R2, MUE and PI for the 3 and 5
series. Each distribution was simulated drawing 106 times from a normal distri-
bution related to the experimental, predicted and experimental-predicted data.
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Table 4.3: Experimental, predicted and experimental-predicted error analysis for
the determination coefficient, the mean unsigned error and the predictive index.
The analysis was conducted selecting an interval where the probability to find R2
MUE or PI is 95% and drawing 106 times from a normal distribution.
Experimental
3 Series 5 Series
R2 0.80 ≤ 0.84 ≤ 0.96 0.94 ≤ 0.97 ≤ 0.99
MUE 0.12 ≤ 0.22 ≤ 0.36 0.11 ≤ 0.14 ≤ 0.21
PI 0.76 ≤ 0.92 ≤ 0.98 0.94 ≤ 0.95 ≤ 0.99
Predicted
3 Series 5 Series
R2 0.97 ≤ 0.99 ≤ 0.99 0.96 ≤ 0.99 ≤ 0.99
MUE 0.07 ≤ 0.09 ≤ 0.15 0.06 ≤ 0.13 ≤ 0.22
PI 0.97 ≤ 0.99 ≤ 0.99 0.98 ≤ 0.99 ≤ 0.99
Experimental-Predicted
3 Series 5 Series
R2 0.72 ≤ 0.79 ≤ 0.84 0.72 ≤ 0.77 ≤ 0.83
MUE 0.92 ≤ 1.03 ≤ 1.15 0.45 ≤ 0.60 ≤ 0.72
PI 0.85 ≤ 0.90 ≤ 0.95 0.88 ≤ 0.93 ≤ 0.96
same range interval estimated by using the Experimental-Predicted distribution
and reported in Table 4.3
Binding Affinity is usually predicted by using molecular docking approaches
when the number of hits to validate is extremely high. These methodologies fre-
quently involve two distinct tasks. A first stage where configurational states are
generated by minimising the interaction energy between the ligand-poses and the
receptor, and a second stage where the binding free energy of the complex is es-
timated using scoring functions. The scoring functions are generally based on an
additive functional form related to intra- and inter- energetic molecular terms and
the binding affinity is a weighed sum where the weighted coefficients are optimised
by using different techniques such as multivariate regression analysis, genetic al-
gorithms or artificial neural networks (135;115;136). However, most of the time, the
calculated results are frequently inaccurate compared to more robust method-
ologies. On the other hand, these approaches are extremely fast and therefore
popular. In order to compare the accuracy of the implemented relative free en-
ergy code with a more typical scoring function software, the relative binding free
energy of the selected thrombin inhibitors was also calculated by using Autodock
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Vina (115). A grid of 20 Å × 20 Å× 20 Å was centred around the thrombin binding
site and a docking pose was generated for each ligand. In the docking state, the
protein was rigid. In all instances where comparison was possible, it was veri-
fied that Vina produced a binding pose very similar to the available experimental
data. The Vina predicted binding affinity of the best scoring pose was used for
comparison.
The experimental and predict results using Vina are in Table 4.4 and in Figure
4.12 along with the determined R2, MUE and PI. The Vina relative binding free
energy predictions are quite satisfactory considering the relatively short compu-
tational time compared to the free energy calculations. Furthermore, in the 3
series the Vina MUE estimation outperformed the MUE calculated using the free
energy implementation.
Table 4.4: Experimental and Predicted relative free energy of binding selecting
B as reference state in both series using Vina. The uncertainties were considered
negligible in the Vina calculations. Data is shown in kcal/mol.
Exp Vina
3A 0.7 ± 0.4 −0.1
3B 0.0 ± 0.0 0.0
3C −0.2 ± 0.2 0.0
3D −0.6 ± 0.2 −0.4
3E 0.0 ± 0.2 −0.7
3F −0.8 ± 0.2 −0.4
3G −1.1 ± 0.6 −1.1
3H −1.5 ± 0.6 −1.3
3I −0.9 ± 0.2 −1.2
3J −1.6 ± 0.2 −1.5
3K −0.9 ± 0.2 −1.7
5A −0.8 ± 0.1 0.1
5B 0.0 ± 0.0 0.0
5C −0.9 ± 0.1 0.0
5D −1.5 ± 0.1 −0.6
5E −2.1 ± 0.1 −0.8
5F −2.4 ± 0.2 −0.3
5G −2.6 ± 0.2 −0.2
5H −2.6 ± 0.2 −1.3
5I −3.2 ± 0.3 −1.5
5J −3.4 ± 0.2 −1.5
5K −3.1 ± 0.2 −1.6
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Figure 4.12: Experimental versus Predicted relative free energy of binding se-
lecting B as reference state in both series using Vina. The uncertainties were
considered negligible in the Vina calculations.
The non additivity levels present in the system were then finally calculated
using the equation 4.6. Table 4.5 and Figure 4.13 reports the non additivity
for each ligand calculated for the experimental and the predicted data using the
implemented code (Sire-OpenMM) and Vina.
4.3. Free energy prediction 132
Table 4.5: Experimental and Predicted non-additivity present in the system. The
ligand G in the series 3 is related to the ligand H in the series 5 while the ligand
H in the series 3 is related to the ligand I in the series 5 (Figure 4.8). Data is
shown in kcal/mol
Exp Pred Vina
A −1.5 ± 0.5 −0.6 ± 0.2 0.2
C −0.7 ± 0.2 −0.1 ± 0.05 0.0
D −0.9 ± 0.3 −0.3 ± 0.1 −0.2
E −2.2 ± 0.2 −0.67 ± 0.09 −0.1
F −1.6 ± 0.3 0.1 ± 0.1 0.1
G/H −1.5 ± 0.6 −0.8 ± 0.3 −0.2
H/I −1.7 ± 0.7 −2.5 ± 0.3 −0.2
J −1.8 ± 0.3 −0.1 ± 0.5 0.0
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Figure 4.13: Experimental and Predicted non-additivity levels using the imple-
mented code Sire-OpenMM and Vina. The ligand G in the series 3 is related to
the ligand H in the series 5 while the ligand H in the series 3 is related to the
ligand I in the series 5.
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Figure 4.13 shows that overall Vina is not able to predict the non additivity
levels for the different Thrombin inhibitors. The static model used to describe the
protein by Vina prevents the capture of subtle entropic and enthalpic effects pro-
duced by the binding process and therefore docking calculations should be used
with care. The predicted level of non-additivity by using the Sire-OpenMM im-
plementation is slightly better than the Vina prediction but the overall agreement
is quite poor. Probably, just in the H/I system the agreement is comparable with
the experimental data. The main problem seems to be related to the 3 series.
Indeed, the predicted relative binding affinities are systematically underestimated
for each ligand in this series while this does not happen in the 5 series.
4.4 Free Energy Analysis
Figure 4.14 reports some significant examples of free energy gradient for the sol-
vent and complex simulations used to compute the relative binding free energy
by using the FDTI method described in Chapter two. Furthermore, the result
convergence was validated by considering thermodynamic cycle closures. Indeed,
theoretically along a closed thermodynamic path the free energy change must van-
ish and this is frequently used as a quality control parameter. In the considered
mutations for the 3 and 5 series there are respectively three and four thermo-
dynamic cycles. Figure 4.15 reports the relative binding free energy changes for
each cycle. This analysis showed that the maximum discrepancy for the 3 and 5
series was respectively 0.5 kcal/mol and 1.2 kcal/mol. An interesting calculation
was offered by the mutation 5B → 5A. Although this transformation does not
involve many atoms, it seems to be a very hard alchemical mutation. Figure 4.16
reports the free energy gradient recorded along the three different runs for the
simulation in complex. As shown by Figure 4.16 (a) this transformation presents
a very noisy area between the windows 0 and 0.28750. With the aim of improving
the convergence 12 extra windows were added in this range and simulated for 10
ns producing the result shown in Figure 4.16 (b). However, the extra windows did
not improve the calculation of the relative binding affinity. In order to understand
the issue, one of the window showing a significant change in the free energy gra-
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Solvent and Complex states - 3G to 3A
Solvent and Complex states - 3C to 3B
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Figure 4.14: Free energy gradients for different mutations in solvent and com-
plex. Each selected window was simulated for 5 and 10 ns MD to monitor the
gradient convergence. The free energy gradient uncertainties are plotted using
block averaging selecting a confidence interval of 95%. The solvent simulations
usually exhibit a very smooth and convergent behaviour. On the other hand, the
simulation in complex presented poor convergence for some difficult alchemical
mutations.





































































































Figure 4.15: In the selected alchemical transformations are present three ther-
modynamic cycles related to the 3 Series and four related to the 5 series. In the 3
series the maximum discrepancy from the perfect closure was 0.5 kcal/mol while
in the 5 series 1.2 kcal/mol.
dient between the different runs was selected for further analyses. In particular
the window λ = 0.19045 presented an unsigned free energy gradient difference of
nearly 5 kcal/mol between the second and third run in the simulation in complex.
An analysis of the trajectories highlighted a conformational change of one dihedral
angle in the mutant ligand. The starting dihedral angle between the second and
third run was not the same with a difference of nearly 90 degrees and it was prob-
ably caused by the different starting random conditions along the equilibration
stages for the selected window as shown in Figure 4.17 (a). At half of the third
simulation the dihedral angle flipped to the same dihedral angle recorded for the

















































Figure 4.16: In (a) the free energy gradient related to the mutation 5B → 5A
for the three performed simulations: RUN1, RUN2 and RUN3. In the highlighted
area the window convergence was poor along the runs. In order to mitigate the
issue 12 extra windows were added in this area (b) but, the gradient still presented
convergence problems (RUN extra points) without any significant improvement in
the overall relative free energy of binding.
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second run. The different starting conformations produced different free energy
gradients as shown in Figure 4.17 (b) that eventually will converge to the same
value after the dihedral angle flipping. This phenomenon was also observed for











































Figure 4.17: In the mutation 5B → 5A a difference of nearly 5 kcal/mol in
free energy gradient was recorded for the windows λ = 0.19045 between the sec-
ond (RUN2) and third simulation (RUN3) in complex. The trajectory analysis at
this window showed that the issue was caused by a different starting conforma-
tion in one of the ligand dihedral angle highlighted in (a). During the third run
the dihedral angle flipped to the same dihedral angle recorded in the second run.
The different starting conformations between the two runs produced different free
energy gradients as shown in (b) that eventually will converge to the same value
after the dihedral flipping.
It is also interesting to analyse another problematic simulation that involved
the mutation 3K → 3B in one of the run in complex for a particular window. The
recorded free energy gradient for this run is shown in Figure 4.18 (c) for different
simulation times. The window value λ = 0.57822 produced a drastic variation
of the free energy gradient. The trajectory analysis emphasised the problem,
which was related to one of the structural ions which was trapped by one of the
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mutant carbon atoms in the benzyl ring (Figure 4.18 (a) and 4.18 (b)) producing
a severe gradient change as shown in Figure 4.18 (c). A possible explanation of
this phenomenon is related to the soft core parameters used and in the particular
simulation dynamics. The carbon atom in the benzene ring is a “to dummy” atom
and, as a consequence, the Lenard-Jones and electrostatic parameters approach
to zero when the coupling parameter increase. In the selected trajectory, the
VdW forces seem to be decoupled quicker than the coulomb forces. Therefore,
the electrostatic attraction between the negative charged dummy carbon and the
positive charged Na+ ion is not significantly opposed by the repulsive VdW forces
when the carbon-ion distance become short. This particular run was repeated
and the phenomenon was not observed along the other runs.
4.5 Chapter Conclusions
One of the limiting factors in the SAR stage along the critical path is the non-
additivity of functional groups. In this Chapter the non-additivity of two series
of congeneric inhibitors of the Thrombin protein was investigated by using molec-
ular simulations. In particular the developed relative free energy implementation
detailed in second chapter was used to predict the relative binding affinities of
two investigated Thrombin inhibitor series. The predicted relative binding affini-
ties were overall in good agreement with the experimental data as shown by the
selected statistical quantities R2 coefficient, MUE error and PI index. An error
analysis was also conducted on these statistical measurements between the experi-
mental, predicted and experimental-predicted data. The analysis showed that the
experimental binding affinities of the 5 Series presented overall improved statistics
compared to the 3 Series and this could indicate that this series is more reliable
compared to the 3 Series. The error analysis results of the experimental-predicted
data showed that the calculated statistics are in the same range of the predicted
ones. Although the predicted relative binding affinities were in good agreement
with the experimental data the prediction of the non-additivity levels was poor.
The main problem seems to be related to the predicted relative binding affinities
of the 3 Series, which systematically underestimate the experimental values. The






















































t = 2.363 ns t = 2.364 ns t = 2.365 ns t = 2.366 ns t = 2.367 ns
Figure 4.18: The mutation 3K → 3B presented a very interesting behaviour
for the window λ = 0.57822 in one simulation. In (a) one of the structural ion
Na+ was trapped by one of the mutant carbon atom in the benzyl ring along the
trajectory. The event in (b) was recorded at about 2.3 ns by checking the distance
between the ion and the carbon. In (c) the overall gradient presents a jump at
the selected window, which is disappearing increasing the simulation time due to
the accumulation of gradient values. This simulation was not considered in the
analysis stage. This event is probably caused by the use of the soft core potential.
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issue could be related to force field parameterisations in this series and further
investigations are required. The non-additivity levels were also predicted by us-
ing Vina, a scoring function docking program but, the level of agreement was
extremely poor in this case and confirming that subtle enthalpic and entropic
effect cannot be easily predicted by scoring function approaches.
“But don’t you see that the whole trouble lies here? In words, words.
Each one of us has within him a whole world of things, each man of us
his own special world. And how can we ever come to an understanding
if I put in the words I utter the sense and value of things as I see them;
while you who listen to me must inevitably translate them according to
the conception of things each one of you has within himself. We think
we understand each other, but we never really do”
— Luigi Pirandello. Six characters in search of an author
5
Possible origins of Non-Additivity
5.1 Non-Additivity hypotheses
T
he correct prediction of the relative free energy of binding between
the inhibitors of Thrombin is the starting point to rationalise the non-
additivity origins in the system. Although, the agreement between
experimental and predicted data is satisfactory as shown in Figure 4.10, the pre-
dicted non-additivity levels for the different ligands were not in systematically
good agreement with the experimental data and, therefore, it was not possible to
conduct an orderly analysis on each system to determine non-additivity causes.
However, the predicted non additivity in the ligand pairs H/I (Figures 4.13) justi-
fies a detailed analysis of this system only. It is worth to remember that the ligand
5I in the 5 Series corresponds to the ligand 3H in the 3 Series (apart from the extra
amino group) and the predicted non-additivity level was calculated considering
141
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the ligand B as reference state in both series as follows:
NAH/I = ∆∆G5B→5I −∆∆G3B→3H (5.1)
In the previous equation, each relative binding affinity was computed along two
thermodynamic paths as shown in Figure 5.1. Because of time constraints, the
present analysis focused on the transformations H/I → A i.e. 5I → 5A and


























Figure 5.1: The non-additivity in the system H/I is evaluated computing the
relative binding affinities along two paths for each series. The path 5B → 5I =
5B → 5A→ 5I and 3B → 3H = 3B → 3A→ 3H.
There are many factors that may trigger the non-additivity in the Thrombin
system and in particular entropic or enthalpic contributions were investigated
here. An entropic effect could be generated by the additional amino group in the
5 series that may produce a protein or ligand rigidification (or both) compared
to the 3 series where the amino group is missing. In addition, the positive charge
of the amino group could have an enthalpic contribution related to a significant
change in the electrostatic interactions between the 5 series inhibitors and the
solvent compared to the 3 series. All the previous effects may cooperate together
or one could be more significant than the others.
Nowadays, the main role of simulations is to predict experimental data. How-
ever, if computational models are relatively correct, it is possible to validate hy-
potheses that would not be possible to experimentally prove or disprove, for in-
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stance, due to experimental limitation techniques. With the aim of discovering
the origin of non-additivity in the selected system, it is possible to design com-
putational experiments where the rigidity of the molecules, or the strength of
ligand-solvent interactions, are artificially modified. The idea relies on the follow-
ing working hypothesis:
“if an opportune change of the ligand/protein rigidity or both or, the
ligand-solvent interactions, removes the non-additivity in the system,
then, the non-additivity source can be ascribed to that change”
In order to prove or disprove this hypothesis, the following computational exper-
iments were attempted:
• effects of protein flexibility change on the non-additivity. If the non-additivity
origin is due to a change in the protein flexibility between the ligands in the
3 and 5 series then, a protein rigidification prior binding should suppress
the non-additivity;
• effects of the ligand flexibility change on the non-additivity. If the addition
of the amino group changes the ligand flexibility then restraining all the
ligands in their binding mode should suppress the non-additivity;
• effect of solvent interactions. If the non-additivity is caused by a change
in the ligand-solvent interactions then a simulation where these interactions
are limited should suppress the non-additivity.
With the aim of testing the previous hypotheses, the relative binding free energy
implementation described in Chapter two was modified and extended. The first
hypothesis related to the the protein rigidification can be tested by adding an
artificial protein rigidification restraint. Indeed, if the amino group would change
the protein rigidity it will not be able to further rigidify an already rigid protein
and, therefore, the non-additivity should be suppressed. In order to rigidify the
protein, a positional restraint potential was implemented and added to the relative
binding free energy code. The potential was applied on selected protein atoms
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and its implemented functional form is:
U(ri) = kp(ri − ri0) · (ri − ri0) , (5.2)
where ri is the position of a protein atom i, ri0 the selected space position to
restraint the atom i, the constant kp a parameter used to control the positional
restraint strength and the symbol “ · ” denotes the vectorial scalar product.
In a similar way, to test the second hypothesis related to the change in ligand
rigidity, restraint distances were applied between specific atom pairs. Indeed, the
addition of the amino group will not be able to further rigidify an already rigid
ligand and therefore the non-additivity should be suppressed if this was the cause.
Atom pairs were judiciously selected between the ligand and the protein and the
following restraining potential was applied between these pairs:
U(rij) = kd max(0, (rij − reqij )2 −D2ij) , (5.3)
where reqij is the selected restraint distance between atom pair i and j, rij the
atom pair distance, kd a parameter used to control the restraint distance strength
and Dij a distance parameter used to control when apply the restraint. This
approach was preferred to positional restraints to rigidify the ligands, because it
allows small fluctuations between interatomic distances during the simulations.
Finally, in order to test if the non-additivity is produced by changes in the
non-bonded interactions between the amino group in the 5 series and the solvent,
a new potential was implemented and applied between a selected ligand atom and
all the solvent atoms. The aim of the designed potential was to keep the solvent
molecules far from the ligand and, therefore, to reducing the electrostatic and
Lennard Jones interactions with the amino group. The functional form of the
implemented potential is as follows:
U(rpj) = kb(rpj −Db)2θ(Db − rpj) , (5.4)
where, p and j are respectively the selected ligand atom and a solvent atom, rpj
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the distance between atom p and atom j, kb a parameter used to control the force
strength applied between atom i and j, Db a penalised solvent atom distance and
θ the Heaviside function. In brief, this potential defines a spherical shield volume
centred on atom p with radius Db where solvent molecules are discouraged to
enter.
5.2 Validating the non-additivity hypotheses
In the considered H/I system the non-additivity is quantified by using equation
5.1. Additionally, the thermodynamic paths 5B → 5I and 3B → 3H (Figure 5.1)
present two single mutations each: 5B → 5I = 5B → 5A→ 5I and 3B → 3H =
3B → 3A→ 3H. As a consequence, equation 5.1 can be rewritten in terms of the
non-additivity along each single path as follows:
NAH/I = ∆∆G5B→5I −∆∆G3B→3H =
= ∆∆G5B→5A + ∆∆G5A→5I −∆∆G3B→3A −∆∆G3A→3H =
= ∆∆G5B→5A −∆∆G3B→3A + ∆∆G5A→5I −∆∆G3A→3H =
= NA1 +NA2 ,
(5.5)
where NA1 = ∆∆G5B→5A −∆∆G3B→3A and NA2 = ∆∆G5A→5I −∆∆G3A→3H
are the single non-additivity contributions along each path. The hypotheses re-
lated to the rigidity and/or ligand-solvent interactions changes have as final goal
to suppress the non-additivity in the system. Therefore, the previous equation
must suppress NAH/I = 0 which, in terms of single non-additivity components
NA1 and NA2 is translated into the following statement:
NAH/I = 0 ⇐⇒ NA1 = 0 and NA2 = 0 (5.6)
The analysis in this chapter was restricted to annihilate NA2 only. It is worth
to remember that to compute NA2 it is necessary to perform two alchemical
transformations and calculate the free energy changes required to mutate the
starting ligand into the final one respectively in the protein-binding site and in
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solvent Figure 4.7. In order to calculate the two relative free energy changes,
each system was assembled and set as detailed in Chapter § 4.2. The relative
free energy calculations were performed by using the implemented code, adding
the potentials detailed in the equations 5.2, 5.3 and 5.4. The main parameters
used in the calculations are detailed below. The transformations were performed
selecting 16 λ windows: (0.00000, 0.00616, 0.02447, 0.07368, 0.11980, 0.19045,
0.28534, 0.40631, 0.57822, 0.70755, 0.80955, 0.88020, 0.92632, 0.97553, 0.99384
and 1.00000). In order to circumvent steric clashes, a soft core potential was used
between atoms that can be created or annihilated as described in Chapter two.
The coulomb power and the delta shift soft-core parameters were respectively set
to 0 and 2. Free energy changes were calculated by using the FDTI method setting
the delta increment to ∆λ = 10−3. The TI integral was numerically estimated
by using a polynomial interpolation of seventh-order. In the production run each
window was sampled for 5 ns in the complex and solvent state by using the NPT
ensemble setting the pressure and the temperature respectively to 1 atm and
300 K. The pressure was regulated by using the Monte Carlo Barostat (101;102)
with an update frequency of 25 MD steps. The Andersen Thermostat (82) was
used to keep the temperature constant selecting a collision coefficient of 10 ps−1.
The simulations were performed by using the Leapfrog-Verlet integrator scheme
with 2 fs time step. All the bonds were constrained to their equilibrium distance
and the non-bonded interactions were evaluated by using an atom based cut off
scheme setting the cutoff distance to 10 Å . The electrostatic interactions were
calculated by using reaction field with the medium dielectric constant set to the
water dielectric constant (εsolvent = 78.3). 2.5 · 104 gradient values were collected
in a 5 ns simulation. In order to circumvent steric clashes at beginning of the
production run due to the equilibration stage performed on the starting mutant
only (λ = 0), each window was re-minimized for 500 steps and re-equilibrated.
This stage was performed by changing the coupling parameter between 0 and the
selected window in steps of 0.1. For each one of these values an equilibration of
2 ps with a 0.5 fs time step was performed, setting the pressure and temperature
respectively to 1 atm and 300 K. At the end of the re-equilibration stage the time
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step was re-set to 2 fs and no data was collected. All the simulations in complex
and solvent were repeated three times and the uncertainties were estimated as
standard error of the mean over the three independent runs. In this chapter,
the above detailed relative free energy protocol will be used to test the different
non-additivity origin hypotheses and it will be referred as the relative free energy
protocol.
In order to test the hypothesis related to the protein rigidification, the po-
tential energy expression detailed in equation 5.2 was applied on selected protein
atoms. In particular all the protein heavy atoms i.e. atoms with atomic mass
> 1.10 amu were restrained to their starting position by using a force constant
kp = 10 kcal mol−1 Å−2 (equation 5.2). In this case the ligand free simulations
were not influenced by the application of the positional restraints. A comparison
between the non-additivity computed by using or not protein positional restraints
is reported in Figure 5.2 while, Figure 5.3 (a) and 5.3 (b) shows the Thrombin
protein by colouring its atoms by using calculated B factors respectively for the
flexible and the restrained protein.
Although the experimental non-additivity level is not in agreement with the
predicted data in the selected system, the addition of positional restraints on
the protein heavy atoms seem able to suppress the non-additivity in the system.
This partial result could corroborate the experimental considerations of Baum et
al. (76) that suggested a binding site rigidification effect through B-factor analysis.
However, to prove or disprove this hypothesis, the calculation should be extended
to all the selected Thrombin inhibitors when their non-additivity prediction levels
will be in better agreement with the experimental data.
With the aim of validating also a possible ligand rigidification effect, restraint
distances implemented by using equation 5.3 were applied to selected ligand atoms
(intra-ligand restraints) and between ligand and protein atoms (inter-ligand re-
straints) to prevent orientational changes of the ligand respect to the protein. The
selected atom pairs are reported in Figure 5.4. The equilibrium distances reqij in
equation 5.3 were set as the starting distances between the selected atom pairs.
The restrained force constants were set to kd = 25 kcal mol−1 Å−2 while Dij
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Figure 5.2: A comparison between the Experimental (light blue), the Predicted
(red) and the Predicted (green) by using positional Restraints on the protein heavy
atoms in the system H/I. In both series the ligand A was selected as reference state.
The application of the positional restraints seems to suppress the non-additivity
in the system.
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Figure 5.3: A comparison between the B factors calculated for the un-restrained
5I complex system. (a) The B factor of the protein in complex with the ligand 5I
was calculated by measuring the rmsd of each atom along the trajectory selecting
as reference frame the average atomic positions recorded along the simuation. (b)
The B factor calculated as in (a) but restraining the protein heavy atoms. In
the scale the blue color indicates low B factor values and, therefore, rigid protein

























Figure 5.4: Atom pairs selected to apply restrain distances. A restraint distance
was applied between circled atoms with the same colour. Intra-ligand and inter-
ligand restraint distances were selected.
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(equation 5.3) was set to 0.2 Å. The calculation of non-additivity requires also
the simulations in solvent in this case and, the intra-ligand restraint distances il-
lustrated in Figure 5.4 were applied to the ligands only. Furthermore, the protein
heavy atoms in the complex simulations were restrained to their starting positions
by using the positional restraint potential detailed in the equation 5.2 with the
force constant kp = 10 kcal mol−1 Å−2. All the relative free energy calculations
with the addition of restraint distances and positional restraint potentials were
performed by using the relative free energy protocol previously detailed and, re-
sults are reported in Figure 5.5. The addition of the restraint distances seem to
Experimental
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ΔΔG5Ag5B - ΔΔG3Ag3H 
Figure 5.5: A comparison between the Experimental (light blue), Predicted (red)
and Predicted (green) by using positional Restraints on the protein heavy atoms
and applying restraint distances between selected atom pairs (Figure 5.4) in the
H/I system. In both series the ligand A was selected as reference state. In this
case a positive cooperativity appears in the system.
have an impact on the non-additivity, increasing its value from nearly 0.0 to +0.7
kcal/mol compared to the case with just positional restraints (Figure 5.2). How-
ever, this effect could be caused by the problematic convergence recorded for the
transformation 5I → 5A in the complex state as illustrated in Figure 5.6. Indeed,
the window values λ = 0.19045 and λ = 0.28534 present convergence problems.
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Figure 5.6: Free energy gradient related to the 5I → 5A alchemical mutation
in complex state recorded over three independent runs. The windows λ = 0.19045
and λ = 0.28534 present poor convergence that could produce a significant error
in the numerical integration and therefore a poor non-additivity estimation.
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In this case, the whole free energy gradient undergoes a significant energy change
between its extreme values (λ = 0 and λ = 1.0) and poor convergence in some win-
dow values could produce a significant error in the numerical integration used to
compute the free energy changes. Therefore, the non-additivity increment could
be a false positive effect and further investigations are required to clarify this
result.
The final hypothesis tested was related to the change in the non-bonded in-
teractions between the amino group introduced in the 5 series and the solvent. In
order to limit these interactions and suppress the non-additivity in the system,
the potential in equation 5.4 was implemented. The main effect of this poten-
tial is to create a spherical volume around the ligand where solvent molecules
are discouraged to enter. The simulated spherical potential was centred on the
ligand atom illustrated in Figure 5.7 with a radius of Db = 7 Å. The potential








Figure 5.7: In green the ligand atom selected to apply the potential described in
equation 5.4. This atom interacts with all the solvent atoms creating a spherical
volume where solvent atoms are penalised to enter and, therefore, limiting the
non-bonded interactions between ligand and solvent.
was applied on both complex and solvent simulations for the mutations 5I → 5A
and 3H → 3A. Furthermore, positional restraints and restraint distance poten-
tials were also applied and set as detailed for the other hypotheses. The relative
free energy simulations were performed by using the relative free energy protocol
already described and results are reported in Figure 5.8. In order to check if the
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ΔΔG5Ag5B - ΔΔG3Ag3H 
Figure 5.8: A comparison between the Experimental (light blue), Predicted (red)
and Predicted (green) by using positional Restraints on the protein heavy atoms,
applying restraint distances between selected atom pairs (Figure 1.4) and creating
a penalised solvent volume around the ligand in the H/I system. In both series
the ligand A was selected as reference state. In this case the non-additivity seems
to reappear in the system.
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spherical potential was effectively limiting the non-bonded ligand interactions the
cumulative averages of the number of solvent molecules around the ligand were
calculated by post-processing the simulated trajectories. Figure 5.9 reports an
example of the calculated cumulative averages and Figure 5.10 reports a compar-
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Figure 5.9: A comparison between the cumulative average of the solvent molecule
number around the ligand recorded along the complex state mutation 5I → 5A
selecting the window λ = 0.0. The green line represents the system where all the
potentials detailed by equations 5.2, 5.3 and 5.4 are considered and the red line
the system without them. The radius parameter in equation 5.4, which defines the
penalised solvent spherical volume was set to Db = 7 Å in this case.
The predicted non-additivity level (Figure 5.8) is significant in this case and
seems to reach the same level produced without the application of the potentials
5.2, 5.3 and 5.4. This behaviour can only be explained in terms of noisy and
not converged alchemical simulations, which prevent the correct quantification
of the non-additivity in the system. Figure 5.11 reports the different gradients
recorded for all the mutations involved in the non-additivity calculations related
to the system H/I considering A as reference state. In at least two mutations
3H → 3A in the solvent state and, 5I → 5A in the complex state there are
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Figure 5.10: Two snapshots extracted from two alchemical mutations of 5I → 5A
selecting the window λ = 0.0. In (a) and (b) the potentials 5.2, 5.3 and 5.4
where respectively not used and used during the simulations. Part of the Thrombin
protein binding site is illustrated by using a grey shaded surface, while red spheres
are used for oxygen water atoms. The transparent blue sphere represents the
penalised solvent region. In (a) more water molecules are recorded compared to
(b) as expected.
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serious convergence problems in many window values. A first recognised problem
in the noisy complex simulation 5I → 5A seems to be caused by the dehydration
volume created around the ligand. In this volume, the positive charged amino
group does not have to electrostatically interact with the polar water molecules
and, in many simulations seems to form an intra-electrostatic interaction with one
of the two-ligand oxygen as illustrated in Figure 5.12. Probably, selecting extra
restraint distances could have mitigated this behaviour. Another source of noise
in the system could be caused by the effect of the reaction forces on the ligand
produced by the pressure of the water molecules. Indeed these forces are applied
on the selected ligand atom to centre the sphere potential as illustrated in Figure
5.7. It is difficult to quantify this effect but, in the complex state simulations
the water pressure should further buried the ligand in the binding site due to the
system anisotropicity while, the effect should be less pronounced in the solvent
state simulations due to the system isotropicity.
5.3 Chapter Conclusions
In this chapter a rationalisation of the non-additivity origins in the Thrombin
system was attempted by analysing the non-additivity in specific inhibitors of
Thrombin. Three hypotheses were tested related to an entropic effect of rigidifi-
cation of the protein/ligand and an enthalpic contribution caused by changes in
ligand-solvent interactions. With the aim of validating these hypotheses, three
computational experiments were attempted to suppress the non-additivity in the
considered systems. However, the obtained results were not able to clearly prove or
disprove the hypotheses although, the protein rigidification was able to remove the
non-additivity in the system. The other two hypotheses presented computational
problems with the convergence of the free energy gradient and with unexpected
binding mode changes to fix and future work is required to validate their reliable
application to elucidate non-additivity. This chapter is a first effort to rationalise
the origins of non-additivity in Thrombin, while non-additivity was suppressed
with the use of a rigid protein protocol, more work is needed to confirm this effect
also applies to every ligand in the considered data set. The following chapter will



























































Figure 5.11: Free energy gradients for the considered alchemical mutations in
complex and solvent states recorded over three independent runs. In this case,
the protein and the ligands were restrained by applying potentials 5.2, 5.3 while,
the ligand-solvent interactions were limited by creating a penalised solvent volume
around the ligand by using the potential 5.4. The mutations 5I → 5A in complex
state and 3H → 3A in solvent state present convergence issues in many window
values and, therefore, the predicted non-additivity is unreliable.
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Figure 5.12: The intra-molecular distance between one of the hydrogen of the
amino group in the 5I ligand and one of the indicated ligand oxygen atoms recorded
along the complex state simulation 5I → 5A for the window value λ = 0 applying
the implemented potentials 5.2, 5.3 and 5.4. The dehydrated volume produced by
the potential 5.4 facilitates and intra-molecular interaction changing the binding
mode of the ligand along the simulation and producing noisy gradient values.
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summarise and give conclusions on the whole thesis work.
6
Conclusions
In the pharmaceutical industry the use of computational methods has significantly
increased in the last 25 years. In-silico methods have made meaningful contri-
butions in the drug discovery and development process such as lead generation,
lead optimization, prediction of drug likeness, de novo design, ligand docking,
modulation of ADME and toxicity. However, the precise determination of the
binding affinity and its entropic and enthalpic components is still considered the
“Holy Grail” of computational chemists (137). The main factors that discourage
the routine use of molecular simulations to support medicinal chemist workflows
are computational cost, inaccuracy and setup difficulties. To be useful, a com-
putational prediction should be performed quicker than the related experimental
measurement. In the statistical mechanics framework, the computation of the
binding affinity requires the sampling of many configurations of a protein-ligand
complex to ensure that the ensemble average produces results comparable with the
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experimental measurements. This requirement could be very difficult to achieve
for biomolecular systems because of the high number of degree of freedoms in-
volved in the simulations. Inaccuracies in the binding affinity prediction are often
correlated to molecular models used to describe biomolecular systems. Force field
parameters are often optimised to predict specific properties for specific classes of
molecules and they could in principle fail to predict other properties when they
are applied on molecular systems that differ from a training set. In addition many
computational models used to simulate biomolecular systems neglect important
aspects such as polarizability or changes in covalent interactions. Currently, the
calculation of binding affinity by molecular simulations seems to be more an “art to
master” than a standardised protocol to use. The modern computational chemist
needs to be a skilled computer scientist in addition to being a “clever observer”,
“modeller” and “result analyst” of the underlying physico-chemical processes. The
use of many configuration files, terminal applications and operating system knowl-
edge are required and the learning curve might be very steep indeed. The above
reasons are just the main problems to overcome before pharmaceutical companies
will consider binding affinity calculations by molecular simulations a valuable and
effective new way for the development of new drugs.
This thesis aims to address the issue of computational cost of binding affinity
calculations by delivering a new tool for the calculation of relative binding affini-
ties, allowing larger compound data sets to be studied in a reasonable time. This
was achieved by merging two pieces of software: Sire and the OpenMM APIs. The
former is a flexible molecular modelling framework for bio-molecular modelling,
enabling easy definition and editing of molecular parameters and implementation
of new molecular simulation methods. On the other hand, the OpenMM APIs
are able to perform efficient MD simulations on modern specialised hardware such
as GPUs. The resulting implementation is flexible and quick enough to compu-
tationally explore “new science” which lacks in alternative commercial software
packages. Frequently such software packages are restricted to predefined and rigid
simulation schemes, which do not fit in the scientific research context where many
new ideas need to be tested and validated.
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Chapter two described the relative free energy implementation. This is based
on alchemical transformations and in particular on the single topology method.
This technique uses a shared scaffold to transform a ligand into another. Bonded
and non-bonded force field parameters are linearly interpolated between the start-
ing and final ligand force field parameters by using the coupling parameter ap-
proach. The single topology method is used in conjunction with the FDTI method
to calculate free energy gradients over a selected set of coupling parameter values
to be numerically integrated and to calculate the free energy change associated
with the ligand transformation. In the implementation, three categories of atoms
were defined to perform the mutation: “to dummy”, “from dummy” and “hard”
atoms. These atom groups respectively represent atoms that can disappear, ap-
pear or be consistently present along the alchemical mutation. The presence of “to
dummy” and “from dummy” atom groups might produce numerical instabilities
along the alchemical simulations and, therefore, the non-bonded interactions were
softened in the implementation by using a soft-core potential. The implementa-
tion was initially tested on 100 alchemical mutations in vacuum to perform single
point energy calculations. Subsequently, relative free energies of solvation of many
small molecules were evaluated. The results were in agreement with experimental
data.
Chapter 3 investigated from a computational point of view the effect of molec-
ular flexibility on conformational equilibria of a set of molecules with two main
moieties linked together by flexible carbon chains. These molecules can exper-
imentally adopt different conformers in chloroform solution and, in particular,
they are able to form an intra-molecular hydrogen bond. Experimentally the free
energy change between a “folded” state where the intra-molecular hydrogen bond
was formed and an “unfolded” state where the hydrogen bond was broken was
measured for different lengths of the carbon chain. Computational simulations
modelled the experimental setting, trying to reproduce the free energy change
between the “folded” and “unfolded” states by using molecular dynamics sim-
ulations. In the computational setting a major problem was the derivation of
parameters and, in particular, the charge calculations. The AM1-BCC charge
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method was not able to accurately reproduce the experimental data and the CM5
charge method was preferred. However, results were not in good agreement with
the experimental data. In many cases the source of discrepancy was related to
the different sensitivity between the experimental and computational model be-
tween the “folded” and “unfolded” populations. In order to improve the results,
other force field parameters were changed such as Lennard-Jones and torsional
parameters. The results showed that these parameters do not have a significant
impact on the computed free energies. The charge calculation seems to have the
greatest impact on the simulations, and the use of more advanced models such
as polarizable force fields may improve the agreement between predictions and
experimental data.
In the lead optimisation stage iterative SAR studies are performed to improve
the binding affinity of promising hits. However, this process is particularly diffi-
cult. The main causes are related to the optimisation of the entropic and enthalpic
contributions. Binding enthalpy optimisation is notoriously difficult to improve
and it depends on the optimisation of VdW forces/hydrogen bonds and desolvation
of polar groups. On the other hand, entropic optimisations are related to confor-
mational entropy changes and solvation entropy. One of the main simplification
introduced in the routine workflow of medicinal chemists is the additivity of the
binding affinity i.e. the assumption that free energy can be decomposed into sum
of independent components ascribed to specific parts of a system. Chapter four
investigated a series of congeneric inhibitors of the Thrombin protein that present
non-additivity behaviour. The implemented code was applied to the calculation
of the relative binding affinities of two series of Thrombin inhibitors named the
3 and 5 series. Results were in in good agreement with the experimental data
in many cases and in order to quantify the level of agreement and in-depth error
analysis was conducted between the experimental and the predicted data by using
different statistical quantities such as the coefficient of determination (R2), the
mean unsigned error (MUE) and the predictive index (PI). The error analysis
showed that the predicted statistical quantities are in the selected error analysis
confidence interval and, on average, the experimental and predicted data of the
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5 series are quantitatively better than the 3 series. Although the accuracy of
the predicted binding affinities is significant, the prediction of the non-additivity
levels among the thrombin inhibitors was poor. One of the main issues is the
systematic underestimation of the binding affinity in the 3 series compared to
the 5 series, which could be related to force field parameterisation problems, and
further investigations are required to prove or disprove this point.
Even though the predicted non-additivity levels were poor, in at least one
system the predicted level was comparable with the experimental data and, the
non-additivity origins were analysed for this system only. In order to address
the possible non-additivity sources three hypotheses were suggested i.e. changes
in the protein or ligand flexibilities or changes in the ligand-solvent interactions.
With the aim of testing these hypotheses, three computational experiments were
designed with the goal to suppress the non-additivity present in the system. In a
first computational experiment, the protein was rigidified by applying positional
restraints to selected protein atoms and results showed that the non-additivity was
suppressed from the system. A second computational experiment rigidified the lig-
ands by using distance restraints applied between selected atom pairs, while a final
experiment tried to limit the ligand-solvent interactions by defining a penalised
solvent volume around the ligands. Unfortunately, difficulties with convergence
of the calculated free energies biased these two last computational experiments
and, therefore, it was not possible to clearly prove or disprove their impact on the
selected system. Although the protein rigidification setup succeeded in suppress-
ing non additivity for just one studied system, this could suggest that changes
in the protein flexibility might be the origin of the non-additivity in the Throm-
bin inhibitors, and this would corroborate with the experimental observation of a
binding site rigidification as evidenced by B factor measurements.
An initial goal of this thesis was also to develop a computationally efficient rel-
ative free energy implementation; however, benchmarks have not been presented
so far. An in-depth analysis of the code speed-up has not been performed. In
the end, the research project focused more on result correctness than a pure code
optimization. Sire and the OpenMM APIs have been extensively tested and op-
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timised and the implementation speed-up relies on these two software packages.
Indeed, the ultimate goal was to merge the two pre-existing codes. However,
in the code interface particular attention was taken to handle efficiently system
creations and trajectories storing to avoid bottlenecks. The solvated Thrombin
system presented on average 34 ·103 atoms; it was possible to run relative binding
affinity calculations by using two different GPU architectures. Roughly speak-
ing the time required to run 10 ns simulation per window on an NVidia M2090
GPU card was approximately 14 hours while the time was nearly halved by using
a more recent GPU architecture such as the NVidia K20. This result is quite
encouraging. The same piece of code applied on the same system and tested on
two architectures (the former ca. 3 year older than the latter), was able to half
the computational time. This suggests that the computational cost is no longer
a problem in the binding free energy calculations context and efforts should ad-
dress other problems. It was not possible to make a comparison between CPU
versus GPU benchmarks but it is the author’s opinion that this is an unrealistic
comparison. Architecturally, the CPU is composed of only few cores with lots
of cache memory that can handle a few software threads at a time. It is also
designed to handle interrupts, virtual memory and storage, which are required
by the modern operating systems to perform most of the processing in everyday
computing. In contrast, a GPU is composed of hundreds of cores that can handle
thousands of threads simultaneously. Modern GPUs are capable of performing
vector operations and floating-point arithmetic, with the latest cards that full
support double-precision floating-point arithmetic and make them most suited to
highly parallelizable operations such as in scientific computing. However, a com-
parison should be possible on their effective market cost. Gaming GPUs that can
be used to perform scientific calculations have on average the same market cost of
a server CPU solution but benefiting of speed-up of 100 times in many scientific
computing applications.
The implementation calculates relative binding free energies and not absolute
binding free energies. Usually, the computation of a relative free energy of binding
is thought to be more efficient compared to an absolute free energy of binding.
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This is partly due to the hope that in the hypothesis of incorrect sampling for both
ligands the errors in the difference will vanish, but in general, this cancellation
of errors cannot be taken for granted. In addition, in the SAR stage there is
the need to compare the binding affinity of prominent hits and therefore in drug
development and discovery process this quantity is more significant to enhance
the medicinal chemist workflow. In the studied Thrombin inhibitors the predicted
order potency assessed by using the PI index was quite significant for both the
examined series with a value greater than 0.9 (−1 6 PI 6 1).
The implemented code is based on the single topology method where bonded
and non-bonded parameter terms are interpolated between a starting a final lig-
and by using a coupling parameter technique. On the other hand, in the dual
topology method both ligands are present at the same time; the interatomic in-
teractions are gradually scaled between the ligands and the environment by using
the coupling parameter such that at the beginning and in the end of the ligand
transformation it is respectively present the starting and final ligand only. An
advantage of the single topology method is that the perturbation is localized and
it should produce faster convergence. On the other hand, the two ligands need to
be structurally similar while, in the dual topology they can be arbitrarily differ-
ent. The soft-core potential is extremely useful to mitigate numerical instabilities
in simulations where atoms can appear or disappear. However, its correct setting
might be very difficult in some simulations. For instance, in one of the Thrombin
inhibitor mutation a monoatomic ion in solution was trapped by one “to dummy”
carbon atom. The problem was related to the quicker softening of LJ interactions,
compared to the softening of the Coulombic interactions. The selected decoupling
schedule gave reasonable results in most of the simulated system, but it is hard
to find a general protocol. A possibility is to decouple the LJ and the Coulomb
terms in two separate simulations however, this would double the computational
time.
A key point of the implementation is its flexibility. During the entire project
the code was many time extended to explore new methods, for instance the imple-
mentation of distance restraints or the application of a penalized solvent volume
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around the ligand in the Chapter five. The definition of interaction groups in Sire
and OpenMM is very easy and allows simulations that would be very difficult to
implement with other simulation packages. Another advantage of this implemen-
tation is that the sampling of a molecular system can be done by using MD and
MMC. The hybrid method could gain from both the previous techniques. The
size of the time step in the MD method is a significant drawback, which affects
its accuracy; large time steps can break the convergence as well as the energy
conservation in isolated systems. On the other hand, the movement of all the
particles in one integration step is an advantage. MMC is not deterministic and,
as a consequence, the generation of new moves can be completely arbitrary; the
only restriction is in respect of the detailed balance equation. Hybrid MD-MMC
relaxes the restriction on the size of the time step. A high value will produce a
“bad movement” in the phase space of MD simulations but if the resulting con-
figuration is subjected to a Metropolis acceptance test the canonical ensemble is
preserved. Furthermore, by using MD to generate moves the system tends to
move in regions of configuration space with lower energy and hence moves are
more “clever” than simple displacements. The implementation of the hybrid code
would be not particular difficult at this stage of the project. Sire is able to perform
fast MMC moves and OpenMM is able to perform fast MD moves. Therefore, the
code already presents an advanced infrastructure where to build an extension to
support hybrid MD-MMC. This would be best accomplished by writing Sire ob-
jects in C++ that requires adequate programming expertise, but fortunately once
written, the Sire object classes are accessible to non-expert users via a Python
front end.
In conclusion, the author is confident that the broad aim of this research
project has been achieved. An efficient implementation of relative binding affin-
ity calculation protocols by molecular simulations has been developed and made
available to the scientific community. The software has been extensively tested
by applications on different biomolecular systems, such as the Thrombin enzyme,
showing good agreement with experimental data even though the origins of non-
additivity effects in this system needs further investigations. In general, software
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tools should be used to help researchers to test new ideas and simplify their rou-
tinely work. There have already been examples where the code was used not just
in the hands of the thesis author. The code was involved in the validation of an
implementation of the Grid-Cell theory resulting in a publication (138). In addi-
tion, recently, the implementation was extended to support the GLYCAM force
field and, binding free energy calculations of protein-carbohydrate complexes were
performed producing good agreement with experimental data (139). To summarise,
the implementation is flexible enough to test and validate new ideas in free energy
calculations and overall in molecular simulations.
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Wilfred F. van Gunsteren. Avoiding singularities and numerical instabilities
in free energy calculations based on molecular simulations. Chemical Physics
Letters, 222(6):529–539, 1994.
[62] Gerhard Hummer, Lawrence R. Pratt, and Angel E. Garćıa. Free Energy
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[139] Sushil K. Mishra, Gaetano Calabró, Hannes H. Loeffler, Julien Michel, and
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